lamivudine has been researched along with Hepatitis B Virus Infection in 1171 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 102 (8.71) | 18.2507 |
| 2000's | 706 (60.29) | 29.6817 |
| 2010's | 333 (28.44) | 24.3611 |
| 2020's | 30 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Gochfeld, DJ; Hamann, MT | 1 |
| Hosmane, RS; Korba, BE; Zhang, N; Zhang, P | 1 |
| Chen, JJ; Cheng, P; Jiang, ZY; Ma, YB; Zhang, FX; Zhang, Q; Zhang, XM | 1 |
| Huang, RL; Janmanchi, D; Lin, CH; Tseng, YP; Wang, KC; Yeh, SF | 1 |
| Coughlin, JE; Govardhan, CP; Green, CE; Iyer, RP; Kirk, CJ; Korba, BE; Mirsalis, J; Morrey, JD; O'Loughlin, K; Padmanabhan, S; Zhang, G | 1 |
| Cen, S; Han, YX; He, HW; Hong, B; Jiang, JD; Kreiswirth, B; Li, BW; Li, ZR; Liu, F; Peng, ZG; Perlin, D; Shao, RG; Song, DQ; Sun, CH; Wang, YP; You, XF; Yu, LY; Zhao, LX | 1 |
| Feng, CL; Lu, W; Luo, Y; Tang, W; Wang, GF; Yang, L; Yao, JP; Zuo, JP | 1 |
| Duan, WH; Qu, SJ; Tan, CH; Wang, GF; Yao, SY; Zhu, DY; Zuo, JP | 1 |
| Campos, RH; Cavallaro, LV; Gagey, D; Lantaño, B; Moglioni, AG; Moltrasio, GY; Ugliarolo, EA | 1 |
| Agrawal, B; Kumar, R; Liang, C; Shakya, N; Tyrrell, DL; Vedi, S | 1 |
| Han, A; Hou, L; Li, L; Luo, X; Qi, X; Qing, K; Shi, S; Ye, F | 1 |
| Wang, G; Zhang, F | 1 |
| Chang, YC; Chou, BH; Huang, TJ; Kuo, YC; Lin, SJ; Yang, CL; Yang, LM | 1 |
| Chang, J; Kang, J; Niu, P; Peng, Y; Qiao, Y; Wan, N; Wang, Q; Wang, SQ; Wang, XJ; Wu, J; Yang, Q; Yu, W; Zheng, L | 1 |
| Chang, J; Liu, B; Liu, Y; Lu, J; Ma, H; Peng, Y; Qiao, Y; Song, C; Wang, J; Wu, J; Yu, W | 1 |
| Chen, X; Cheng, W; Li, X; Lin, W; Liu, H; Lu, F; Wang, J; Zhang, H | 1 |
| Gu, X; Guan, M; Li, X; Qiu, J; Zhang, Y; Zhou, Q; Zou, Y | 1 |
| Chen, WC; Cheng, JS; Kao, SS; Li, YD; Li, YR; Lin, HS; Lu, CM; Sun, WC; Tsai, TJ; Tsai, WL; Tsay, FW; Wang, HM; Yin, CH | 1 |
| Musyoki, SK; Onyango, DM; Wandera, BO | 1 |
| Chen, Y; Huang, H; Lai, X; Lan, J; Lu, Y; Luo, Y; Ni, L; Shi, J; Si, T; Tan, Y; Wu, Y; Ye, B; Yu, J; Zhao, Y; Zhu, P | 1 |
| Anderson, M; Badal-Faesen, S; Bhattacharya, D; Chinula, L; Cloherty, G; Gaseitsiwe, S; Hawkins, C; Holzmayer, V; Kang, M; Kuhns, M; Lama, J; Matining, R; Mulinda, N; Murphy, R; Peters, M; Samaneka, W; Sugandhavesa, P; Thio, C | 1 |
| Dieterich, D; Roediger, R; Smyth, EK | 1 |
| Bhat, R; Jayaram, B; Kiruthika, S; Vivekanandan, P | 1 |
| Araujo, NM; Araújo, ORC; da Motta de Mello, V; de Almeida Ribeiro, CR; de Paula, VS; Lewis-Ximenez, LL; Martinelli, KG; Spitz, N | 1 |
| Chandiwana, P; Duri, K; Gumbo, FZ; Marere, T; Mataramvura, H; Mazengera, LR; Mazhandu, AJ; Munjoma, PT | 1 |
| Gao, S; Gui, X; Ke, H; Xiong, Y; Yang, R | 1 |
| Bai, X; Qian, X; Su, C; Yang, X; Zhao, P | 1 |
| Huang, YS; Hung, CC; Ko, WC; Lee, YC; Lee, YT; Li, CW; Lin, JJ; Lin, KY; Lin, SP; Liu, CE; Tang, HJ; Wang, NC; Yang, HJ | 1 |
| Buzo, BF; de Seixas Santos Nastri, AC; Marques Rossetti, RA; Mendrone-Júnior, A; Ramos, JF; Rocha, V; Salles, N | 1 |
| Kogure, T; Niizuma, K; Ogawa, Y; Tominaga, T | 1 |
| Cai, H; Duan, X; Fu, D; Gao, X; Hu, Y; Kang, K; Li, Z; Liu, M; Yi, W; Zhou, M | 1 |
| Choi, YM; Kim, BJ; Kim, H; Lee, SA; Lee, SY | 1 |
| Astbury, S; Costa Nunes Soares, MM; Irving, WL; Jalal, P; Jardim, ACG; King, B; McClure, CP; Peprah, E; Sabeer, FT; Saeed, CH; Shimizu, JF; Tarr, AW | 1 |
| Amponsah-Dacosta, E; Blackard, JT; Burnett, RJ; Gededzha, MP; Kyaw, T; Lukhwareni, A; Mphahlele, MJ; Selabe, SG | 1 |
| Chan, A; Cheung, TT; Chu, KW; Dai, WC; Fung, J; Lo, CM; Ma, KW; Mak, LY; Seto, WK; She, WH; Sin, SL; Wong, T; Yuen, MF | 1 |
| Cai, WP; Deng, XZ; Hu, FY; Lan, Y; Li, F; Li, LH; Nie, Y | 1 |
| Boye, CS; Chemin, I; Cissé, AM; Cohen, D; Diop-Ndiaye, H; Dramé, A; Kébé-Fall, K; Laborde-Balen, G; Lô, G; Mboup, S; Ndiaye, AJS; Pujol, FH; Taverne, B; Touré-Kane, C; Toyé, RM | 1 |
| Chan, HLY; Gaggar, A; Ganova-Raeva, L; Khudyakov, Y; Kitrinos, K; Lara, J; Thai, H; Xia, GL; Xu, X | 1 |
| Dunn, D; Gilks, C; Gilson, R; Hakim, J; Kaleebu, P; Kityo, C; Musoro, G; Pillay, D; Price, H; Vudriko, T | 1 |
| Shen, M; Sun, X; Wang, B; Wang, C; Xu, H; Yang, X; Zhu, K | 1 |
| Asaftei, SD; Biasin, E; Calvo, PL; Carpino, A; Catalano, S; Cisarò, F; Dell'Olio, D; Fagioli, F; Opramolla, A; Peruzzi, L; Pinon, M; Pizzol, A; Quarello, P; Rigazio, C | 1 |
| Enomoto, M; Kawada, N; Nishiguchi, S; Tamori, A; Yoshida, K | 1 |
| Kuczaj, A; Przybyłowski, P; Warwas, S; Zembala, M | 1 |
| Chen, J; Fan, Y; Qi, J; Shen, Y; Wang, Y; Wu, D; Xu, Y | 1 |
| Chayama, K; Chung, TL; Dahari, H; Durso-Cain, K; Ishida, Y; Perelson, AS; Reinharz, V; Tateno, C; Tsuge, M; Uprichard, SL | 1 |
| Khamadi, SA; Lihana, RW; Mabeya, SN; Ngugi, C; Nyamache, AK | 1 |
| Buzzetti, E; Davidson, BR; Gurusamy, KS; Mantzoukis, K; Rodríguez-Perálvarez, M; Thorburn, D; Tsochatzis, E | 1 |
| Deng, J; Li, T; Li, Y; Su, MZ; Wang, QY; Wang, S; Xiang, KH; Xu, XZ; Zhao, CY; Zhuang, H | 1 |
| Lao, XM; Lin, GL; Miao, B | 1 |
| Gane, EJ | 1 |
| Gore, ML; Jatta, A; Lemoine, M; Ndow, G; Njie, R; Sabally, S; Sadiq, F; Shimakawa, Y; Sow, A; Suso, P; Tamba, S; Thursz, MR; Touré-Kane, C | 1 |
| Chen, CL; Li, WF; Lin, CC; Lin, LM; Lin, TL; Lin, YH; Loh, PY; Wang, SH | 1 |
| Ahir, BK; Li, LQ; Wu, GB; Zhang, CY; Zhong, JH | 1 |
| Battisti, A; Cerretti, R; Cerva, C; Colagrossi, L; Cudillo, L; Maffongelli, G; Mariotti, B; Salpini, R; Sarmati, L; Svicher, V | 1 |
| Agarwal, A; Alexander, PE; Chang, Y; Foroutan, F; Guyatt, GH; Hepworth, E; Lee, Y; Lesi, O; Mah Ming, J; Merglen, A; Mir, H; Mirza, R; Siemieniuk, RA; Zeraatkar, D; Zhang, Y | 1 |
| Cathcart, AL; Delaney, WE; Kitrinos, KM; Liu, Y | 1 |
| Chang, CS; Lee, SW; Lee, TY; Li, YC; Liao, YJ; Wu, CY; Yang, SS; Yeh, HZ | 1 |
| Adinolfi, LE; Boemio, A; Capoluongo, N; Coppola, N; D'Amore, C; Esposito, M; Guastafierro, S; Macera, M; Marrone, A; Mastrullo, L; Minichini, C; Onorato, L; Pisaturo, M; Rinaldi, L; Sagnelli, E; Siniscalchi, I | 1 |
| Aw, PPK; Burkholder, WF; de Sessions, PF; Hibberd, M; Hong, LZ; Hong, S; Hue, S; Li, CH; Lim, SG; Nagarajan, N; See, LX; Wilm, A; Zhu, YO | 1 |
| Han, Z; Huang, M; Liu, J; Shi, H; Xia, J; Xue, J; Zhang, S; Zhu, Z | 1 |
| Endo, T; Ito, K; Saitoh, S; Sugiura, T; Suzuki, M; Tajiri, H; Tanaka, Y; Wakano, Y | 1 |
| Arshad, B; Chen, HR; Dai, W; Kong, LQ; Li, X; Wu, H; Wu, KN; Wu, YT; Xu, Z | 1 |
| Arai, M; Fujiwara, K; Haga, Y; Kanda, T; Kato, N; Nakamura, M; Oda, S; Yasui, S; Yokosuka, O; Yonemitsu, Y | 1 |
| Padma, UD; Surendran, S; Udayakumar, VP | 1 |
| Chen, Q; Liu, W; Liu, YT; Wang, FL; Zhu, GY | 1 |
| Andersson, MI; Chotun, N; Maponga, TG; Nel, ER; Strobele, S | 1 |
| Abdou Chekaraou, M; Anglaret, X; Boyd, A; Danel, C; Delaugerre, C; Eholié, SP; Gabillard, D; Lacombe, K; Mahjoub, N; Maylin, S; Moh, R; Zoulim, F | 1 |
| Butler, EK; Cloherty, GA; de Medina, M; Gersch, J; Holzmayer, V; Kuhns, M; Luk, KC; McNamara, A; Schiff, E | 1 |
| Alkım, C; Alkım, H; Colak, T; İyisoy, MS; Karayakar, F; Koksal, AR; Sahin, M; Şen, İ; Yetim, A | 1 |
| Calò, F; Coppola, N; Di Caprio, G; Martini, S; Pisaturo, M; Portunato, F | 1 |
| Jiang, X; Luo, A; Ren, H | 1 |
| Han, Y; Xia, S; Zhou, J | 1 |
| Angelucci, E; Bruzzone, B; Caligiuri, P; Di Grazia, C; Dominietto, A; Gualandi, F; Lamparelli, T; Mikulska, M; Nicolini, LA; Viscoli, C; Zappulo, E | 1 |
| Baldini, L; Corradini, P; Facchetti, F; Farina, L; Goldaniga, M; Grossi, G; Labanca, S; Lampertico, P; Loglio, A; Lunghi, G; Pompa, A; Rumi, M; Viganò, M | 1 |
| Chen, QY; Fang, ZL; Harrison, TJ; Hu, LP; Jia, HH; Li, KW; Liang, SJ; Ren, CC; Wang, C; Wang, XY; Yang, QL | 1 |
| Naing, C; Poovorawan, Y; Tong, KS | 1 |
| Bell, TG; Kramvis, A; Singh, L; Yousif, M | 1 |
| Agyingi, K; Domkam, I; Joyce, AN; Keou, CK; Mbu, RE; Moudourou, S; Nanfack, A; Njefi, K; Sosso, S; Takang, W; Takou, D; Torimiro, JN | 1 |
| Foaud, HM; Gmal El Din, A; Mahmoud, F; Maklad, S | 1 |
| Gao, X; Jia, J; Li, M; Li, T; Liu, W; Ma, N; Tang, L; Yan, L; Yang, L; Yu, F; Zhang, X | 1 |
| Li, T; Lin, C; Qu, Y; Wang, L; Wang, Y; Yang, B | 1 |
| Dong, Y; Liu, W; Wang, L; Zhao, P; Zhu, S | 1 |
| Beggel, B; Kaiser, R; Neumann-Fraune, M; Pfister, H; Verheyen, J | 1 |
| David, E; Marengo, A; Marzano, A; Rizzetto, M | 1 |
| Angus, PW; Gane, EJ; McCaughan, GW; Patterson, S; Strasser, SI | 1 |
| Chen, Y; Gao, Z; Han, Y; Han, Z; Jia, G; Li, C; Liu, J; Luo, G; Shi, Y; Xia, L; Yin, F; Zhou, X; Zhu, J | 1 |
| Gupta, S; Healy, SA; Melvin, AJ | 1 |
| Cheung, KW; Seto, MT; Wong, SF | 1 |
| Gatanaga, H; Hayashida, T; Oka, S; Tanuma, J | 1 |
| Özenirler, S; Sucak, GT; Suyanı, E; Yaşar, DG | 1 |
| Bohorquez, HE; Bruce, DS; Carmody, IC; Cohen, AJ; Girgrah, N; Joshi, S; Loss, GE; Mason, AL; Reichman, TW; Therapondos, G | 1 |
| Cook, L; Day, SL; Graham, SM; Jerome, KR; Kim, HN; Mandaliya, KN; Masese, LN; McClelland, RS; Odem-Davis, K; Scott, J | 1 |
| Brown, RS; Brubaker, WD; Chang, MS; Emond, JC; Guarrera, JV; Olsen, SK; Pichardo, EM; Rosenthal-Cogan, L; Stiles, JB | 1 |
| Jiang, B; Li, L; Li, ZF; Song, SB; Xiu, DR; Yuan, CH; Zhang, TL | 1 |
| Angeletti, C; Antonucci, G; Armignacco, O; Cassola, G; De Stefano, G; Girardi, E; Grossi, P; Mazzotta, F; Orani, A; Pagano, G; Petrosillo, N; Puoti, M; Sagnelli, C; Sagnelli, E | 1 |
| Chen, GC; Chen, QK; Huang, KH; Min, XH; Qing, Q; Su, H; Yu, T; Yuan, YH; Zhan, J; Zhao, LN | 1 |
| Hu, RH; Lee, CY; Lee, PH; Tsai, MK; Yang, YW | 1 |
| Chew, E; Seymour, JF; Thursky, K | 1 |
| Goyal, N; Gupta, S; Kumar, A; Taneja, S; Wadhawan, M | 1 |
| Alessio, L; Brunetto, M; Cavallone, D; Colombatto, P; Coppola, N; Messina, V; Moriconi, F; Pisaturo, M; Sagnelli, C; Sagnelli, E; Tonziello, G | 1 |
| Chen, Y; Li, LJ; Lv, GC; Sheng, JF; Yang, YD; Yao, JM; Zheng, L | 1 |
| Botes, ME; Hamers, RL; Hoepelman, AI; Ive, P; Rinke de Wit, TF; Sigaloff, KC; Siwale, M; Stevens, WS; Wallis, CL; Zaaijer, HL | 1 |
| Arase, Y; Ichida, T; Imazeki, F; Ito, K; Karino, Y; Kurosaki, M; Maeshiro, T; Masaki, N; Michitaka, K; Mita, E; Mizokami, M; Murata, K; Saito, T; Sugiyama, M; Takikawa, Y; Tanaka, Y; Tanuma, J; Toyoda, H; Umemura, T; Yamamoto, K; Yatsuhashi, H; Yoneda, M; Yotsuyanagi, H | 1 |
| Chang, SC; Chang, SY; Chuang, YC; Hung, CC; Sheng, WH; Sun, HY; Tsai, MS | 1 |
| Fung, JY; Lo, CM; Wong, TC | 1 |
| Chen, JY; Hu, JH; Jia, HY; Li, LJ; Lian, JS; Lu, YF; Xiang, DR; Yang, YD; Yu, L; Zeng, LY; Zhang, YM; Zheng, L | 1 |
| Gao, YJ; Jin, B; Li, HW; Liu, ZW; Ma, XM; Meng, FP; Su, HB; Zhang, M; Zhao, JM | 1 |
| Choi, JY; Choi, Y; Hong, G; Kim, H; Lee, HW; Lee, K; Lee, KW; Mori, S; Park, MS; Suh, KS; Suh, SW; Yi, NJ; Yoo, T | 1 |
| Su, QM; Ye, XG | 1 |
| Abdallah, HB; Abdelli, MN; Bouali, R; El Kossai, I; Haddad, W; Haloues, M; Harzallah, K; Hmida, J; Manaa, J; Romdhane, NB | 1 |
| Bock, CT; Brosteanu, O; Fiedler, GM; Franke, A; Manns, MP; Römmele, U; Rößler, S; Ruf, B; Spengler, U; Teuber, G; Thiery, J; Tillmann, HL; Trautwein, C; Wächtler, M; Wedemeyer, H; Wiegand, J; Zeuzem, S | 1 |
| Ayres, A; Bayliss, J; Bowden, DS; Glass, A; Hong, SP; Jackson, KM; Kim, SO; Levy, MT; Locarnini, SA; Luciani, F; Maley, M; Manoharan, S; Yoo, W; Yuen, L | 1 |
| Ahn, SH; Chon, CY; Han, KH; Kim, DY; Kim, HS; Kim, MN; Kim, SU; Lee, CK; Lee, S; Park, JY | 1 |
| Chen, CY; Chien, RN; Chuang, WL; Hsieh, TY; Hu, CT; Hu, TH; Kao, JH; Lin, CC; Lin, HC; Peng, CY | 1 |
| Calvaruso, V; Craxì, A | 1 |
| Chen, SR; Ke, WM; Lai, J; Lin, CS; Yang, L; Zhang, YQ | 1 |
| Chung, RT; Fishman, JA; Wright, AJ | 1 |
| Forde, J; Hews, S; Kuang, Y; Packer, A | 1 |
| Choun, K; De Weggheleire, A; Lynen, L; Phirum, L; Thai, S; van Griensven, J | 1 |
| De Renzo, A; La Mura, V; Masarone, M; Pane, F; Perna, F; Persico, M; Romano, M; Rosato, V; Sasso, FC; Signoriello, G | 1 |
| Gil, E; Hewitt, P; Manson, J; Parker, S; Reyal, Y; Ward, K; Wilson, S | 1 |
| Gu, XB; Huang, LH; Jiang, XH; Qiu, YW; Wang, D; Wu, HY; Xiao-Juan, Y; Yu, P; Zhu, YF | 1 |
| Amorosa, VK; Chang, KM; De La Torre, P; Frank, I; Gross, R; Hafkin, JS; Kostman, JR; Lo Re, V; Localio, AR; Mounzer, K; Osborn, MK; Stern, JJ | 1 |
| Aykas, F; Basak, M; Karahan, S; Karaman, A; Oguz, A; Unal, D; Uslu, E | 1 |
| Aberg, JA; Hollabaugh, K; Kang, M; Koletar, SL; Pham, V; Smurzynski, M; Wu, K | 1 |
| Li, LQ; Ma, L; Zhong, JH | 1 |
| Chatterjee, U; Davison, S; Glass, A; Greenup, AJ; Holdaway, S; Jackson, K; Levy, MT; Locarnini, SA; Nguyen, V; Samarasinghe, D; Tan, PK | 1 |
| Cheng, L; Geng, L; Wang, W; Wu, L; Yan, S; Ye, Y; Yu, J; Yu, S; Yu, Z; Zhang, W; Zheng, S | 1 |
| Coffin, CS; Gill, MJ; Michalak, TI; Mulrooney-Cousins, PM; Nishikawa, S; Osiowy, C; van der Meer, F; van Marle, G | 1 |
| Alexopoulos, S; Kasraianfard, A; Lindberg, L; Rezaei, N; Watt, KD | 1 |
| Chan, GC; Chan, TM; Choy, BY; Kwan, LP; Ma, MK; Mok, MM; Seto, WK; Tang, CS; Yap, DY; Yuen, MF; Yung, S | 1 |
| de Zoysa, JR; Gane, EJ; Ow, MM | 1 |
| Lin, GN; Liu, DY; Peng, JW; Xia, ZJ; Xiao, JJ | 1 |
| Barone, M; Di Leo, A; Iannone, A | 1 |
| Cho, M; Choi, JY; Han, KH; Hwang, JS; Kim, BI; Kim, DJ; Lee, CK; Lee, HJ; Paik, SW; Suh, DJ; Um, SH; Woo, HY; Yoon, SK | 1 |
| Patel, K; Tillmann, HL | 1 |
| Aoudjane, S; Beloukas, A; Chaponda, M; Geretti, AM; González Del Castillo, AA; Hopkins, M; Khoo, S; Noguera, M; O'Connor, J; van Oosterhout, JJ | 1 |
| Cao, H; Han, J; Jiao, Z; Zhang, D | 1 |
| Amici, R; Andreotti, M; Buonomo, E; Ceffa, S; Giuliano, M; Jere, H; Leone, P; Mancinelli, S; Mancini, MG; Marazzi, MC; Palombi, L; Pirillo, MF; Sagno, JB; Scarcella, P; Vella, S | 1 |
| Jin, S; Lv, H; Wang, Z; Xu, H; Yuan, Y; Zhang, W; Zheng, L | 1 |
| Chen, L; Chen, LF; Chen, YQ; Hu, HD; Li, H; Ren, H; Zhang, HM | 1 |
| Chen, X; Gao, W; Li, D; Peng, J; Wen, F; Xia, J; Xu, C; Xu, M; Yao, Z | 1 |
| Cho, YK; Cui, XJ; Jeong, SU; Song, BC | 1 |
| Rosenthal, P | 1 |
| Ehrhardt, S; Guo, N; Nelson, K; Thio, CL; Xie, C | 1 |
| Jiao, Z; Yan, L; Zhang, D | 1 |
| Avihingsanon, Y; Chancharoenthana, W; Eiam-Ong, S; Kittikowit, W; Kittiskulnam, P; Leelahavanichkul, A; Pongpirul, K; Praditpornsilpa, K; Suankratay, C; Townamchai, N; Tungsanga, K; Wattanatorn, S | 1 |
| Hong, R; Lang, X; Li, Z; Xiang-Hui, Y; Xiao-Feng, S; Yan, Z | 1 |
| Hamada-Tsutsumi, S; Imamura, J; Sugiura, W; Tanaka, Y; Watanabe, T; Yokomaku, Y | 1 |
| Abramson, JS; Chung, RT | 1 |
| Cao, Y; Huang, H; Li, H; Li, X; Lin, S; Lin, T; Lin, Y; Liu, Q; Peng, J; Wang, W; Wu, X; Xu, B; Ye, S; Zhang, H; Zhu, J | 1 |
| Changchien, CS; Chen, CH; Hsu, MC; Hu, TH; Hung, CH; Lee, CM; Lu, SN; Wang, JH; Yao, CC | 1 |
| Geipel, A; Gerlich, WH; Glebe, D; Kaiser, R; Neumann-Fraune, M; Niekamp, H; Protzer, U; Seiz, PL; Zhang, K | 1 |
| Kim, DY; Kim, KM; Lee, SG; Lee, YJ; Namgoong, JM; Oh, SH; Song, SM | 1 |
| Ding, XC; Hu, HD; Hu, P; Liao, Y; Liu, JY; Ren, H; Sheng, YJ; Tang, H; Tong, SW; Zhang, DZ; Zhou, Z | 1 |
| Choudhary, NS; Goja, S; Menon, PB; Mohanka, R; Rastogi, A; Saigal, S; Saraf, N; Soin, AS | 1 |
| Bagal, B; Bhat, V; Gawande, J; Gupta, A; Kannan, S; Khattry, N; Mathew, L; Punatar, S | 1 |
| Abbott, K; Ahn, J; Avery, RK; Bloom, RD; Blumberg, E; Brown, K; Dadhania, DM; Danziger-Isakov, L; Doucette, KE; Grossi, P; Horslen, S; Huprikar, S; Korenblat, K; Kotton, CN; Koval, C; Kumar, D; Kumar, V; Laskin, BL; Lease, ED; Levitsky, J; Lu, K; McDermott, JK; Mone, T; Morris, MI; Mougdil, A; Naugler, S; Orlowski, JP; Pillai, A; Venkat, VL | 1 |
| Hong, SP; Hwang, SG; Jang, ES; Jeong, SH; Kang, SK; Lee, JH; Park, SJ | 1 |
| Yuen, MF | 1 |
| Dong, H; Guan, GJ; Jiang, W; Liu, LQ; Liu, T; Liu, XC; Xu, Y | 1 |
| Akarca, US; Bademkiran, F; Duman, S; Ersoz, G; Gunsar, F; Karasu, Z; Kose, T; Ozutemiz, O; Sozbilen, M; Turan, I; Yapali, S | 1 |
| Chan, HN; Ha, CY; Lai, HK; Law, MF; Ng, C; Yeung, YM; Yip, SF | 1 |
| Ahmadinejad, Z; Dashti, H; Jafarian, A; Kasraianfard, A; Moini, M; Najafi, A; Nassiri-Toosi, M; Salimi, J | 1 |
| Bowden, S; Chang, TT; Chao, YC; de Man, RA; Gish, RG; Han, KH; Llamoso, C; Locarnini, S; Tang, H; Yu, M | 1 |
| Fong, TL; Hsieh, MJ; Khemichian, S; Kim, J; Limurti, J; Zhang, SR | 1 |
| Cui, X; Dai, J; Huang, M; Jiang, X; Li, J; Ning, H; Su, F; Yang, S | 1 |
| Chen, L; Gao, J; Pan, L; Tang, W; Ye, X; Zhang, X; Zheng, R; Zheng, W | 1 |
| Apica, B; Ocama, P; Opio, K; Seremba, E | 1 |
| Battegay, M; Bernasconi, E; Bihl, F; Calmy, A; Caminada, AP; Cavassini, M; Ledergeber, B; Martinetti, G; Rickenbach, M; Vernazza, P; Wandeler, G; Weber, R | 1 |
| Cao, F; Chen, T; He, Y; Jin, L; Liu, J; Qi, C; Wang, J; Yan, T; Yang, Y; Zhang, S; Zhao, Y | 1 |
| Gao, GF; Gohda, J; Gu, L; Guan, S; Han, Y; Hosoya, N; Huang, Y; Ishida, T; Iwamoto, A; Kawana-Tachikawa, A; Li, T; Li, Y; Liu, W; Song, X; Xie, J; Yang, F; Zhu, T | 1 |
| Anglaret, X; Boyd, A; Danel, C; Delaugerre, C; Eholié, SP; Gabillard, D; Girard, PM; Lacombefor, K; Mahjoub, N; Maylin, S; Moh, R; Zoulim, F | 1 |
| Gao, Y; Guo, X; Li, H; Li, J; Liu, Y; Liu, Z; Yang, M; Zhang, M; Zhao, J | 1 |
| Choi, GH; Choi, JS; Joo, DJ; Ju, MK; Kim, MS; Kim, SI; Lee, J; Lee, JG; Lee, JJ; Song, SH | 1 |
| Min, L; Pian, J; Zhang, P | 1 |
| Chuang, WL; Dai, CY; Hsieh, MH; Hsieh, MY; Huang, CF; Huang, CI; Huang, JF; Yeh, ML; Yu, ML | 1 |
| Chen, CL; Lin, CC; Yong, CC | 1 |
| Aliosmanoglu, I; Cetinkaya, R; Erbis, H; Kocak, H; Suleymanlar, G; Ulger, BV; Yilmaz, VT | 1 |
| Choe, YH; Choi, GS; Joh, JW; Kim, JM; Kwon, CH; Lee, S; Lee, SK; Park, JB | 1 |
| Cai, XF; Guo, H; Hu, JL; Huang, AL; Long, QX; Luo, YY; Tao, Y; Zhang, WL | 1 |
| Du, S; Guo, F; Han, Y; Li, T; Li, Y; Lv, W; Qiu, Z; Song, X; Thio, CL; Wang, H; Wang, N; Xie, J; Zhu, T | 1 |
| Dai, M; Fan, Z; Huang, F; Jiang, Q; Lin, R; Liu, Q; Shang, J; Sun, J; Wang, H; Xu, N; Zhang, Y | 1 |
| Ohdan, H; Onoe, T; Tahara, H; Tanaka, Y | 1 |
| Archampong, TN; Boamah, I; Flanigan, T; Gillani, FS; Kenu, E; Kwara, A; Lartey, M; Obo-Akwa, A; Sagoe, KW; Yang, H | 1 |
| Rund, D | 1 |
| Gosnell, BI; John, MA; Manzini, TC; Moosa, MS; Ramdial, P | 1 |
| Beck, IA; Frenkel, LM; Jourdain, G; Khamduang, W; Laomanit, L; Ngo-Giang-Huong, N; Payant, R | 1 |
| Casarin, P; Castelnovo, L; Dal Maso, L; Gattei, V; Mauro, E; Mazzaro, C; Monti, G; Pozzato, G; Urraro, T; Zignego, AL | 1 |
| Chen, FY; Cheng, Z; Huang, HH; Shi, KQ; Zhang, MY; Zheng, JN; Zheng, MH; Zhu, GQ; Zou, ZL | 1 |
| Lai, F; Min, T; Wu, H; Wu, X; Zhang, M; Zhang, X | 1 |
| Archampong, TN; Blackard, JT; Boyce, CL; Kenu, E; Kwara, A; Lartey, M; Obo-Akwa, A; Sagoe, KW | 1 |
| Battegay, M; Bernasconi, E; Braun, DL; Darling, K; Günthard, HF; Hirzel, C; Hoffmann, M; Kouyos, RD; Kovari, H; Marzel, A; Rougemont, M; Scherrer, AU; Shilaih, M | 1 |
| Luis, AP; Luo, H; Pan, M; Shuai, P; Xiong, Z; Yu, S; Zhang, Z | 1 |
| Andreoni, M; Arcese, W; Battisti, A; Bianchi, A; Cantonetti, M; Cerretti, R; Cerva, C; Colagrossi, L; Cudillo, L; De Angelis, G; Di Carlo, D; Maffongelli, G; Malagnino, V; Perno, CF; Picardi, A; Pollicita, M; Ricciardi, A; Salpini, R; Sarmati, L; Svicher, V | 1 |
| Chmura, A; Cieciura, T; Jonas, M; Małkowski, P; Wasiak, D; Łągiewska, B | 1 |
| He, CX; Hua, BL; Jin, HZ; Li, L; Liu, YH; Yan, TM; Zuo, YG | 1 |
| Andreone, P; Conti, F; Cucchetti, A; Ercolani, G; Loggi, E; Pinna, AD | 1 |
| Brescia Morra, V; De Rosa, A; Matarazzo, M; Pane, C; Saccà, F | 1 |
| Makvandi, M | 1 |
| Caccamo, L | 1 |
| Brancaccio, G; Ciardiello, F; Dallio, M; Del Prete, S; Fabozzi, A; Federico, A; Gaeta, GB; Iodice, P; Loguercio, C | 1 |
| Dong, C; Gao, W; Ma, N; Shen, ZY; Sun, C; Wang, K; Zheng, WP | 1 |
| Aurpibul, L; Bunupuradah, T; Hansudewechakul, R; Kanjanavanit, S; Kosalaraksa, P; Lumbiganon, P; Puthanakit, T; Taeprasert, P | 1 |
| Chang, SC; Chang, SY; Chuang, YC; Huang, YS; Hung, CC; Lee, KY; Liu, WC; Sheng, WH; Su, YC; Sun, HY | 1 |
| Boyd, A; Lacombe, K; Miailhes, P; Zoulim, F | 1 |
| Arcaini, L; Gotti, M; Merli, M; Rattotti, S | 1 |
| Bessong, PO; Gachara, G; Kimbi, HK; Lum, E; Magoro, T; Mavhandu, L; Ndip, RN | 1 |
| Maki, N; Matsumoto, A; Tanaka, E; Yoshizawa, K | 1 |
| Amouri, A; Chtourou, L; Mnif, L; Tahri, N | 1 |
| Calabresi, A; Carosi, G; Cologni, G; Costarelli, S; Lapadula, G; Puoti, M; Quiros-Roldan, E; Tirelli, V; Torti, C; Zaltron, S | 1 |
| Huang, HJ; Li, GY; Sheng, JL | 1 |
| Li, MW; Wang, YM; Xie, SF; Yang, DH; Zhao, NF | 1 |
| Chan, HL; Chan, HY; Chim, AM; Sung, JJ; Wong, GL; Wong, VW | 1 |
| Rong-Rong, Y; Shi-Cheng, G; Xi-En, G; Yong-Xi, Z | 1 |
| Hino, T; Hisamochi, A; Ide, T; Koga, H; Koga, Y; Kumashiro, R; Kuwahara, R; Ogata, K; Sata, M; Takao, Y; Tanaka, K | 1 |
| Fujioka, S; Ikeda, H; Iwasaki, Y; Kobashi, H; Miyake, Y; Sakaguchi, K; Shiratori, Y; Takaguchi, K; Takaki, A | 1 |
| Jeong, S; Kim, HG; Kim, YS; Kwon, KS; Lee, DH; Lee, JI; Lee, JW; Park, HJ; Shin, YW | 1 |
| Ba, MC; Cui, SZ; Li, ML; Lu, Q; Shi, HJ; Tang, YQ; Wang, B; Wang, JK; Wu, YB; Zhang, XL; Zhao, HY; Zhu, XF | 1 |
| Aberer, E; Gruber, MJ; Gruber-Wackernagel, A; Hermann, J; Scarpatetti, M | 1 |
| Bock, CT; Finger, A; Heidrich, B; Manns, MP; Michel, G; Rosenau, J; Tillmann, HL; Wedemeyer, H; Wiegand, J | 1 |
| Lu, AW; Shen, Y; Wu, MP; Yang, RW; Zheng, SS | 1 |
| Amin, J; Avihingsanon, A; Bowden, S; Cooper, DA; Dore, GJ; Lewin, SR; Locarnini, S; Marks, P; Matthews, GV; Petcharapirat, P; Rerknimitr, R; Ruxrungtham, K; Sasadeusz, J | 1 |
| Itoh, A; Naoki, H; Sugiura, K; Sugiura, M; Takashi, T | 1 |
| Bellini, C; Bernasconi, E; Cavassini, M; Chave, JP; Evison, J; Fehr, J; Kaiser, L; Keiser, O; Telenti, A; Vernazza, P; Weber, R | 1 |
| Beckebaum, S; Cicinnati, VR; Gerken, G; Sotiropoulos, GC | 1 |
| Bacq, Y; Baty, G; de Muret, A; Dubois, F; Negreanu, L | 1 |
| Angus, PW; Patterson, SJ | 2 |
| Akay, S; Karasu, Z | 1 |
| Angus, PW; Gane, E; McCaughan, GW; Patterson, SJ; Strasser, SI | 1 |
| Bhattacharya, D; Donovan, RM; Imperial, JC; Israelski, D; Katzenstein, D; Keeffe, EB; Wong, A | 1 |
| Liu, M; Wang, L; Yang, S | 1 |
| Cai, CJ; Chen, GH; Jiang, H; Jiang, N; Li, H; Li, X; Lu, MQ; Wang, GS; Xu, C; Yang, Q; Yang, Y; Yi, HM; Yi, SH; Zhang, J; Zhang, JF | 1 |
| Alessandrelli, F; Azzaroli, F; Buonfiglioli, F; Lisotti, A; Mazzella, G; Montagnani, M | 1 |
| Cassola, G; Feasi, M; Torresin, A | 2 |
| Rao, W; Wu, X; Xiu, D | 1 |
| Degertekin, B; Hussain, M; Lok, AS; Oberhelman, K; Tan, J | 1 |
| Arslan, U; Artac, M; Basaranoglu, M; Boruban, MC; Eren, OO; Yavas, O | 1 |
| Fais, VC; Gonçales Junior, FL; Gonçales, NS; Jardim, RN; Pereira, JS | 1 |
| Cappelli, B; Faraci, M; Fioredda, F; Giacchino, R; Giudice, CL; Lanino, E; Morreale, G | 1 |
| Akdogan, A; Bayraktar, Y; Bilgen, SA; Calguneri, M; Ersoy, O; Ertenli, I; Kalyoncu, U; Karadag, O; Kiraz, S; Yonem, O | 1 |
| Apalla, Z; Ioannides, D; Lazaridou, E; Patsatsi, A; Trigoni, A | 1 |
| Benhamou, Y; Dominguez, S; Duvivier, C; Ingiliz, P; Katlama, C; Poynard, T; Thibault, V; Valantin, MA | 1 |
| Kumar, M; Sarin, SK | 1 |
| Degertekin, B; Lok, AS | 2 |
| García Buey, L; González Mateos, F; Moreno Otero, R | 1 |
| Barreiro, P; García-Samaniego, J; Martín-Carbonero, L | 1 |
| Dorobantu, B; Gangone, E; Gheorghe, L; Hrehoret, D; Iacob, S; Matei, E; Popescu, I | 1 |
| Fontana, RJ | 2 |
| Avihingsanon, A; Bowden, S; Dore, GJ; Lewin, SR; Locarnini, SA; Marks, P; Matthews, G; Perelson, AS; Ribeiro, RM; Ruxrungtham, K | 1 |
| Chan, TM; Tang, C; Tse, KC; Yip, TP; Yung, S | 1 |
| Agarwal, SK; Das, P; Dinda, AK; Khaira, A; Mahajan, S; Makhariya, G; Sharma, A; Tiwari, SC; Upadhyay, BK | 1 |
| Atkins, M; Campbell, F; Chang, CN; Cui, YT; Gardner, S; Li, XM; Liang, ZQ; Qiao, FY; Wang, L; Xu, WM; Yang, H; Zhang, SL | 1 |
| Perrillo, R | 1 |
| Arrifin, N; Audsley, J; Ayres, A; Bartholomeusz, A; Crowe, SM; Lewin, SR; Locarnini, SA; Mijch, A; Sasadeusz, J; Yuen, LK | 1 |
| Cheong, JY; Cho, SW; Choi, JM; Hong, SP; Kim, SO; Kwon, HC; Yoo, WD | 1 |
| Kurbegov, AC; Sokol, RJ | 1 |
| Alvarez-Uria, G; Ratcliffe, L; Vilar, J | 1 |
| Baumert, TF; Doffoel, M; Fafi-Kremer, S; Gut, JP; Habersetzer, F; Pastor, R; Schvoerer, E; Stoll-Keller, F | 1 |
| Amini-Bavil-Olyaee, S; Herbers, U; Luedde, T; Sheldon, J; Tacke, F; Trautwein, C | 1 |
| Deeney, HN; Dusheiko, GM | 1 |
| Ahmed, A; Babrzadeh, F; Egholm, M; Gharizadeh, B; Hanczaruk, B; Holmes, SP; Liu, T; Margeridon-Thermet, S; Shafer, RW; Shahriar, R; Shulman, NS; Simen, BB; Wang, C | 1 |
| Chen, L; Wan, MB; Yu, DM; Zhang, Q; Zhang, XX | 1 |
| Blázquez de Castro, AM; García Rodríguez, JA; González San Martín, F; Gutiérrez-Zufiaurre, N; Muñoz Bellido, JL; Muñoz-Criado, S; Pérez-Grande, R; Vázquez López, L | 1 |
| Chen, ZY; Li, B; Li, G; Ma, YK; Wang, WT; Wen, TF; Wu, H; Xu, MQ; Yan, LN; Yang, JY; Zeng, Y; Zhao, JC | 1 |
| Boricić, I; Delić, D; Nesić, Z; Prostran, M; Svirtlih, N | 1 |
| Chiba, T; Ichinohe, T; Kadowaki, N; Marusawa, H; Uchiyama, T; Ueda, Y | 1 |
| Bocket, L; Boulanger, L; Canva, V; Coursier, J; Dharancy, S; Dieu, E; Gonzalez, F; Mathurin, P | 1 |
| Burnett, RJ; Mphahlele, MJ; Selabe, SG; Song, E | 1 |
| Abdel Razek, W; Belghiti, J; Durand, F; Francoz, C; Lada, O; Marcellin, P; Moucari, R; Valla, D | 1 |
| Airò, P; Bazzani, C; Frassi, M; Puoti, M; Scarsi, M; Zingarelli, S | 1 |
| Karsaliakos, P; Mylonakis, E; Ziakas, PD | 1 |
| D'Andrea, M; Dessanti, ML; Miglioresi, L; Morrone, A; Nosotti, L; Paviglianiti, A; Petti, MC; Pimpinelli, F | 1 |
| Gao, DM; Guo, QL; Li, N; Liu, Y; Lu, SC; Wang, ML; Wu, JS; Xia, RP; Zhang, Y | 1 |
| Rizzetto, M | 2 |
| Samuel, D | 4 |
| Mas, A | 1 |
| Biemond, BJ; Jansen, PL; Reesink, HW; Takkenberg, RB; ten Cate, DF; Zaaijer, HL | 1 |
| Aoki, T; Fujiwara, H; Iwama, K; Kimura, S; Matsue, K; Odawara, J; Takeuch, M; Yamakura, M | 1 |
| Childs, R; John Barrett, A; Koklanaris, E; Le, Q; Savani, BN; Shenoy, A | 1 |
| Borro, P; Sumberaz, A; Testino, G | 1 |
| Fan, LY; Ling, N; Ren, H; Shi, XF; Wang, ZY; Zhang, DZ; Zhong, S; Zhou, Z | 1 |
| Bowden, S; Dore, GJ; Goodman, Z; Lewin, SR; Locarnini, S; Marks, P; Matthews, GV; Philp, FH; Sasadeusz, J; Seaberg, E; Tang, Y; Thio, CL | 1 |
| Deterding, K; Manns, M; Potthoff, A; Rifai, K; Strassburg, C; Wedemeyer, H | 1 |
| Mullen, JE; Tong, CY; Wong, T | 1 |
| Enomoto, M; Habu, D; Imanishi, Y; Iwai, S; Kawada, N; Kobayashi, S; Morikawa, H; Sakaguchi, H; Shiomi, S; Tamori, A | 1 |
| Chen, CH; Hu, TH; Kuo, CY; Lee, CM; Ma, MC; Pei, SN; Wang, MC | 1 |
| Baka-Cwierz, B; Chudek, J; Ficek, J; Karkoszka, H; Kolonko, A; Wiecek, A | 1 |
| Jia, JD; Wang, BE; Zhang, FK; Zhang, JY; Zhang, Y | 1 |
| Eguchi, K; Eguchi, S; Fujimoto, M; Ichikawa, T; Kanematsu, T; Miyaaki, H; Nagaoka, S; Nakao, K; Shibata, H; Takatsuki, M; Yatsuhashi, H | 1 |
| Cai, Q; Gao, Y; Huang, H; Lin, T; Lin, X; Liu, Y; Peng, R | 1 |
| Eugenidis, N; Giouleme, O; Gkisakis, D; Grammatikos, N; Katsinelos, P; Koumaras, H; Koumerkeridis, G; Mpoumponaris, A; Panderi, A; Patsiaoura, K; Theodoropoulos, K; Tziomalos, K; Vassiliadis, TG | 1 |
| He, XS; Hu, AB; Ma, Y; Tai, Q; Wang, GD | 1 |
| Lo, GH | 1 |
| Acar, A; Aydin, A; Eken, A; Eyigün, CP; Görenek, L; Pahsa, A; Sayal, A | 1 |
| Aghemo, A; Agnelli, F; Colombo, M; Donato, MF; Iavarone, M; Lampertico, P; Rumi, MG; Viganò, M | 1 |
| Figueiredo, FF; Gomes, SA; Lago, BV; Mello, FC; Motta, JS; Perez, RM | 1 |
| Albrecht, H; Jorgensen, P; Marcus, U; Schürmann, D; Suttorp, N | 1 |
| Evans, J; Jarrin, I; Lafuente-Lafuente, C; Mazeron, MC; Parrinello, M; Schnepf, N; Sellier, P; Simoneau, G | 1 |
| Chow, WC; Koo, YX; Lim, ST; Tan, DS; Tan, IB; Tao, M | 1 |
| Chen, CW; Chen, CX; Fu, QC; He, CL; Liu, B; Ma, Y; Pan, XN; Wang, MR; Wang, QC; Zhen, RD; Zhou, YJ | 1 |
| Baqai, S; Inoue, M; Karino, Y; Kurbanov, F; Lai, CL; Mizokami, M; Mukaide, M; Orito, E; Sakaguchi, K; Sata, M; Shin-I, T; Tanaka, Y; Yamada, G; Yokosuka, O; Yuen, MF | 1 |
| Belem, AM; Bisseye, C; Gnoula, C; Ilboudo, D; Kabre, GB; Karou, DS; Nikiema, JB; Onadja, SM; Ouermi, D; Pietra, V; Pignatelli, S; Sanou, DS; Simpore, J | 1 |
| Kang, P; Li, SC; Sun, LJ; Yu, JW; Zhao, YH | 2 |
| Cheng, YA; Dang, SS; Jia, XL; Liu, EQ; Song, P; Sun, MZ; Zhang, X | 1 |
| Berg, T; Böcher, WO; Buggisch, P; de Man, RA; Deterding, K; Erhardt, A; Feucht, HH; Hüppe, D; Möller, B; Petersen, J; Reinders, JG; Rhode, P; Sarrazin, C; Spengler, U; Stein, K; Trojan, J; van Bömmel, F; Wasmuth, HE; Wedemeyer, H; Wiedenmann, B | 1 |
| Guy, DG; Katz, LH; Paul, M; Tur-Kaspa, R | 2 |
| Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I | 1 |
| Burroughs, AK; Cholongitas, E; Papatheodoridis, GV | 1 |
| Boland, GJ; Boot, HJ; Janssen, HL; van der Eijk, AA; Veldhuijzen, IK; Wouters, MG | 1 |
| Ikeda, K | 2 |
| Boccadoro, M; Bruno, B; Festuccia, M; Fiore, F; Giaccone, L; Marengo, A; Marzano, A; Pittaluga, F; Resta, I; Rizzetto, M; Sorasio, R | 1 |
| Fukai, K; Ise, M; Kojima, H; Kumagai, K; Mimura, N; Sakai, C; Takagi, T; Tsujimura, H; Yokosuka, O | 1 |
| Goto, H; Hayashi, K; Hirooka, Y; Ishigami, M; Itoh, A; Katano, Y; Kumada, T; Nakano, I; Toyoda, H; Yano, M; Yoshioka, K | 1 |
| Jie, YS; Li, G; Shu, X; Wei, ZW; Xie, QF; Xu, QH; Zhang, K | 1 |
| Chen, LY; Li, B; Li, XH; Liu, SY; Luo, RL; Peng, JF; Tang, W; Wang, ZQ; Xu, LM; Yin, ZH; Zhang, W; Zhou, BP | 1 |
| Cao, Q; Tang, YT; Zhang, DZ | 1 |
| Wang, FY; Yin, XL; Zhang, Y; Zhou, JH | 1 |
| Bruno, S; Maisonneuve, P; Mondelli, MU; Raimondi, S | 1 |
| Mutimer, D | 5 |
| Chi, AC; Saab, S; Tong, MJ; Waterman, B | 1 |
| Berg, CL; Coffin, CS; Curry, MP; Dove, LM; Nissen, NN; Ragni, M; Regenstein, FG; Roland, ME; Sherman, KE; Stock, PG; Terrault, NA | 1 |
| Kiertiburanakul, S; Manosuthi, W; Sungkanuparph, S; Wongprasit, P | 1 |
| Khedmat, H; Taheri, S | 1 |
| Kaita, K; Mendoza, K; Osiowy, C; Solar, K | 1 |
| Chee, GM; Poordad, F | 1 |
| Fukushima, K; Inoue, J; Kakazu, E; Kimura, O; Kondo, Y; Obara, N; Shimosegawa, T; Ueno, Y; Wakui, Y | 1 |
| Locarnini, S | 2 |
| Chiba, T; Nakanishi, Y; Seno, H; Yamashita, Y | 1 |
| Boroń-Kaczmarska, A; Cianciara, J; Flisiak, R; Gładysz, A; Halota, W; Juszczyk, J; Kryczka, W; Małkowski, P; Pawłowska, M; Simon, K | 1 |
| Jiang, L; Yan, LN | 1 |
| Di Bisceglie, AM; Firnhaber, C; Maskew, M; McNamara, L; Reyneke, A; Schulze, D | 1 |
| Chen, J; Jia, JD; Ma, H; Yi, L; You, H | 1 |
| Pár, A | 1 |
| Li, X; Ma, L; Schreiber, A; Shi, Z; Yang, Y | 1 |
| Choi, JJ; Jang, H; Kim, J; Park, H; Son, Y | 1 |
| Chen, L; Liu, Y; Ren, X; Si, L; Wang, Y; Xu, D; Xu, T; Xu, Z; Zhao, J; Zhong, Y | 1 |
| Castaing, D; Delvart, V; Duclos-Vallee, JC; Roche, B; Roque-Afonso, AM; Samuel, D; Sebagh, M | 1 |
| Li, JG; Liu, L; Tang, YZ; Wang, XH; Wang, YM; Zhou, JJ | 1 |
| Alavian, SM; Fallahian, F; Fallahian, V; Zamani, F | 1 |
| Chae, HB; Goo, JC; Hong, SP; Jeong, JI; Kim, BU; Kim, SO; Park, BC; Park, SM; Youn, SJ | 1 |
| Coffin, CS; Michalak, TI; Mulrooney-Cousins, PM; Peters, MG; Roberts, JP; Terrault, NA; van Marle, G | 1 |
| Chun, J; Kim, BG; Kim, W; Kim, YJ; Lee, HS; Lee, KL; Park, KU; Suh, KS; Yi, NJ; Yoon, JH | 1 |
| Gianini, RJ; Gomes-Gouvêa, MS; Leite, OM; Locarnini, S; Martins, LG; Mendes-Correa, MC; Pinho, JR; Santana, RA; Silva, MH; Sitnik, R; Uip, DE; Yuen, L | 1 |
| Brock, GN; Buell, JF; Eng, M; Marvin, MR; Ouseph, R; Ravindra, K | 1 |
| Gane, E | 1 |
| Cheng, N; Jiang, L; Li, B; Wang, W; Wei, Y; Wen, T; Xu, M; Yan, L; Yang, J; Zhao, J | 1 |
| Dixit, V; Fabrizi, F; Martin, P; Messa, P | 1 |
| Aki, Z; Haznedar, R; Ozkurt, ZN; Sucak, GT; Yağci, M; Yeğin, ZA | 1 |
| Du, Z; Gao, YT; Hang, T; Jing, L; Li, Y; Liu, L; Liu, T; Wu, ZP | 1 |
| Gong, HY; Liu, ZG; Zhang, HY; Zhang, Z | 1 |
| Bock, CT; Damerow, H; Locarnini, S; Tillmann, HL; Walker, C; Wiegand, J; Yuen, L | 1 |
| Li, Q; Li, X; Liu, Y; Wang, L; Wong, VW; Xin, S; Xu, D; Xu, Z; Zhao, J; Zhong, Y | 1 |
| Bouzas, MB; Cassino, L; Giuliano, SF; Laufer, N; Quarleri, J | 1 |
| Asaka, M; Chuma, M; Hige, S; Horimoto, H; Kobayashi, T; Nakanishi, M; Natsuizaka, M; Sho, T; Yamamoto, K; Yamamoto, Y; Yoshida, S | 1 |
| Chang, PY; Chao, TY; Chen, YC; Dai, MS; Ho, CL; Kao, WY; Tsai, SH; Wu, YY; Yu, JC | 1 |
| Cui, X; Fang, D; Inagaki, Y; Kokudo, N; Qi, F; Tang, W; Wang, D; Xu, H | 1 |
| Chen, Z; Shi, Y; Shu, ZY; Wu, YH; Yang, J; Zhang, WJ | 1 |
| Gomes-Gouvêa, MS; Guastini, Cde F; Lemos, MF; Mendes-Correa, MC; Oba, IT; Pinho, JR; Silva, AC; Spina, AM | 1 |
| Egashira, T; Kobayashi, M; Kumada, H; Nagano, M; Suzuki, F; Tadokoro, K; Yamaguchi, T | 1 |
| Chang, MH; Chen, CY; Chen, HL; Lu, FL; Ni, YH | 1 |
| Cheung, CK; Lau, GK; Lo, CM; Man, K | 1 |
| Guo, CC; Guo, HQ; Huang, JJ; Huang, Y; Li, HR; Lin, TY; Pu, XX; Xie, Y; Zhai, LZ; Zhang, X; Zhu, HL | 1 |
| Boot, HJ; Cuypers, HT; Koppelman, MH; van Swieten, P; Zaaijer, HL | 1 |
| Christodoulou, DK; Katsanos, KH; Tsianos, EV; Tsianos, VE; Vagias, I; Zervou, E; Zioga, H; Zois, CD | 1 |
| Deutsch, M; Hatziyanni, E; Manolakopoulos, S; Papadopoulos, N; Vassilopoulos, D | 1 |
| Bansal, S; Carey, I; D'Antiga, L; Longhi, MS; Ma, Y; Mesa, IR; Mieli-Vergani, G; Vergani, D | 1 |
| Bartels, M; Berg, T; Hartmann, J; Jonas, S; Karlas, T; Maier, M; Mössner, J; Tillmann, HL; Weimann, A; Wiegand, J | 1 |
| Andreone, P; Bacci, M; Burra, P; Canova, D; Cursaro, C; Fiorentino, B; Guazzini, S; Marengo, A; Marzano, A; Riili, A; Volpes, R | 1 |
| Roche, B; Samuel, D | 3 |
| Mallet, V; Pol, S; Vallet-Pichard, A | 1 |
| Afzal, S; Ali, L; Ali, M; Badar, S; Butt, S; Hussain, A; Idrees, M; Munir, S; Rehman, IU; Saleem, S | 1 |
| Ahn, JS; Choi, MS; Gwak, GY; Im, YH; Kang, ES; Kim, KH; Lee, JE; Nam, SJ; Park, YH; Yang, JH; Yun, J | 1 |
| Awi, D; Cavenaugh, JS; Hill, AV; McConkey, SJ; Mendy, M; Whittle, H | 1 |
| Kang, P; Sun, LJ; Yan, BZ; Yu, JW; Zhao, YH | 1 |
| Brock, GN; Buell, JF; Carrubba, CJ; Eng, M; Ferguson, N; Marvin, MR; Mostajabi, F | 1 |
| Andersen, ES; Christensen, PB; Frigstad, SO; Kjær, M; Konopski, Z; Krarup, H; Leutscher, P; Moessner, B; Weiland, O; Weis, N; Westin, J | 1 |
| Akbas, E; Aktas, S; Atiq, A; Haberal, M; Karakayali, H; Selcuk, H; Sevmis, S; Zia, HH | 1 |
| Chen, K; Deng, H; Feng, H; Jia, W; Jin, L; Li, S; Liu, F; Long, M; Rao, N; Song, E; Su, F; Wu, J | 1 |
| Arcaini, L; Bruno, R; Lucioni, M; Merli, M; Paulli, M; Rattotti, S; Riboni, R; Vercelli, A | 1 |
| Goh, YT; Han, ST; Hwang, WY; Linn, YC; Mya, DH; Tan, DC | 1 |
| Chen, XQ; Li, M; Lin, GN; Peng, JW; Xia, ZJ | 1 |
| Chen, XY; Gui, X; Yang, RR; Zhu, Y | 1 |
| Ji, Y; Jiang, H; Ju, L; Kan, N; Wu, K; Yu, M | 1 |
| Ladapo, TA; Lesi, AE; Lesi, OA; Onifade, EU | 1 |
| Kawano, K; Nampei, A; Shi, K; Takeuchi, E; Tsuboi, H; Tsujii, A; Yoshihara, H | 1 |
| Akriviadis, E; Cholongitas, E; Goulis, J; Papatheodoridis, GV | 1 |
| Aghasadeghi, MR; Ardestani, MS; Bahramali, G; Davar Siadat, S; Delbaz, SA; Farahani, A; Memarnejadian, A; Mohraz, M; Mostafavi, E; Sadat, SM; Saraji, AA; Vahabpour, R | 1 |
| Gonzalez-García, J; Labarga, P; Pineda, JA; Poveda, E; Rodriguez, C; Santos, J; Sobrino, P; Soriano, V; Tuma, P; Tural, C; Vidal, F | 1 |
| Deng, L; Gao, S; Gui, X; Liang, K; Rong, Y; Xiong, Y; Yan, Y; Yang, R; Zhang, Y | 1 |
| Block, TM; Clearfield, E; Cuconati, A; Goddard, C; Guo, H; Mills, C; Morrey, JD; Motter, NE; Xiao, T; Xu, X; Yu, W; Zhao, K | 1 |
| Giles, M; Sasadeusz, J; Visvanathan, K | 1 |
| Arat, M; Idilman, R | 1 |
| Goetzl, L; Lazenby, GB; Lintzenich, AE; Newman, R; Simpson, KN; Unal, ER | 1 |
| Cent, A; Chung, MH; Cook, L; Jerome, KR; John-Stewart, G; Kim, HN; Lule, G; Morrow, RA; Richardson, B; Scott, J; Tapia, K | 1 |
| Cao, J; Li, SY; Lu, XJ; Qin, L; Song, XB; Wang, J; Wang, LL; Ying, BW; Zhang, L; Zhou, J; Zhou, Y | 1 |
| Lim, Z; Moses, SE; Zuckerman, MA | 1 |
| Chien, RN; Hu, CC; Lai, MW; Lin, CL; Yeh, CT | 1 |
| Chen, T; He, Y; Liu, H; Liu, X; Wang, K; Yan, Z; Zhang, S; Zhao, Y | 1 |
| Chen, HH; Hung, HF | 1 |
| Cao, GW; Han, L; Wang, HY; Xie, JX; Zhang, HW; Zhang, Q | 1 |
| Deutsch, M; Ketikoglou, I; Manesis, EK; Manolakopoulos, S; Mela, M; Papatheodoridis, GV; Striki, A; Tzourmakliotis, D | 1 |
| Branger, M; Collin, G; Fraqueiro, G; Gervais, A; Hamet, G; Lada, O; Marcellin, P; Martinot-Peignoux, M; Matheron, S; Moucari, R; Peytavin, G; Roquebert, B | 1 |
| An, H; Byun, KS; Hyun, JJ; Jung, ES; Kang, HS; Kim, CD; Kim, DJ; Kim, JH; Kim, TH; Lee, HS; Ryu, HS; Seo, YS; Um, SH; Yeon, JE; Yim, HJ; Yoon, E | 1 |
| Dalekos, GN; Tillmann, HL; Zachou, K | 1 |
| García-Alonso, FJ; Martín-Mateos, RM; Moreira Vicente, V | 1 |
| Andreoni, M; Bertoli, A; Ceccarelli, L; Perno, CF; Ricciardi, A; Salpini, R; Sarmati, L; Sarrecchia, C; Sordillo, P; Svicher, V | 1 |
| Wong, GL | 1 |
| Fontana, RJ; Singal, AK | 1 |
| Aghokeng, AF; Bourgeois, A; Delaporte, E; Ducos, J; Kenfack, A; Kouanfack, C; Laurent, C; Mondain, AM; Mpoudi-Ngolé, E | 1 |
| Gharebaghiyan, A; Sharifi, Z; Yari, F | 1 |
| Chen, H; Deng, SP; Guan, XL; Li, J; Niu, XT; Su, XJ; Tang, MT; Wu, Q; Yang, RY | 1 |
| Ji, Y; Jiang, H; Jiang, Q; Ju, L; Tang, X; Wu, K; Wu, M; Yu, M | 1 |
| Bae, SC; Choi, IA; Kim, SI; Lee, EB; Lee, EY; Lee, YJ; Park, MC; Park, YB; Ryu, HH; Shin, K; Song, YW; Yoo, B; Yoo, WH | 1 |
| Chang, MH; Changchien, CS; Chen, CH; Hu, TH; Hung, CH; Lee, CM; Lu, SN; Wang, JH | 1 |
| Allweiss, L; Bierwolf, J; Dandri, M; Lütgehetmann, M; Matthes, E; Petersen, J; Pollok, JM; Volz, T; Warlich, M | 1 |
| Gervain, J; Horváth, G; Hunyady, B; Makara, M; Pár, A; Szalay, F; Telegdy, L; Tornai, I; Ujhelyi, E | 1 |
| Jiang, JH; Ma, F; Sun, CY; Wang, N; Wang, QD; Wang, YF; Yang, XA; Yin, DT; Zhang, Y; Zheng, LY; Zhou, YB | 1 |
| Chen, GF; Dai, JZ; Ji, D; Li, L; Li, X; Liu, Y; Si, LL; Wang, L; Xin, SJ; Xu, D; Xu, Z; Yao, Z | 1 |
| Ahn, SH; Chon, CY; Han, KH; Kim, DY; Lee, JM; Lee, MH; Park, JY; Ryu, HJ; Son, CY | 1 |
| An, H; Chang, J; Chen, L; Dong, L; Guo, X; Li, Y; Tao, L; Wang, Q; Yang, X; Yu, X; Zheng, L | 1 |
| Deng, YL; Gao, W; Jiang, WT; Qu, W; Rao, W; Shen, ZY; Sun, LY; Sun, XY; Zhang, JJ; Zhang, YM; Zhu, ZJ | 1 |
| Alavian, SM; Jazayeri, SM | 1 |
| Campo, DS; Dimitrova, Z; Ganova-Raeva, L; Khudyakov, Y; Lara, J; Lok, A; Ramachandran, S; Teo, CG; Thai, H; Xia, G | 1 |
| Dusheiko, G | 2 |
| Chen, YC; Chen, YS; Chi, NH; Chou, NK; Chuang, MK; Huang, SC; Ko, WJ; Tsao, CI; Wang, CH; Wang, SS; Wu, IH; Yu, HY | 1 |
| Guyatt, G; Heels-Ansdell, D; Sun, X; Walter, SD | 1 |
| Han, Y; Li, T; Li, Y; Wang, H; Zhang, C; Zhang, X; Zhu, T | 1 |
| Akriviadis, E; Antoniadis, N; Cholongitas, E; Goulis, I; Papanikolaou, V; Vasiliadis, T | 1 |
| Chandrasekar, PH; Liu, CY; Masood, A; Schiffer, CA | 1 |
| Arberas-Diez, B; Casals-Seoane, F; Moreno-Otero, R | 1 |
| Fernandes, CA; Gomes, SA; Lago, BV; Lewis-Ximenez, LL; Mello, FC | 1 |
| Aparicio, M; Chamorro, C | 1 |
| Ko, SY; Lee, HC; Lee, JE; Oh, HB; Park, CW | 1 |
| Aguilar, C; Brown, RS; Buti, M; Fagan, EA; Leu, CS; Pereira, MR; Tilson, HH; Verna, EC | 1 |
| Alvarez, F; Beland, K; Bouron Dal Soglio, D; Lapierre, P; Mas, E; Yousef, Y | 1 |
| Buranabanjasatean, S; Buranawanitchakorn, Y; Gaudy-Graffin, C; Goudeau, A; Halue, G; Jourdain, G; Khamduang, W; Kunkongkapan, S; Lallemant, M; Luekamlung, N; Moreau, A; Ngo-Giang-Huong, N; Sirirungsi, W | 1 |
| Ankcorn, M; Appiah, L; Chadwick, D; Foster, G; Geretti, AM; Phillips, R; Sarfo, S; Schwab, U; Stanley, A | 1 |
| Kim, BG; Kim, D; Kim, IK; Kim, W; Kim, YJ; Lee, HS; Yoon, JH | 1 |
| Berg, T; Bock, FJ; Deterding, K; Feucht, HH; Hüppe, D; Möller, B; Trojan, J; van Bömmel, F; Wasmuth, HE; Wedemeyer, H | 1 |
| Boxall, E; Kaskar, S; Kelly, D; Sira, J; Workman, J | 1 |
| Amici, R; Andreotti, M; Ceffa, S; Erba, F; Galluzzo, C; Giuliano, M; Jere, H; Liotta, G; Luhanga, R; Mancinelli, S; Marazzi, MC; Maulidi, M; Palombi, L; Pirillo, M; Sagno, JB; Vella, S | 1 |
| Hu, Z; Huang, P; Lu, W; Luo, Q; Xiong, Q; Yang, Y; Zhang, N; Zhong, Y | 1 |
| Babiker, ZOE; Hogan, C; Ustianowski, A; Wilkins, E | 1 |
| Baxa, DM; Borroto-Esoda, K; Chappell, BJ; Golembieski, A; Gordon, SC; Jovanovich, J; Kizy, A; Krishnan, PV; Sharif, O; Shetron-Rama, L; Snow-Lampart, A; Thekdi, AD | 1 |
| Grabmeier-Pfistershammer, K; Kosi, L; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Strassl, R | 1 |
| Fu, D; Huang, Y; Ma, Y; Shen, X; Wu, H; Wu, S | 1 |
| Han, SW; Im, SA; Jeong, SH; Keam, B; Kim, DY; Kim, JH; Kim, JW; Kim, TY; Kim, YJ; Lee, HJ; Lee, JH; Lee, JS; Lee, KW; Oh, DY; Yoon, JH | 1 |
| Calise, F; Cordone, G; De Luca, M; Di Costanzo, GG; Imparato, M; Lanza, AG; Migliaccio, C; Picciotto, FP; Scuderi, V; Tortora, R; Utech, W | 1 |
| Fan, L; Fang, C; Li, JY; Wang, L; Wang, YH; Xu, J; Xu, W; Zhang, R | 1 |
| Angeli, P; Cavallin, M; Fasolato, S; Gatta, A; Gola, E; Morando, F; Rosi, S | 1 |
| Banerjee, A; Biswas, A; Chakrabarti, S; Chakravarty, R; Datta, S; Guha, SK; Pal, A; Panigrahi, R; Saha, B; Sarkar, N | 1 |
| Chen, J; Chen, ZH; Dong, M; Li, X; Lin, Q; Lin, ZX; Ma, XK; Ruan, DY; Wan, XB; Wang, TT; Wei, L; Wen, JY; Wu, XY; Xing, YF | 1 |
| Baik, SK; Chae, HB; Hong, SP; Kim, CW; Kim, JH; Kim, MY; Kim, YS; Lee, CD; Lee, JI; Lee, JW; Lee, MS; Park, CK; Park, SH; Seo, YS; Um, SH; Yim, HJ; Yoon, EL | 1 |
| Candusso, M; Iorio, R; Liccardo, D; Riva, S; Torre, G; Tufano, M | 1 |
| Girndt, M; Köhler, H | 1 |
| Agnes, S; De Martini, D; Flore, R; Gasbarrini, A; Gentiloni Silveri, N; Migneco, A; Ojetti, V; Pola, P; Santoliquido, A | 1 |
| Davis, GL; Keeffe, EB | 1 |
| Angus, PW | 1 |
| Huang, D; Liang, T; Lu, A; Wang, W; Wu, J; Zheng, S | 1 |
| Abdelhamed, AM; Furman, PA; Isom, HC; Kelley, CM; Miller, TG | 1 |
| Berg, T; Schürmann, D; van Bömmel, F; Wünsche, T | 1 |
| de Man, RA; Janssen, HL; Niesters, HG; Sprengers, D; van Gelder, T; Zondervan, PE | 1 |
| Arat, M; Bozdayi, AM; Bozkaya, H; Cinar, K; Erekul, S; Koç, H; Törüner, M; Uzunalimoğlu, O; Yurdaydin, C | 1 |
| Hollander, A; Lindh, G; Sangfelt, P; Uhnoo, I; Weiland, O | 1 |
| Chan, FK; Chan, HL; Chui, AK; Lau, WY; Rao, AR; Sung, JJ; Tse, CH; Wong, J; Wong, ML | 1 |
| Berg, T; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D; Steinmüller, T | 1 |
| Fischer, L; Meier, D; Rogiers, X; Sterneck, M; Zöllner, B | 1 |
| Engler, S; Kallinowski, B; Klar, E; Sauer, P; Stremmel, W | 1 |
| Bozdayi, AM; Bozkaya, H; Erkan, O; Karayalcin, S; Uzunalimoglu, O; Yurdaydin, C | 1 |
| Allende, H; Buti, M; Castells, L; Esteban, R; Guardia, J; Jardí, R; Margarit, C; Pumarola, T; Rodríguez, F; Sánchez-Avila, JF; Vargas, V | 1 |
| Lok, AS | 1 |
| Terrault, NA | 1 |
| Muñoz, SJ | 1 |
| Pruett, T | 2 |
| Torresi, J | 1 |
| Cutz, E; Petric, M; Roberts, EA; Yeung, LT | 1 |
| Hanada, S; Harada, M; Kaji, R; Kumashiro, R; Sata, M | 1 |
| Cuchacovich, R; Espinoza, LR; Menon, Y; Singh, R | 1 |
| Lau, GK; Liang, R; Lie, A | 1 |
| Chan, TM; Cheng, IK; Fang, GX; Ho, SK; Lai, KN; Tang, CS | 1 |
| Dieterich, DT | 1 |
| Alloway, RR; Bagous, T; Egidi, MF; Gaber, AO; Grewal, HP; Hardinger, KL; Honaker, MR; Kizilisik, AT; Shokouh-Amiri, MH; Stratta, RJ; Trofe, J; Vera, SR | 1 |
| Fontana, RJ; Lok, AS | 2 |
| Beigelman, L; Blatt, LM; Bowman, K; Conrad, A; Johnson, DA; Lee, PA; Macejak, DG; Maloney, L; McSwiggen, JA; Mokler, VR; Morrey, JD; Morrissey, DV; O'Brien, JT; Overly, SL; Pavco, PA; Schmid, P; Shaffer, CS; Vargeese, C | 1 |
| Chen, CL; Chen, YS; Cheng, YF; Chiu, KW; de Villa, VH; Huang, TL; Jawan, B; Wang, CC; Wang, SH | 1 |
| Andreone, P; Bernardi, M; Biselli, M; Cursaro, C; Di Giammarino, L; Felline, F; Gramenzi, A; Lorenzini, S; Morelli, MC; Porzio, F; Sama, C; Spinucci, G | 1 |
| Broelsch, CE; Gerken, G; Karliova, M; Malago, M; Rothaar, T; Treichel, U; Trippler, M; Valentin-Gamazo, C | 1 |
| Luo, K; Yu, L; Zhu, Y | 1 |
| Chung, YH; Jung, S; Lee, HC; Lee, YS; Park, HJ; Park, YH; Song, HG; Suh, DJ | 1 |
| Ahn, BM; Bae, SH; Cho, SH; Choi, JY; Han, NI; Jang, JW; Lee, CD; Lee, YS; Nam, SW; Park, DH; Park, TW; Park, YM; Yang, JM; Yoon, SK | 1 |
| Anschuetz, G; Baker, A; Brown, N; Everson, G; Fontana, RJ; Gardner, SD; Griffiths, D; Hann, HW; Riely, C; Schiff, ER; Wright, T | 1 |
| Benhamou, Y; Thibault, V; Tubiana, R | 1 |
| Aikawa, A; Akima, M; Hasegawa, A; Ishii, K; Matsumaru, K; Nonaka, H; Shinohara, M; Sumino, Y | 1 |
| Busuttil, RW; Durazo, F; Edelstein, M; Farmer, D; Ghobrial, RM; Goldstein, L; Han, SH; Holt, C; Hu, R; Kunder, G; Martin, P; Saab, S | 1 |
| Barg-Hock, H; Becker, T; Bleck, JS; Bock, CT; Böker, KH; Flemming, P; Klempnauer, J; Manns, MP; Rosenau, J; Tillmann, HL; Trautwein, C | 1 |
| Berg, T; Hopf, U; Schernick, A; Van Bömmel, F | 1 |
| de Man, RA; Janssen, HL; Kwekkeboom, J; Niesters, HG; Schalm, SW; Sprengers, D | 1 |
| Adams, P | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Saitoh, S; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A | 1 |
| Fan, ST; Lai, CL; Liu, CL; Lo, CM; Wong, J | 1 |
| Chan, HW; Tong, KL; Tsang, WK | 1 |
| Burroughs, AK; Papatheodoridis, GV; Sevastianos, V | 1 |
| Bar-Nathan, N; Ben-Ari, Z; Mor, E; Shaharabani, E; Shapira, Z; Tur-Kaspa, R | 1 |
| Bernardos, A; Cañas, E; Díaz, C; García, I; Gómez, MA; Hinojosa, R; Martín, C; Pareja, F; Pascasio, JM; Pérez-Bernal, JB; Sayago, M; Serrano, J; Sousa, JM; Tamayo, MJ | 1 |
| Yan, J; Zhang, LS; Zhao, XK | 1 |
| Bartholomeusz, A; Bowden, S; Locarnini, S | 1 |
| Cevreska, L; Efremov, DG; Georgievski, B; Panovska, I; Pivkova, A | 1 |
| Chen, M; Deng, W; Li, X; Ruan, L; Wang, Y; Zhou, G; Zhou, S; Zhou, Z | 1 |
| Boyer, N; Castelnau, C; Marcellin, P | 1 |
| Färkkilä, M | 1 |
| Bohane, TD; Connor, FL; Kennedy, SE; Rosenberg, AR | 1 |
| Feber, J; Filler, G; Le Saux, N; Weiler, G | 1 |
| Cirocco, R; Kato, T; Levi, DM; Madariaga, J; Nery, JR; Nery-Avila, C; Nishida, S; Reddy, KR; Ruiz, P; Schiff, E; Tzakis, AG; Weppler, D | 1 |
| Schwarz, KB | 1 |
| Brandwein, J; Gupta, V; Kamel-Reid, S; Lipton, JH; Messner, HA; Minden, MD | 1 |
| Buti, M; Casafont, F; Cruz de Castro, E; García-Rey, C; González, A; Herrero, JI; Jardí, R; Mas, A; Miras, M; Prieto, M | 1 |
| Zoulim, F | 3 |
| Kessler, HH; Marth, E; Stauber, RE; Stelzl, E | 1 |
| Allwinn, R; Caspary, WF; Faust, D; Rabenau, HF; Zeuzem, S | 1 |
| Hidaka, S; Horiike, N; Iuchi, H; Konishi, I; Michitaka, K; Miyake, T; Nakanishi, S; Onji, M; Yoshino, I | 1 |
| Castellví, JM; del Río, N; Diloy, R; Hernández, JA; Martínez, X; Salat, D | 1 |
| Rossi, G | 1 |
| Ohmoto, K; Tsuduki, M; Yamamoto, S | 1 |
| Ben-Ari, Z; Melzer, E; Schmilovitz-Weiss, H; Tur-Kaspa, R | 1 |
| Ahmed, A; Ahmed, AM; Garcia, G; Keeffe, EB; Nguyen, MH; Simpson, ND; Simpson, PW | 1 |
| de Man, RA; Janssen, HL; Niesters, HG; Schalm, SW; van Nunen, AB; van Zonneveld, M | 1 |
| Kimura, T; Kiyosawa, K; Maki, N; Matsumoto, A; Orii, K; Rokuhara, A; Sun, X; Tanaka, E; Yagi, S; Yamaura, T | 1 |
| Boucher, CA; Haverkamp, M; Hoepelman, AI; Smit, M; Weersink, A | 1 |
| Bock, CT; Dienes, HP; Klein, C; Kubicka, S; Locarnini, S; Manns, MP; Trautwein, C; Wedemeyer, H; Wüstefeld, T | 1 |
| Maeda, Y; Okamoto, R; Sasaki, T | 1 |
| Ayres, A; Bartholomeusz, A; Cooley, L; Crowe, S; Lewin, S; Locarnini, S; Mijch, A; Sasadeusz, J | 1 |
| Hou, HY; Li, AM; Li, XM; Shen, HM; Shi, MF; Shi, ZJ; Teng, BQ; Yang, YB; Zou, L | 1 |
| Berger, F; Boillot, O; Chevallier, P; Dumortier, J; Scoazec, JY | 1 |
| Hou, JL; Luo, KX; Sun, J; Wang, ZH; Xiao, L; Zhang, L | 1 |
| Chen, YM; Lei, Y; Xiang, GQ; Zhang, HH; Zhang, WY | 1 |
| Cai, C; Chen, G; He, X; Huang, J; Lu, M; Wang, G; Yang, Y; Zhu, X | 2 |
| Disel, U; Paydas, S; Sahin, B; Yavuz, S | 1 |
| Chiba, T; Fukai, K; Goto, S; Imazeki, F; Narita, M; Saisho, H; Shishido, H; Yokosuka, O | 1 |
| Andreone, P; Bernardi, M; Biselli, M; Cursaro, C; Gramenzi, A; Lorenzini, S | 1 |
| Albeniz Arbizu, E; Barcena Marugan, R; de Vicente Lopez, E; Garcia Gonzalez, M; Mateo Lindeman, M; Moraleda Garcia, G; Oton Nieto, E | 1 |
| Albeniz Arbizu, E; Barcena Marugan, R; Carrera Alonso, E; de Vicente Lopez, E; Garcia Gonzalez, M; Martin Davila, P; Moreno Garcia, J; Nuño Vazquez-Garza, J; Oton Nieto, E | 1 |
| Ahn, SH; Chang, HY; Han, KH; Kim, KH; Kim, SI; Lee, KH; Seong, BL; Tong, S; Yoon, YJ | 1 |
| Ali, HY | 1 |
| Maier, KP | 1 |
| Asari, S; Deguchi, M; Ichigo, K; Iwatani, Y; Kagita, M; Kanakura, Y; Nakano, T; Sasahara, Y; Tahara, K | 1 |
| Sablon, E; Shapiro, F; Zoulim, F | 1 |
| Cheng, VC; Lau, GK; Lo, CM | 1 |
| Elefsiniotis, IS; Kafiri, G; Ketikoglou, I; Mavrogiannis, C; Moulakakis, A; Pantazis, KD | 1 |
| Bai, YJ; Lv, GT; Wang, Y; Yan, XJ; Zhang, WH; Zhao, JR | 1 |
| Chan, AO; Fan, ST; Kato, T; Lai, CL; Mizokami, M; Ng, IO; Sum, SM; Wong, DK; Yuan, HJ; Yuen, JC; Yuen, MF | 1 |
| Beckebaum, S; Broelsch, CE; Cicinnati, VR; Gerken, G | 1 |
| Cao, YJ; Huang, JS; Lin, LY; Wang, H; Zhou, DY | 1 |
| Huang, DS; Liang, TB; Wang, WL; Wu, J; Xu, X; Zheng, SS | 1 |
| Ciancia, R; De Divitiis, B; De Renzo, A; Del Giudice, A; Pane, F; Persico, M; Picardi, M; Quintarelli, C; Rotoli, B; Salvatore, F | 1 |
| Fan, J; Liang, WF; Xie, YJ; Yang, DH; Zhao, NF | 1 |
| Pai, RB; Pai, SB; Schinazi, RF | 1 |
| Berenberg, JL; Mills, SJ; Ramos, F | 1 |
| Buster, EH; Schalm, SW; van der Eijk, AA | 1 |
| De Diego, L; Martín, E; Martín, L; Martínez, MC; Rendón, P; Soria, MJ | 1 |
| Balistreri, WF; Hochman, JA | 1 |
| Bertoletti, A; Gilson, RJ; Lascar, RM; Lopes, AR; Maini, MK | 1 |
| Gong, Q; Liu, C; Lu, Z; Wang, Y; Zhang, D; Zhang, S; Zhang, X | 1 |
| Kang, YK; Kim, E; Kim, SB; Kim, SW; Kim, WK; Lee, GW; Lee, JH; Lee, JL; Lee, JS; Lee, KH; Oh, S; Ryu, MH; Suh, C | 1 |
| Arinaga, T; Hisamochi, A; Ide, T; Koga, Y; Kumashiro, R; Kuwahara, R; Ogata, K; Sata, M; Tanaka, K | 1 |
| Lee, HC; Suh, DJ | 1 |
| Lai, CL; Poynard, T; Ratziu, V; Yuen, MF | 1 |
| Heathcote, J | 1 |
| Perrillo, RP | 3 |
| Berenguer, M; Wright, TL | 1 |
| Altmeyer, P; Boms, S; Gambichler, T; Paech, V; Rotterdam, S; Stücker, M | 1 |
| Au, WY; Cheng, HC; Cheung, M; Fong, DY; Lai, LS; Lau, GK; Liang, R; Lie, A; Ngan, R; Yiu, HH; Zhang, HY | 1 |
| Kirchner, JT; Lin, KW | 1 |
| Chan, AO; Hui, CK; Lai, CL; Sablon, E; Sum, SM; Wang, BC; Wong, DK; Yuan, HJ; Yuen, MF | 1 |
| Dussaix, E; Férey, MP; Fki, L; Mackiewicz, V; Roque-Afonso, AM | 1 |
| Brown, NA | 1 |
| Kobayashi, S | 1 |
| Benhamou, Y | 1 |
| Chan, AT; Chan, PK; Ho, WM; Johnson, PJ; Lam, KC; Lee, JJ; Lei, KI; Leung, TW; Mok, TS; Yeo, W; Zee, B; Zhong, S | 1 |
| Lavanchy, D | 1 |
| Akan, H; Akbulut, H; Arat, M; Arslan, O; Beksaç, M; Bozdayi, M; Idilman, R; Karayalçin, S; Ozcan, M; Ozden, A; Soydan, E; Soykan, I; Törüner, M; Türkyilmaz, AR; Van Thiel, DH | 1 |
| Mauss, S | 1 |
| Ganem, D; Prince, AM | 1 |
| Bilici, A; Ozguroglu, M; Serdengecti, S; Turna, H | 1 |
| Blockmans, D; De Backer, AI; Deeren, DH; Malbrain, ML; Verbraeken, H | 1 |
| Bonino, F; Brunetto, MR; Casazza, G; Favre, C; Macchia, P; Menconi, MC; Nardi, M; Oliveri, F | 1 |
| Cheung, ST; Fan, ST; Lai, CL; Liu, CL; Lo, CM; Ng, IO | 1 |
| Chen, HY; Song, PH; Tian, DY; Xu, D; Zhang, ZG | 1 |
| Chao, TY; Dai, MS; Lu, JJ; Shyu, RY; Wu, PF | 2 |
| Chen, TY; Lee, YC; Su, WC; Tsao, CJ; Young, KC | 1 |
| Bunnapradist, S; Dixit, V; Dulai, G; Fabrizi, F; Martin, P | 1 |
| Hino, T; Ide, T; Inoue, H; Koga, Y; Kumashiro, R; Kuwahara, R; Sata, M; Tanabe, R; Tanaka, E | 1 |
| Maggiolo, F; Ripamonti, D; Suter, F | 1 |
| Attili, A; Berloco, P; Callejon, V; Ferretti, G; Ferretti, S; Ginanni Corradini, S; Iappelli, M; Lilli, D; Mancini, C; Masini, A; Merli, M; Rivanera, D; Rossi, M; Tanzilli, P | 1 |
| Angelico, M; Di Paolo, D; Lenci, I; Piccolo, P; Tisone, G; Zazza, S | 1 |
| Abbas, Z; Jafri, W; Khokhar, N; Shah, SH; Zuberi, SJ | 1 |
| Angus, P; Locarnini, S | 1 |
| Chien, RN; Liaw, YF; Yeh, CT | 1 |
| Elefsiniotis, IS; Mpotsi, C; Pantazis, KD; Paparizos, V | 1 |
| Chan, FK; Chan, HL; Chui, AK; Hui, AY; Lai, EC; Lau, WY; Rao, AR; Sung, JJ; Wong, J | 1 |
| Black, A; Dixon, JS; el-Sayed, MH; el-Tawil, A; Karim, AM; Shanab, G | 1 |
| Asaka, M; Imamura, M; Kanamori, H; Kawamura, T; Masauzi, N; Miura, T; Obara, S; Saitoh, S; Tanaka, J; Tsutsumi, Y; Yamada, M | 1 |
| Bielefeld, P; Cohen, P; Guillevin, L; Hausfater, P; Imbert, B; Larroche, C; Loustaud-Ratti, V; Mahr, A; Petitjean, P; Queyrel, V; Roudier, J; Smadja, D | 1 |
| Perelson, AS; Ribeiro, RM | 1 |
| Bunnapradist, S; Fabrizi, F; Martin, P | 1 |
| Chan, TM; Ho, SK; Lai, KN; Tang, CS; Tse, KC | 1 |
| Drake, A; Mijch, A; Sasadeusz, J | 1 |
| Cooksley, WG | 1 |
| Janssen, HL; Schalm, SW; van Zonneveld, M | 1 |
| Buti, M; Esteban, R; Guardia, J; Jardi, R; Martinez, M; Rodriguez-Frias, F; Schaper, M; Valdes, A | 1 |
| Huh, W; Joh, JW; Kim, DJ; Kim, JA; Kim, SJ; Kim, YG; Lee, KW; Oh, HY | 1 |
| Murphy, MJ; Wilcox, RD | 1 |
| Benhamou, Y; Cahour, A; Katlama, C; Lada, O; Poynard, T; Thibault, V | 1 |
| Ayaz, C; Değertekin, H; Kokoğlu, OF; Yalçin, K | 1 |
| Avci, IY; Bozdayi, AM; Eyigun, CP; Pahsa, A; Turkyilmaz, AR; Yurdaydin, C | 1 |
| Ayres, A; Bartholomeusz, A; Bowden, S; Lau, D; Lewin, SR; Locarnini, S; Walters, T; Wightman, F | 1 |
| Borlenghi, E; Cariani, E; Motta, M; Pelizzari, AM; Rossi, G; Turconi, P | 1 |
| Cote, PJ; Delaney, WE; Gerin, JL; Jacob, JR; Korba, BE; Tennant, BC; Toshkov, I | 1 |
| Enomoto, M; Hino, M; Nishiguchi, S; Seki, S; Yamane, T | 1 |
| Lim, YS; Suh, DJ | 1 |
| Cho, M; Heo, J; Jang, HJ; Kang, DH; Kim, CM; Kim, GH; Kim, HH; Park, HK; Shin, YM; Song, GA; Yang, US | 1 |
| Angus, P; Ayres, A; Bartholomeusz, A; Colonno, RJ; Discotto, L; Levine, SM; Locarnini, S; Plym, M; Pokornowski, K; Rose, RE; Sievert, W; Tenney, DJ; Thompson, G; Walsh, AW; Warner, N; Weinheimer, SP; Yu, CF | 1 |
| Chao, TY; Dai, MS; Kao, WY; Liu, TM; Shyu, RY | 1 |
| Kondili, LA; Mutimer, D; Osman, H | 1 |
| Andreone, P; Bernardi, M; Biselli, M; Cammà, C; Cursaro, C; Gramenzi, A; Trevisani, F | 1 |
| Chan, AO; Lai, CL; Sablon, E; Wong, BC; Wong, DK; Yuan, HJ; Yuen, MF | 1 |
| Cho, B; Cho, M; Heo, J; Jang, H; Jun, H; Kim, C; Kim, H; Park, H; Shin, W | 1 |
| Antonio, G; Federica, S; Giuseppe, L; Luca, L; Michela, T; Nicola, P; Paola, P; Patrizia, C; Simona, S | 1 |
| Käser, L; Kolyvanos Naumann, U; Vetter, W | 1 |
| Asahina, Y; Izumi, N | 1 |
| Matsumura, M | 1 |
| Fujiwara, K; Mochida, S | 1 |
| Yoshiba, M | 1 |
| Makuuchi, M; Sugawara, Y | 1 |
| Albert, J; Lindström, A; Odeberg, J | 1 |
| Bani-Sadr, F; Molina, JM; Palmer, P; Scieux, C | 1 |
| Curry, MP | 1 |
| De Medina, M; Madariaga, J; Montalbano, M; Neff, GW; Nery, C; Nery, J; O'brien, CB; Ruiz, P; Safdar, K; Schiff, ER; Shire, N; Tzakis, AG | 1 |
| Basso, M; Campo, N; Delfino, A; Martelli, A; Mattioli, F; Pelli, N; Picciotto, A; Torre, F | 1 |
| Duncan, R; Lau, DT; Madariaga, JR; Montalbano, M; Muslu, H; Neff, GW; Nery, C; Nery, J; O'Brien, CB; Ruiz, P; Safdar, K; Schiff, ER; Shire, NJ; Tzakis, AG | 1 |
| Ambu, S; Ancarani, F; Bonasso, M; Bruno, R; Cozzi-Lepri, A; d'Arminio Monforte, A; Ferraro, T; Puoti, M; Santantonio, T; Toti, M; Tundo, P | 1 |
| Da Costa, M; Dan, YY; Isaac, J; Lee, HL; Lee, KH; Lee, YM; Lim, SG; Mak, K; Prabhakaran, K; Sutedja, DS; Wai, CT; Wee, A | 1 |
| Chen, YS; Chi, NH; Chou, NK; Hsu, RB; Huang, SC; Ko, WJ; Lai, MY; Lee, YT; Liau, CS; Tsao, CI; Wang, SS; Yu, HY | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Saitoh, S; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A | 1 |
| Ackerman, Z; Ben-Ari, Z; Lurie, Y; Reshef, R; Rosner, G; Safadi, R; Sbeit, W; Schmilovitz-Weiss, H; Sikuler, E; Tur-Kaspa, R; Zuckerman, E | 1 |
| Liu, C; Lu, Y; Pan, CE; Wang, B; Wu, Z; Yu, L | 1 |
| Akiyoshi, J; Itano, S; Koga, H; Kumashiro, R; Kurogi, J; Matsugaki, S; Nagamatsu, H; Nagaoka, S; Sata, M; Tajiri, N; Torimura, T; Yamasaki, S | 1 |
| Telegdy, L | 1 |
| Däumer, M; Kaiser, R; Matz, B; Rockstroh, JK; Schewe, CK; Schildgen, O; Vogel, M; Weitner, L | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Matsuda, M; Ooga, H; Saitoh, S; Satoh, J; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y; Tsubota, A | 1 |
| D'Onofrio, M; Marrone, A; Ricciotti, R; Ruggiero, G; Utili, R; Zampino, R | 1 |
| Christian, CL | 1 |
| Cotler, SJ; Mohanty, SR | 1 |
| Ali, H; Egawa, H; Kasahara, M; Marusawa, H; Nabeshima, M; Ogawa, K; Tanaka, K; Ueda, M; Uryuhara, K | 1 |
| Akay, S; Akyildiz, M; Karasu, Z; Tokat, Y | 1 |
| Duan, XZ; Li, HW; Wang, FS; Wang, M; Xu, D; Zhuang, H | 1 |
| Akarca, U; Akyildiz, M; Arikan, C; Batur, Y; Demirbas, T; Ersoz, G; Gunsar, F; Karasu, Z; Kilic, M; Kobat, A; Ozacar, T; Tokat, Y | 1 |
| Ando, K; Fukuno, K; Hara, T; Imawari, M; Kasahara, S; Moriwaki, H; Onishi, H; Oyama, M; Sawada, M; Takahashi, T; Takai, S; Takami, T; Tomita, E; Tsurumi, H; Yamada, T | 1 |
| Enjoji, M; Kotoh, K; Nakamuta, M; Nawata, H; Noguchi, K; Sugimoto, R; Tsuruta, S | 1 |
| Caccamo, L; Colombo, M; Fassati, LR; Lunghi, G; Maggioni, M; Radice, F; Romeo, R; Rossi, G | 1 |
| Abbadessa, V; Ammatuna, E; Calvaruso, G; Craxí, A; Di Stefano, R; Di Trapani, R; Ferraro, D; Iannitto, E; Minardi, V; Mulè, A; Stefano, RD; Trapani, RD | 1 |
| Adani, GL; Baccarani, U; Bresadola, F; Della Rocca, G; Risaliti, A; Viale, P | 1 |
| Bo, P; Burra, P; Cillo, U; Loreno, M; Naoumov, N; Senzolo, M | 1 |
| Chen, LY; Huang, J; Li, ZG; Qiao, P; Qiu, JM; Wang, SQ | 1 |
| Alessandria, C; Carenzi, S; Debernardi-Venon, W; Franchello, A; Gaia, S; Ghisetti, V; Marzano, A; Premoli, A; Rizzetto, M; Salizzoni, M | 1 |
| Akuta, N; Arfase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Matsuda, M; Miyakawa, Y; Saitoh, S; Sato, J; Someya, T; Suzuki, F; Suzuki, Y; Watabiki, S | 1 |
| Cho, YS; Chon, CY; Han, KH; Lee, CK; Moon, YM; Park, IS; Suh, JH; Won, SY | 1 |
| Gehri, M; Gerner, P; Laubscher, B; Roulet, M; Wirth, S | 1 |
| Bunnapradist, S; Fabrizi, F; Martin, P; Messa, PG; Rusconi, E; Villa, M | 1 |
| Choi, BC; Lei, XY; Li, D; Men, K; Xu, DZ; Yan, YP; Zhang, JX | 1 |
| Joh, JW; Kim, SJ; Lee, DH; Lee, HH; Lee, KW; Park, JW; Yoo, BC | 1 |
| Idilman, R | 2 |
| Ceballos, M; Diaz, F; Garcia, A; Garcia, T; González, P; Mazuecos, A; Rivero, M | 1 |
| Barrios Peinado, C; Cuervas-Mons Martínez, V; Herreros de Tejada Echanojáuregui, A; López Monclús, J; Lucena de la Poza, JL; Moreno Planas, JM; Portero Azorin, F; Revilla Negro, J; Rubio González, E; Sánchez Turrión, V | 1 |
| Hiraoka, A; Hirooka, M; Horiike, N; Iuchi, H; Kubo, Y; Kumagi, T; Kurose, K; Michitaka, K; Miyaoka, H; Ohmoto, M; Okada, S; Onji, M; Uehara, T; Yamamoto, K; Yamashita, Y | 1 |
| Feucht, HH; Laufs, R; Petersen, J; Schröter, M; Sterneck, M; Wursthorn, K; Zöllner, B | 1 |
| Akalin, E; Ames, S; Bromberg, JS; Murphy, B; Sehgal, V | 1 |
| Chen, PM; Chiou, TJ; Hsiao, LT; Lee, MY; Lin, PC; Poh, SB | 1 |
| Colombo, M; Donato, MF | 1 |
| Alaimo, G; Almasio, PL; Bonura, C; Cappello, M; Craxì, A; Di Marco, V; Di Stefano, R; Ferraro, D; Giglio, M; Parisi, P | 1 |
| Asaka, M; Imamura, M; Kanamori, H; Masauzi, N; Mori, A; Tanaka, J; Tsutsumi, Y | 1 |
| Lei, XY; Li, D; Men, K; Xu, DZ; Yan, YP; Zhang, JX | 1 |
| Chen, H; Cheng, SQ; Cong, WM; Shen, F; Wang, PJ; Wu, MC; Yang, JH; Zhao, YX | 1 |
| Cañas, C; Casais, LA; Casanova, A; Chahri, N; Figueras, J; Gornals, J; Lopez, C; Taltavull, TC; Verdura, B | 1 |
| Gao, ZL; Gu, L; Huang, YS; Li, G; Ma, HH; Peng, XM; Xie, QF | 1 |
| Hou, W; Li, MW; Liu, KZ; Wo, JE | 1 |
| Choi, MS; Koh, KC; Lee, JH; Moon, W; Moon, YM; Paik, SW; Rhee, JC; Shim, SG; Yoo, BC | 1 |
| Chao, TY; Dai, MS | 1 |
| Bellido, D; Casado, JL; Chamorro, AJ; Moreno, S | 1 |
| Au, WY; Cheung, WW; Hui, CK; Kwong, YL; Lau, GK; Leung, N; Liang, R; Lie, AK; Wong, BC; Yueng, YH; Zhang, HY | 1 |
| Chen, HS; Feng, LL; Guo, XB; He, JY; Yang, RY; Zhang, FX; Zhu, YT | 1 |
| Chiba, T; Fukai, K; Imamura, T; Imazeki, F; Kanda, T; Kojima, H; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O | 1 |
| Erb, SR; Ho, JK; Hoskins, PJ; Law, JK; Steinbrecher, UP; Yoshida, EM | 1 |
| Chen, Y; Liu, XX; Wei, L; Yu, YX | 1 |
| Chan, AT; Chan, PK; Ho, WM; Hui, EP; Johnson, PJ; Lam, KC; Lee, JJ; Mo, FK; Mok, TS; Yeo, W | 1 |
| Yatsuhashi, H | 1 |
| Liu, F; Ma, ZM; Wang, YX; Wen, YM; Weng, XH; Yao, X; Zhang, JM | 1 |
| Husa, P | 1 |
| de Silva, HJ; Herath, CA; Sheriff, MH | 1 |
| Ahn, BM; Bae, SH; Cho, SH; Choi, JY; Chung, KW; Han, NI; Jang, JW; Sun, HS; Yang, JM; Yoon, SK | 1 |
| Cao, Y; Geng, H; Hua, B; Sun, Y; Wang, H; Yu, A | 1 |
| Choi, WB; Chung, YH; Kim, KM; Lee, HC; Lee, YS; Lim, YS; Suh, DJ | 1 |
| Garipidou, V; Giouleme, O; Perifanis, V; Tziomalos, K; Vakalopoulou, S; Vassiliadis, T | 1 |
| Colby, TJ; Erion, MD; Fujitaki, JM; Reddy, KR; van Poelje, PD | 1 |
| Chayama, K; Fujimoto, Y; Hiraga, N; Imamura, M; Iwao, E; Noguchi, C; Ochi, H; Oga, H; Takahashi, S; Takaishi, H; Tateno, C; Tsuge, M; Yoshizato, K | 1 |
| Chen, CJ; Cheng, G; He, YS; Liu, N; Ou, ZY | 1 |
| Shen, ZY; Wang, ZF; Zhu, ZJ | 1 |
| Berg, T; Seehofer, D | 1 |
| Araki, Y; Fujio, K; Fujioka, S; Hashimoto, K; Iwasaki, Y; Kaneyoshi, T; Kobashi, H; Nishida, T; Piao, CY; Sakaguchi, K; Senoh, T; Shiratori, Y; Terada, R | 1 |
| Bester, R; Cotton, MF; de Waal, N; Rabie, H | 1 |
| Colombo, M; Cortelezzi, A; Deliliers, GL; Fantini, NN; Lampertico, P; Pasquini, MC; Viganò, M; Zilioli, VR | 1 |
| Colombo, M; Iavarone, M; Lampertico, P; Lunghi, G; Manenti, E; Viganò, M | 1 |
| Chen, DS; Kao, JH; Liu, CJ | 2 |
| Hashimoto, K; Kishikawa, K; Kuwano, H; Maehara, Y; Mochida, Y; Shimada, M; Shimura, T; Soejima, Y; Suehiro, T; Yoshizumi, T | 1 |
| Lai, MY; Lee, SD; Ng, YY; Yang, WC | 1 |
| Aguilar-Benavides, S; Alvarado-Esquivel, C; Conde-González, CJ; de la Ascensión Carrera-Gracia, M; Juárez-Figueroa, L; Ruiz-Maya, L; Sablon, E; Torres-Valenzuela, A | 1 |
| Bradarić, N | 1 |
| Beld, MG; Lange, JM; Pogány, K; Prins, JM; Wit, FW; Zaaijer, HL | 1 |
| Avilés, JF; Bárcena, R; Barrios, C; Buti, M; Casanovas, T; Cuervas, V; De la Mata, M; Del Campo, S; Delgado, M; Dieguez, ML; Fraga, E; Gonzalez, A; Herrero, JI; Loinaz, C; Mas, A; Moraleda, G; Moreno, JM; Muñoz, R; Otero, A; Prieto, M; Rueda, M; Sousa, JM | 1 |
| Barcena, R; Blesa, C; Foruny, JR; Garcia-Garzon, S; Garcia-Gonzalez, M; Moreno, A; Moreno-Zamora, A; Oton, E; Ruiz, P | 1 |
| Chiang, YJ; Chu, SH; Fang, JT; Huang, CC; Huang, JY; Lin, HH; Tian, YC; Wu, MS; Yang, CW; Yen, TH; Yu, CC | 1 |
| Shah, SR | 1 |
| Chao, TC; Chen, PM; Chiou, TJ; Chu, CJ; Hsiao, LT; Lin, YC; Liu, JH; Tzeng, CH; Wang, WS; Yang, MH; Yen, CC | 1 |
| de Man, RA; de Vries-Sluijs, TE; Hansen, BE; Osterhaus, AD; van der Eijk, AA; van der Ende, ME | 1 |
| Akuta, N; Arase, Y; Hosaka, T; Ikeda, K; Kobayashi, M; Kumada, H; Matsuda, M; Saitoh, S; Satoh, J; Sezaki, H; Someya, T; Suzuki, F; Suzuki, Y; Watahiki, S | 1 |
| Chayama, K; Iino, S; Imamura, M; Kawata, S; Kimura, T; Kiyosawa, K; Kobayashi, M; Maki, N; Matsumoto, A; Minami, M; Mizokami, M; Nagaoka, S; Okanoue, T; Suzuki, F; Tanaka, E; Tanaka, Y; Yatsuhashi, H; Yotsuyanagi, H | 1 |
| Arai, S; Hasumi, M; Hatori, M; Makino, T; Okugi, H; Shibata, Y; Suzuki, K | 1 |
| Fouillard, L; Gozlan, J; Serfaty, L | 1 |
| Guan, ZZ; He, YF; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Lin, XB; Sun, XF; Wang, FH; Xia, ZJ; Zhang, L | 1 |
| Zhang, FK | 1 |
| Cai, HD; Liu, M; Wang, L | 1 |
| Gu, HX; Hattori, T; Li, D; Zhang, SY; Zhong, ZH; Zhuang, M | 1 |
| Benhamou, Y; Fleury, H; Katlama, C; Le Teuff, G; Pellegrin, I; Piketty, C; Rozenbaum, W; Trimoulet, P; Trylesinski, A; Urbinelli, R | 1 |
| Enomoto, M; Nishiguchi, S; Tamori, A | 1 |
| Eguchi, K; Fukushima, T; Gotoh, T; Hayashi, T; Ichikawa, T; Ida, H; Kawakami, A; Nakamura, H; Takeshita, S; Toriyama, K; Tsujino, A | 1 |
| Lee, ST; Ng, YY; Yang, WC | 1 |
| Colak, T; Dalgiç, A; Emiroğlu, R; Filik, L; Gür, G; Haberal, M; Karakayali, H; Moray, G; Ozdemir, N; Yilmaz, U | 1 |
| Akan, M; Akarsu, M; Astarcioğlu, H; Astarcioğlu, I; Karademir, S; Ozkardesler, S; Ozzeybek, D; Sayiner, A; Tankurt, E | 1 |
| Ayres, A; Bartholomeusz, A; Cooper, DA; Dore, GJ; Lewin, S; Locarnini, S; Matthews, GV; Sasaduesz, J; Seaberg, E; Thio, CL | 1 |
| Goffin, E; Horsmans, Y; Kanaan, N | 1 |
| Boninsegna, S; Caroli, D; Fagiuoli, S; Floreani, A; Lobello, S | 1 |
| Schiff, ER; Schreibman, IR | 1 |
| Abelli, LA; Aloisi, A; Casula, F; Chezzi, C; Dettori, G; Martinelli, M; Medici, MC; Valcavi, P | 1 |
| Canbay, A; Dalekos, GN; Eisenbach, C; Encke, J; Gerken, G; Graziadei, I; Hadem, J; Leifeld, L; Manns, MP; Schmidt, H; Schneider, A; Spengler, U; Tillmann, HL; Vogel, W; Wedemeyer, H; Zachou, K | 1 |
| Aranda-Michel, J; Bonatti, H; Dickson, RC; Mendez, J; Satyanarayana, R; Yen, RD | 1 |
| Dan, YY; Lim, SG; Wai, CT; Yeoh, KG | 1 |
| Bakal, I; Ben Ari, Z; Kramer, MR; Morali, G; Shitrit, AB; Shitrit, D | 1 |
| Bizzarri, R; Bonino, F; Brunetto, MR; Choudhury, S; Civitano, L; Colombatto, P; Gieschke, R; Oliveri, F | 1 |
| Gong, ZJ; Jiang, XL; Mizokami, M; Xu, LM; Yuan, J; Zhou, BP | 1 |
| Hasegawa, H; Miyagi, T; Nagasaki, A; Nakachi, S; Shinzato, O; Taira, N; Takasu, N; Tomoyose, T | 1 |
| Tillmann, HL | 1 |
| Kumada, H; Nakamura, H; Suzuki, F | 1 |
| Planas, R; Ribera, JM; Sancho, JM; Vives, S | 1 |
| Cai, CJ; Chen, GH; Lu, MQ; Yang, Y; Zhao, H | 1 |
| Abate, ML; Ciancio, A; Gaia, S; Olivero, A; Rizzetto, M; Smedile, A | 1 |
| Chau, TN; Chiu, MC; Lai, ST; Ng, TK; Tam, CM; Yu, WC | 1 |
| Berg, T; Feucht, HH; Hüppe, D; Möller, B; Sarrazin, C; Spengler, U; van Bömmel, F; Wiedenmann, B; Zöllner, B | 1 |
| Hollinger, FB; Lau, DT | 1 |
| Ayli, D; Dede, F | 1 |
| Lai, KN; Tang, S | 1 |
| Chen, YB; Li, B; Li, ZH; Wang, WT; Wen, TF; Xu, MQ; Yan, LN; Yan, ML; Yang, JY; Zeng, Y | 1 |
| Angelico, M; Carbone, M; Di Paolo, D; Lenci, I; Longhi, C; Tisone, G; Trinito, MO | 1 |
| Chen, CH; Chen, DS; Hsieh, SC; Sheu, JC; Tsai, FC | 1 |
| Grant, RM; Levy, V | 1 |
| Abut, E; Akbayir, N; Bolukbas, C; Bolukbas, FF; Dalay, AR; Horoz, M; Ince, AT; Kendir, T; Ovunc, O; Sokmen, MH | 1 |
| Akcam, M; Artan, R; Gelen, T; Yilmaz, A | 1 |
| Barbaria, F; De Lisi, S; Di Marco, V; Li Vecchi, M; Maringhini, S | 1 |
| Schiff, ER | 2 |
| Arici, C; Castagna, A; Cozzi-Lepri, A; Dabis, F; De Luca, A; Garrido, M; Gervais, A; Gill, J; Ledergerber, B; Lundgren, JD; Milazzo, L; Moller, NF; Monforte, Ad; Mussini, C; Ourishi, N; Paraninfo, G; Puoti, M; Raffi, F; Rickenbach, M; Rockstroh, J; Suarez-Lozano, I; Winnock, M | 1 |
| Acar, K; Aki, Z; Bozdayi, G; Haznedar, R; Sucak, GT; Yağci, M | 1 |
| Han, YS; Joh, JW; Kim, DJ; Kim, SJ; Kwon, CH; Lee, SK; Park, JB; Park, JW | 1 |
| Chen, YS; Chi, NH; Chou, NK; Chu, SH; Hsu, RB; Huang, SC; Ko, WJ; Lai, MY; Tsao, CI; Wang, SS; Yu, HY | 1 |
| Huang, GT; Lee, CZ; Lee, HS; Sheu, JC; Yang, PM | 1 |
| Han, B; Jin, LJ; Shi, M; Wang, RS; Xu, YP; Yang, ZJ; Zhang, H; Zhang, Y; Zhu, YF | 1 |
| Trautwein, C | 1 |
| Ciancia, R; Martinelli, V; Montante, B; Orlando, R; Piazza, M; Portella, G; Rotoli, B; Tiseo, D; Tosone, G | 1 |
| Chiba, T; Egawa, H; Marusawa, H; Takada, Y; Ueda, M; Uemoto, S; Umeda, M | 1 |
| Huang, YW; Kao, JH; Lai, MK; Lai, MY; Lee, PH; Liu, CJ; Tsai, MK; Wang, SS | 1 |
| Devereux, S; Ho, AY; Lim, ZY; Moses, SE; Mufti, GJ; Pagliuca, A; Sudhanva, M; Zuckerman, M | 1 |
| Arabe, J; Gomes, SA; Mello, FC; Niel, C; Rolla, VC; Santos, EA; Sucupira, MV | 1 |
| Pol, S | 2 |
| Cetin, M; Demir, H; Kasem, M; Kuşkonmaz, B; Tavil, B; Uçkan, D | 1 |
| Colonno, R; De Clercq, E; Neyts, J; Ying, C | 1 |
| Dassanayake, AS; de Silva, AP; de Silva, HJ; Manamperi, A | 1 |
| Chen, HC; Hung, CC; Hwang, SJ; Kuo, MC; Tsai, JC; Wang, YC | 1 |
| Cakir, N; Midilli, K; Pamuk, ON; Umit, H | 1 |
| Baldick, CJ; Colonno, RJ; Eggers, B; Fang, J; Hsu, M; Levine, SM; Mazzucco, CE; Plym, MJ; Pokornowski, KA; Poundstone, P; Rose, RE; Tenney, DJ; Walsh, AW; Yang, J; Yu, CF; Zhang, S | 1 |
| Das, K; Hissar, S; Kumar, M; Monga, R; Pande, C; Sarin, SK; Satapathy, S; Sharma, BC | 1 |
| Choi, KH; Hong, SP; Hwang, SG; Kim, S; Ko, KH; Kwon, CI; Lee, JH; Oh, D; Park, PW; Rim, KS | 1 |
| Hester, J; Jain, MK; Lee, WM; Parekh, NK | 1 |
| Dumas, L; Mieli-Vergani, G; Vergani, D | 1 |
| Chen, CL; Cheng, YF; Concejero, A; Eng, HL; Jawan, B; Lin, CC; Lin, TS; Liu, YW; Wang, CC; Wang, SH; Yang, CH; Yong, CC | 1 |
| Cho, YS; Kim, DH; Kim, DY; Kim, HJ; Lee, CK; Park, BK; Park, IS; Suh, JH; Won, SY | 1 |
| Angelousi, AG; Charatsis, GG; Falagas, ME; Lampropoulos, KM; Panos, GZ | 1 |
| Baskin, E; Bilezikçi, B; Canan, O; Melek, E; Ozçay, F; Surmali Onay, O | 1 |
| Iwasaki, Y; Kobashi, H; Matsuda, H; Matsukawa, H; Miyake, Y; Sadamori, H; Sakaguchi, K; Shinoura, S; Shiratori, Y; Takaki, A; Tanaka, N; Terada, R; Umeda, Y; Yagi, T | 1 |
| Attar, N; Comanor, L; Elkin, C; Jain, MK; Keiser, P; Kipnis, P; Lee, WM; Leung, K; Ocampo, A; White, C | 1 |
| Goto, H; Hayashi, K; Hirooka, Y; Honda, T; Ishigami, M; Itoh, A; Katano, Y; Kumada, T; Nakano, I; Takeda, Y; Toyoda, H; Yano, M; Yoshioka, K | 1 |
| Cho, JY; Joh, JW; Kim, SI; Kwon, CH; Lee, KU; Lee, KW; Lee, SK; Suh, KS; Yi, NJ | 1 |
| Lok, AS; Tan, J | 1 |
| Arterburn, S; Borroto-Esoda, K; Brosgart, C; Chuck, S; Colombo, M; Hadziyannis, S; Lai, CL; Neuhaus, P; Samuel, D; Schiff, E; Terrault, N; Tillmann, H; Villeneuve, JP; Zeuzem, S | 1 |
| Cheong, JW; Hahn, JS; Kim, JS; Kim, Y; Lee, CK; Lee, ST; Min, YH; Park, IH; Park, SY | 1 |
| Li, Q; Wen, H | 1 |
| Ishikawa, S; Iwasaki, Y; Kato, J; Kobashi, H; Miyake, Y; Nawa, T; Sakaguchi, K; Shiratori, Y; Takaki, A; Tatsukawa, M | 1 |
| Chen, XG; Li, W; Liu, Y; Niu, YJ; Shen, ZY; Wang, Y; Wei, ZY; Zang, YJ; Zhang, ZT; Zhu, XD | 1 |
| Iino, S; Itoh, F; Koike, K; Moriya, K; Nagase, Y; Okuse, C; Suzuki, M; Suzuki, Y; Takahashi, H; Yotsuyanagi, H | 1 |
| Bendenoun, M; Mazeron, MC; Sanson-le Pors, MJ; Schnepf, N; Sellier, P; Zini, JM | 1 |
| Chheda, MG; Doherty, LM; Drappatz, J; Gigas, DC; Greenberger, NJ; Kesari, S; Weiss, SE; Wen, PY | 1 |
| Sobhonslidsuk, A; Ungkanont, A | 1 |
| Ahn, JS; Hong, YS; Hwang, IG; Jung, CW; Kang, WK; Kim, K; Kim, WS; Koh, KC; Lee, MH; Lee, SC; Lim, TK; Park, BB; Park, S; Uhm, JE | 1 |
| Angus, PW; Crawford, DH; Gane, EJ; Jeffrey, GP; McCaughan, GW; Ring, J; Strasser, S | 1 |
| Alonzo, M; Buell, J; Kaiser, TE; Kemmer, N; Neff, GW; Thomas, M; Zacharias, VC | 1 |
| Rimland, D; Rouphael, NG; Talati, NJ | 1 |
| Dore, GJ; Matthews, GV | 1 |
| Hannoun, C; Lindh, M; Malmström, S | 1 |
| Iino, S | 1 |
| Koike, K; Yotsuyanagi, H | 2 |
| Ding, XR; Lou, SK; Sun, DC; Wang, SQ; Yang, J | 1 |
| Deng, WW; Gu, HX; Li, D; Li, GQ; Wang, JX; Xu, WZ | 1 |
| Bastens, B; Delforge, M; Demoulin, JC; Dupont, P; Fontaine, F; Michels, V; Plomteux, O; Sente, JM | 1 |
| Argentini, C; Canitano, A; Catone, S; D'Ugo, E; Gallinella, B; Giuseppetti, R; Glück, R; Kondili, LA; Orobello, S; Palmieri, G; Rapicetta, M | 1 |
| Yao, G | 1 |
| Bonino, F; Brunetto, MR; Ciccorossi, P; Coco, B; Colombatto, P; Flichman, D; Maina, AM; Moriconi, F; Oliveri, F; Sacco, R | 1 |
| Boehm, S; Hahn, J; Holler, E; Jilg, W; Knöll, A | 1 |
| Celebi Kobak, A; Ersoz, G; Gunsar, F; Karasu, Z; Kilic, M; Ozacar, T; Tekin, F; Tokat, Y; Yuzer, Y | 1 |
| Chang, HR; Lian, JD; Lin, CC | 1 |
| Jiao, Z; Jiao, ZY | 1 |
| Bhat, S; Brennan, TP; Chong, CR; Hale, B; Hegarty, R; Jilek, BL; Liu, JO; McMahon, MA; Shen, L; Siliciano, RF; Thio, CL; Wind-Rotolo, M; Xing, S; Zhou, Y | 1 |
| Kloudová, A; Mrázek, J; Orságová, I; Roznovský, L | 1 |
| Dedek, V; Kabieszová, L; Kloudová, A; Orságová, I; Roznovský, L; Zjevíková, A | 1 |
| Fei, G; Lee, LH; Lim, LC; Lim, ST; Loong, S; Quek, R; Tao, M; Yap, SP | 1 |
| Huang, XT; Lin, F; Zeng, AP | 1 |
| Bader, TF; Fazili, J; Tierney, W | 1 |
| Dong, MH; Joseph, TA; Saab, S; Tong, MJ | 1 |
| Harada, N; Ikegami, T; Maehara, Y; Soejima, Y; Taketomi, A; Uchiyama, H; Yamashita, Y; Yoshizumi, T | 1 |
| Banu, NA; Khan, MA; Khatoon, S; Quadir, E; Rahman, MM | 1 |
| Ayliffe, U; Dervisevic, S; Garcia-Diaz, A; Geretti, AM; Gilson, R; Johnson, M; Nebbia, G; Smith, C; Tedder, R | 1 |
| Esteve, M; González-Huix, F; Loras, C | 1 |
| Brechmann, T; Kohlhaas, K; Vorgerd, M | 1 |
| Gao, SX; Gui, YP; Kong, LH; Liu, WH | 1 |
| Makuuchi, M; Sugawara, Y; Takemura, N; Tamura, S | 1 |
| Cai, CJ; Chen, GH; Jiang, H; Jiang, N; Li, H; Li, X; Lu, MQ; Wang, GS; Xu, C; Yang, Y; Yi, HM; Yi, SH; Zhang, J; Zhang, JF; Zhang, Q; Zhang, YC | 1 |
| Ahn, HJ; Ahn, SH; Han, KH; Huh, KH; Ju, MK; Kim, MS; Kim, SI; Kim, YS | 1 |
| Hayashi, T; Iyama, S; Kato, J; Kawano, Y; Kobune, M; Matsunaga, T; Miyanishi, K; Niitsu, Y; Okuda, T; Ono, K; Sagawa, T; Sato, T; Sato, Y; Takada, K; Takimoto, R | 1 |
| Buti, M; Casafont, F; Esteban, R; González, A; Herrero, JI; Jardi, R; Mas, A; Miras, M; Prieto, M | 1 |
| Niederau, C | 2 |
| Dai, J; Gu, M; Jin, SJ; Lai, W; Li, B; Lu, SC; Tao, CM; Wen, TF; Yan, LN; Zeng, Y; Zhang, XH; Zhao, J; Zhao, JC | 1 |
| Clayton, MM; Feitelson, MA; Schinazi, RF; Sun, B | 1 |
| Kiss, A; Rudin, D; Shah, SM; Sottile, VM; Wetz, RV | 1 |
| Abe, H; Chayama, K; Fujimoto, Y; Hatakeyama, T; Hiraga, N; Imamura, M; Kumada, H; Maekawa, T; Mori, N; Ochi, H; Suzuki, F; Takahashi, S; Tsuge, M; Yatsuji, H | 1 |
| Martyak, LA; Saab, S; Taqavi, E | 1 |
| Coterell, A; Fisher, RA; Luketic, VA; Maluf, D; Posner, MP; Sanyal, AJ; Shiffman, ML; Sterling, RK; Todd Stravitz, R; Yilmaz, N | 1 |
| Colombo, M; Iavarone, M; Lampertico, P; Manenti, E; Sablon, E; Viganò, M | 1 |
| Easley, KA; Lennox, JL; Lu, C; Ofotokun, I; Smithson, SE | 1 |
| Cho, EH; Cho, JY; Cho, YB; Kwon, CH; Lee, HW; Lee, KU; Suh, KS; Yang, SH; Yi, NJ | 1 |
| Akuta, N; Arase, Y; Chihara, N; Hosaka, T; Ikeda, K; Kawamura, Y; Kobayashi, M; Kumada, H; Sezaki, H; Suzuki, F; Suzuki, Y; Watahiki, S; Yatsuji, H | 1 |
| Akyildiz, M; Aydin, U; Karasu, Z; Kilic, M; Ozacar, T; Zeytunlu, M | 1 |
| Chayama, K; Takahashi, S | 1 |
| Harada, S; Kaku, M; Koike, K; Mizokami, M; Oka, S | 1 |
| Chen, ZY; Jiao, ZY; Li, B; Li, ZH; Lu, SC; Ma, YK; Wang, WT; Wen, TF; Xu, MQ; Yan, LN; Yang, JY; Zeng, Y; Zhang, ZW; Zhao, JC | 1 |
| Chen, XY; Dong, JL; Huang, CY; Ma, LN; Sun, GZ | 1 |
| Bahr, MJ; Cornberg, M; Deterding, K; Hadem, J; Manns, MP; Metzler, F; Pothakamuri, SV; Schlaphoff, V; Wedemeyer, H | 1 |
| Choi, MS; Gwak, GY; Huh, W; Joh, JW; Kim, SJ; Koh, KC; Lee, DH; Lee, JH; Oh, HY | 1 |
| Busuttil, RW; Cameron, AM; Ghobrial, RM; Hiatt, JR; Tong, MJ; Zimmerman, MA | 1 |
| Fraser, A; Gafter-Gvili, A; Katz, LH; Leibovici, L; Tur-Kaspa, R | 1 |
| Janssen, HL; Reijnders, JG | 1 |
| Kaczmarski, M; Lebensztejn, DM; Skiba, E; Sobaniec-Łotowska, ME | 1 |
| Adler, G; Dikopoulos, N; Hasel, C; Seufferlein, T; Zizer, E | 1 |
| Foroncewicz, B; Górnicka, B; Krawczyk, M; Mucha, K; Nyckowski, P; Ołdakowska-Jedynak, U; Paczek, L; Paczkowska, A; Patkowski, W; Pilecki, T; Ziarkiewicz-Wróblewska, B; Zieniewicz, K; Ziółkowski, J | 1 |
| Bao, SP; Guan, ZZ; He, YF; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Sun, XF; Wang, FH; Xia, ZJ; Xu, RH; Zhang, L | 1 |
| Gao, LL; Li, Y; Lin, JS; Wang, XY; Zhang, YH | 1 |
| Chen, XY; Chen, Y; Han, ZH; Li, J; Lu, HY; Si, CW; Yu, YY; Zeng, Z; Zhang, JJ; Zhuang, LW | 1 |
| Chang, MC; Chao, TY; Chen, PJ; Cheng, AL; Hsiao, HH; Hsiung, CA; Hsu, C; Hwang, WS; Li, CC; Liao, YM; Lin, SF; Lin, TH; Liu, TW; Su, IJ; Tien, HF; Wang, MC; Wu, HB; Young, JH | 1 |
| Brosgart, CL; Chow, WC; Gardner, SD; Gray, DF; Heathcote, EJ; Lai, JY; Perrillo, RP; Scott, SA; Sung, JJ; Woessner, MA; Zeuzem, S | 1 |
| Barraud, L; Billioud, G; Durantel, S; Pichoud, C; Trépo, C; Villet, S; Zoulim, F | 1 |
| Armignacco, O; Barbarini, G; Barbaro, G; Barlattani, A; Camporiondo, MP; Ferri, F; Francavilla, R; Mazzoni, E; Mecenate, F; Nauri, L; Nosotti, L; Paffetti, A; Pellicelli, AM; Romano, M; Soccorsi, F; Struglia, C; Villani, R | 1 |
| Baldick, CJ; Colonno, RJ; Eggers, BJ; Fang, J; Levine, SM; Pokornowski, KA; Rose, RE; Tenney, DJ; Yu, CF | 1 |
| Kajiwara, E; Kinjo, M; Mizokami, M; Ohashi, T; Sadoshima, S; Tanaka, Y; Uchimura, K | 1 |
| Akdogan, M; Cicek, B; Kilic, ZM; Kuran, S; Odemis, B; Oguz, D; Sasmaz, N | 1 |
| Akin, H; Mert, A; Ozaras, R; Ozturk, R; Senturk, H; Tabak, F; Tahan, V | 1 |
| Shen, ZY; Song, HL; Wang, J; Wang, ZL; Zheng, WP | 1 |
| Brechot, C; Castaing, D; Dussaix, E; Fallot, G; Faria, LC; Ferrari, TC; Gigou, M; Guettier, C; Roche, B; Roque-Afonso, AM; Samuel, D; Sebagh, M | 1 |
| Cane, P; Dudley, T; Freshwater, DA; Mutimer, DJ | 1 |
| Al-Soud, WA; Bielawski, KP; Charmuszko, U; Stalke, P; Wadstrom, T | 1 |
| Alves-Filho, G; Lorena, SL; Mazzali, M; Sevá-Pereira, T; Soares, EC; Urbini Dos Santos, C | 1 |
| Csako, G; Liang, TJ; Loomba, R; Pucino, F; Rowley, AK; Smith, KG; Wesley, R | 1 |
| Altintas, A; Bayan, K; Cil, T; Isikdogan, A; Ozekinci, T; Pasa, S | 1 |
| Girke, J; Manns, MP; Tillmann, HL; Wedemeyer, H; Wiegand, J | 1 |
| Hasenclever, D; Tillmann, HL; Wiegand, J | 1 |
| de Man, RA; Heijtink, RA; Honkoop, P; Schalm, SW | 1 |
| Bartholomew, M; Dienstag, JL; Perrillo, RP; Rubin, M; Schiff, ER; Vicary, C | 1 |
| Merigan, TC | 1 |
| de Man, RA; Heijtink, RA; Niesters, HG; Schalm, SW | 2 |
| Benhamou, Y; Dohin, E; Gentilini, M; Huraux, JM; Katlama, C; Lunel-Fabiani, F; Opolon, P; Poynard, T | 1 |
| Boehme, R; Bonhoeffer, S; Hill, AM; McDade, H; Nowak, MA; Thomas, HC | 1 |
| Grimm, I | 1 |
| Korba, BE | 1 |
| Bain, VG; Fischer, KP; Kneteman, NM; Ma, MM; Tipples, GA; Tyrrell, DL | 1 |
| Pierce, PF; Schnittman, SM | 1 |
| Ahmed, M; Beranek, P; Brown, D; Burroughs, AK; Dusheiko, G; Elias, E; Grellier, L; Kennedy, F; Kibbler, H; McMaster, P; McPhillips, P; Mutimer, D; Rolles, K | 1 |
| Marinos, G; Naoumov, NV; Williams, R | 1 |
| Benhamou, Y; Coutellier, A; Dohin, E; Hamm, N; Herson, S; Katlama, C; Lunel, F; Opolon, P; Poynard, T; Tubiana, R | 1 |
| Bain, VG; Fischer, K; Gutfreund, K; Jewell, LD; Kneteman, NM; Lee, H; Ma, MM; Shapiro, JA; Tipples, G; Tyrrell, DL | 1 |
| Ching, CK; Dent, J; Hill, A; Lai, CL; Li, E; Tung, AK; Wong, BC; Wu, PC; Young, J | 1 |
| Schalm, SW | 1 |
| Bartholomew, MM; Brown, NA; Bunzendahl, H; Condreay, LD; Jansen, RW; Jeffers, LJ; Johnson, LC; Reddy, KR; Schiff, ER; Tzakis, AG | 1 |
| Ben-Ari, Z; Mor, E; Shapira, Z; Shmueli, D; Tur-Kaspa, R | 1 |
| Jung, MC; Sackmann, M; Zachoval, R | 1 |
| de Man, RA; Honkoop, P; Schalm, SW; Zondervan, PE | 1 |
| Terrault, NA; Wright, TL | 1 |
| de Man, RA; Honkoop, P; Niesters, HG; Osterhaus, AD; Schalm, SW | 1 |
| de Man, RA; Honkoop, P; Rademakers, LH; Schalm, SW; Scholte, HR; Van Den Berg, JW; Zondervan, PE | 1 |
| Eggers, HJ | 1 |
| Cattral, MS; Greig, PD; Hemming, AW; Levy, G; Lilly, LB; Philosophe, B; Superina, RA | 1 |
| Bar-Nathan, N; Ben-Ari, Z; Mor, E; Shaharabani, E; Shapira, Z; Shmueli, D; Tur-Kaspa, R | 1 |
| Ahmed, A; Cohn, G; Ehrenpreis, ED; Lissoos, TW; Schiano, TD; Siano, C; Zaitman, D | 1 |
| Barber, J; De Man, RA; Fevery, J; Honkoop, P; Main, J; Nevens, F; Sullivan, MT; Thomas, HC; Tyrrell, DL | 1 |
| Al Faraidy, K; Anderson, FH; Davis, JE; Steinbrecher, UP; Vartanian, RK; Yoshida, EM | 1 |
| Hino, O; Kajino, K; Kamiya, N; Sakurai, J; Takahara, T; Yamamura, Ki; Yuasa, S | 1 |
| Cisterne, JM; Duffaut, M; Durand, D; Henry, S; Icart, J; Rostaing, L | 1 |
| Beuers, U; Mühlhöfer, A; Samtleben, W; Thoenes, GH; von Appen, K; Weiss, M | 1 |
| de Man, RA; Honkoop, P; Niesters, HG | 1 |
| Bain, VG; Davis, JE; Erb, SR; Fischer, KP; Kneteman, NM; Ma, MM; Tyrrell, DL; Yoshida, EM | 1 |
| Arnold, JC; Golling, M; Herfarth, C; Otto, G; Rudek, B; Theilmann, L | 1 |
| de Man, RA; Haagsma, EB; Honkoop, P; Niesters, HG; Osterhaus, AD; Schalm, SW | 1 |
| Allen, MI; Andrews, CW; Brown, N; Condreay, LD; Deslauriers, M; Tipples, GA; Tyrrell, DL; Walters, KA | 1 |
| Arase, Y; Chayama, K; Hashimoto, M; Ikeda, K; Kobayashi, M; Koida, I; Koike, H; Kumada, H; Miyano, Y; Murashima, N; Saitoh, S; Suzuki, Y; Tsubota, A | 1 |
| Herrero, JI; Pardo, F; Prieto, J; Quiroga, J; Riezu-Boj, JI; Sangro, B; Sola, I | 1 |
| Chambers, S; Chapman, BA; Clark, FL; Drummond, MW; Patton, WN | 1 |
| Condreay, L; Debernardi-Venon, W; Marzano, A; Rizzetto, M | 1 |
| Chan, TM; Cheng, IK; Lai, CL; Lai, KN; Li, FK; Wu, PC | 1 |
| Nery, JR; Rodriguez, M; Ruiz, P; Schiff, ER; Tzakis, AG; Weppler, D | 1 |
| De Rosa, G; Pezzullo, L; Picardi, M; Raiola, A; Rotoli, B; Selleri, C | 1 |
| Artinian, L; Busuttil, RW; Conrad, AJ; Goldstein, LI; Goss, JA; Holt, C; Imagawa, DK; Markmann, JF; Markowitz, JS; Martin, P; Murray, NG; Pakrasi, A; Schmidt, P; Seu, P; Stribling, R; Yersiz, H | 1 |
| Cornu, C; Goffin, E; Horsmans, Y; Pirson, Y; Squifflet, JP | 1 |
| Addo, M; Altfeld, M; Kupfer, B; Pult, I; Rockstroh, JK; Spengler, U; Will, H | 1 |
| Bertoletti, A; Boehme, R; Boni, C; Cavalli, A; Ferrari, C; Fiaccadori, F; Panebianco, R; Penna, A; Pilli, M; Scognamiglio, P; Urbani, S | 1 |
| Chamuleau, RA; de Man, RA; Jones, EA; Rietbroek, RC; Smorenburg, S; ter Borg, F | 1 |
| Fujita, R; Handa, K; Inoue, K; Sekiyama, K; Takahashi, Y; Yoshiba, M | 1 |
| Bartholomeusz, AI; de Man, RA; Locarnini, SA; Niesters, HG; Zondervan, PE | 1 |
| Josefson, D | 1 |
| Andreone, P; Belli, L; Bernardi, M; Caraceni, P; Cavallari, A; D'Errico, A; Dal Monte, PR; Ercolani, G; Forti, D; Grazi, GL; Ideo, G; Jovine, E; Mazziotti, A; Milandri, GL | 1 |
| Arazi, J; Ben-Moshe, O; Berr, S; Burakova, T; Dagan, S; Eid, A; Eren, R; Galun, E; Gillard, J; Ilan, E; Jurim, O; Lubin, I; Mansour, TS; Neville, L; Nussbaum, O; Reisner, Y; Shouval, D; Yuen, L | 1 |
| Ahmed, A; Keeffe, EB | 1 |
| Bye, A; Johnson, MA; Moore, KH; Pakes, GE; Yuen, GJ | 1 |
| Ben-Ari, Z; Fraser, G; Kazetsker, A; Tur-Kaspa, R; Zemel, R | 1 |
| Mazzola, M; Pastore, G; Santantonio, T | 1 |
| Ahmed, M; Barmat, S; Boxall, E; Buchan, S; Burroughs, N; Cane, P; Dragon, E; Elias, E; Gutekunst, K; Martin, B; McMaster, P; Mutimer, D; O'Donnell, K; Pillay, D; Rand, D; Shaw, J; Tang, H | 1 |
| Anschuetz, G; Brown, N; Caldwell, S; Crowther, L; Dienstag, J; Farr, G; Gish, R; Levy, G; Martin, P; Perrillo, R; Rakela, J; Schiff, E; Villeneuve, JP; Wright, T | 1 |
| Chen, WN; Koh, S; Leong, AL; Lim, GK; Lim, N; Oon, CJ; Tan, GS | 1 |
| Kumashiro, R; Sata, M | 1 |
| Dulai, G; Higa, L; Kobashigawa, J; Martin, P | 1 |
| Chizzolini, C; Dayer, JM; Guillevin, L; Olivieri, J; Pizzolato, G; Sarasin, F; Wicki, J | 1 |
| Esquivel, CO; Garcia, G; Imperial, JC; Keeffe, EB; Monge, H; So, SK | 1 |
| Bock, T; Böker, KH; Bruns, I; Condreay, LD; Gauthier, J; Glowienka, M; Jäckel, E; Manns, MP; Oldhafer, K; Raab, HR; Tillmann, HL; Trautwein, C | 1 |
| Al-Taie, OH; Gassel, AM; Mörk, H; Scheurlen, M; Weissbrich, B; Wilhelm, M | 1 |
| Chien, RN; Chu, CM; Liaw, YF; Tsai, SL; Yeh, CT | 1 |
| Aldrich, CE; Condreay, LD; Deslauriers, M; Mason, WS; Saputelli, J; Zhou, T | 1 |
| Atkins, M; Barrett, C; Cooper, DA; Dore, GJ; Goh, LE; Thakrar, B | 1 |
| Ben-Ari, Z; Mor, E; Pappo, O; Tur-Kaspa, R; Zemel, R | 1 |
| Adams, O; Braunstein, S; Horneff, G; Niehues, T; Wahn, V | 1 |
| Cane, PA; Mutimer, D; Pillay, D | 1 |
| Agut, H; Benhamou, Y; Bochet, M; Bricaire, F; Katlama, C; Opolon, P; Poynard, T; Seguret, C; Thibault, V | 1 |
| Fiddian, AP | 1 |
| Bárcena, R; del Campo, S; Domínguez-Antonaya, M; López-Sanromán, A; Martínez-Turnes, A; Moreno, N; Urman, J | 1 |
| Bonham, CA; Cacciarelli, TV; Dodson, SF; Fung, JJ; Geller, DA; Rakela, J | 1 |
| Benhamou, Y; Bochet, M; Bricaire, F; Caumes, E; Di Martino, V; Katlama, C; Opolon, P; Poynard, T; Thibault, V | 1 |
| Briceno, MN; Garcia-Kennedy, R; Gish, RR; Osorio, RW; Poordad, FF; Roberts, JP; Yao, FY | 1 |
| Angus, PW; Bartholomeusz, A; Bowden, S; Chui, AK; Jones, RM; Koorey, D; Littlejohn, M; Locarnini, SA; McCaughan, GW; Sheil, AG; Spencer, J; Verran, D | 1 |
| Bortolotti, F; Sokal, EM | 1 |
| Imazeki, F; Saisho, H; Seta, T; Tagawa, M; Yokosuka, O | 1 |
| Castellano, G; Fernández, I; Jiménez, C; Solís Herruzo, JA | 1 |
| Buti, M; Costa, X; Cotrina, M; Esteban, R; Guardia, J; Jardi, R; Pascual, C; Rodriguez-Frias, F | 1 |
| Boxall, L; Buchan, S; Cane, P; Elias, E; Hübscher, S; Martin, B; Mutimer, D; O'Donnell, K; Pillay, D; Ratcliffe, D; Shaw, J; Shields, P | 1 |
| Locarnini, SA; Shaw, T | 1 |
| Gibbs, CS; Howard, T; Jacobsmeyer, S; Lamy, P; Murray, A; Peters, MG; Singer, G; Xiong, X | 1 |
| Chan, JY; Chan, PK; Johnson, PJ; Leung, NW; Steinberg, JL; Tam, JS; Yeo, W; Zhong, S | 1 |
| Battegay, M; Jacob, AL; Maclachlan, D; Tyndall, A | 1 |
| Cane, PA; Cook, P; Dowling, D; Elias, E; Mutimer, D; O'Donnell, K; Pillay, D; Ratcliffe, D; Shaw, J | 1 |
| Renner, EL | 1 |
| De Mautort, E; Fritsch, S; Kempf-Durepaire, G; Krantz, V; Lang, JM; Nicolle, M; Partisani, M; Rey, D; Schmitt, C; Stoll-Keller, F | 1 |
| Beards, G; Cane, PA; Cook, P; Elias, E; Mutimer, D; Pillay, D; Ratcliffe, D | 1 |
| Baccarani, M; Damiani, D; Ermacora, A; Fanin, R; Patriarca, F; Silvestri, F; Sperotto, A; Zaja, F | 1 |
| Baccarani, M; Damiani, D; Ermacora, A; Fanin, R; Silvestri, F; Sperotto, A | 1 |
| Korba, BE; Morrey, JD; Sidwell, RW | 1 |
| Al Asghar, H; Cattral, MS; Greig, PD; Hemming, AW; Humar, A; Levy, GA; Lilly, LB; Malkan, G | 1 |
| Bordin, V; Catalano, C; Di Landro, D; Fabbian, F; Manani, SM; Vogel, W | 1 |
| Bechstein, WO; Berg, T; Hopf, U; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D | 2 |
| Bréchot, C; Chrétien, Y; Fontaine, H; Kreis, H; Legendre, C; Pol, S; Poupon, RE; Thiers, V; Zylberberg, H | 1 |
| Sherlock, CH; Yoshida, EM | 1 |
| Ben-Ari, Z; Fainguelernt, H; Kitay-Cohen, Y; Lishner, M; Tur-Kaspa, R | 1 |
| Deres, K; Rübsamen-Waigmann, H | 1 |
| Schalm, SW; van Wijngaarden, JK | 1 |
| Hopf, U | 1 |
| Atkins, M; Cane, PA; Cooper, D; Pillay, D; Ratcliffe, D | 1 |
| Belle, SH; Colquhoun, SD; Pruett, TL; Samuel, D; Teperman, LW | 1 |
| Kruger, M; Lake, JR; Perrillo, RP; Sievers, T | 1 |
| Barnes, E; Burroughs, A; Dusheiko, G; Webster, G | 1 |
| Angus, PW; Crawford, DH; Gane, EJ; Harley, H; McCaughan, GW | 1 |
| Bonham, CA; de Vera, ME; Dodson, SF; Fung, JJ; Geller, DA; Rakela, J | 1 |
| De Man, RA; Fries, E; Niesters, HG; Osterhaus, AD; Pas, SD | 1 |
| Carey, WD | 1 |
| Main, J; Thomas, HC; Wright, M | 1 |
| Bye, C; Jenkins, JM; Johnson, MA | 1 |
| McGory, R; Pruett, TL | 1 |
| Dodson, SF | 1 |
| Ahmed, M; Anschuetz, G; Barrett, C; Burroughs, A; Dhillon, AP; Dusheiko, G; Elias, E; Grellier, L; Hubscher, S; Mutimer, D; Rolles, K | 1 |
| Bain, VG; Fischer, KP; George, R; Gutfreund, KS; Ma, MM; Tyrrel, DL; Villeneuve, JP; Williams, M; Yoshida, EM | 1 |
| Adams, O; Häussinger, D; Petry, W | 1 |
| Zuckerman, AJ; Zuckerman, JN | 1 |
| Reshef, R; Sbeit, W; Tur-Kaspa, R | 1 |
| Andorno, E; Brizzolara, R; Campo, N; Picciotto, A; Sinelli, N; Torre, F; Valente, U | 1 |
| Chan, PK; Ho, WM; Hui, P; Johnson, PJ; Leung, NW; Steinberg, JL; Tam, JS; Yeo, W; Zee, B; Zhong, S | 1 |
| Erhardt, A; Guillevin, L; Häussinger, D; Neuen-Jacob, E; Sagir, A | 1 |
| Fujii, S; Fujiwara, T; Fukuda, S; Sezaki, T; Sunami, K; Yoshida, C | 1 |
| Busuttil, RW; Chen, P; Dawson, S; Farmer, DG; Ghobrial, RM; Goldstein, L; Han, SH; Holt, C; King, K; Kunder, G; Martin, P; Ofman, J; Yersiz, H | 1 |
| Marzano, A; Rizzetto, M | 1 |
| Demetriou, D; Ferenci, P; Kletzmayr, J; Kovarik, J; Müller, C; Puchhammer-Stöckl, E; Watschinger, B | 1 |
| Chiwakata, CB; Dietrich, M; Günther, S; Hannoun, C; Manegold, C; Polywka, S; Wywiol, A | 1 |
| Hu, RH; Lai, MY; Lee, CJ; Lee, PH; Tsai, MK | 1 |
| Fischer, L; Rogiers, X; Sterneck, M; Zöllner, B | 1 |
| Ho, MC; Hu, RH; Lai, HS; Lai, MY; Lee, PH; Tsai, MK; Yang, PM | 1 |
| Choi, IS; Choi, SH; Heo, JS; Joh, JW; Kim, SJ; Kim, SM; Kim, YI; Koh, KC; Lee, BB; Lee, JH; Lee, SK; Lee, WY; Paik, SW; Park, JH; Peck, KR; Sohn, TS; Song, JH | 1 |
| Beleza, M; Gomes, A; Macedo, G; Maia, JC; Ribeiro, A; Teixeira, A | 1 |
| Gondo, H; Himeji, D; Kaji, Y; Niho, Y; Sata, M; Uchida, N | 1 |
| Ben-Ari, Z; Mor, E; Shapira, Z; Tur-Kaspa, R | 1 |
| Cheung, ST; Fan, ST; Lai, CL; Liu, CL; Lo, CM; Ng, IO; Wong, J; Yuen, MF | 1 |
| Martin, P; Rosen, HR | 1 |
| Bechstein, WO; Hopf, U; Naumann, U; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D | 1 |
| Maddrey, WC | 1 |
| Doo, E; Liang, TJ | 1 |
| Han, DJ; Jung, JG; Kim, SB; Kim, SC; Kim, TH; Lee, SK; Park, JS; Park, SK; Yang, WS; Yu, ES | 1 |
| Jia, Y; Liu, G; Ren, H; Wang, H; Xiong, Y; Zhang, D; Zhuo, Z | 1 |
| Vargas, HE | 1 |
| Grande Santamaría, L; Romero Gómez, M; Suárez García, E | 1 |
| Forns, X; Sánchez-Tapias, JM | 1 |
| Brown, D; Dusheiko, GM; Saunders, NA; Teo, CG; Whalley, SA | 1 |
| Bastian, H; Batallan, A; Benifla, JL; Faucher, P; Madelenat, P; Matheron, S; Morau, G | 1 |
| Endo, T; Fujimoto, K; Haseyama, Y; Koike, T; Koizumi, K; Nishio, M; Sakai, T; Sawada, K; Takashima, H; Yamamoto, S | 1 |
| Boeker, KH; Manns, MP; Rosenau, J; Tillmann, HL; Trautwein, C | 1 |
| Fujii, N; Harada, M; Kiura, K; Matsuo, K; Shimomura, H; Shinagawa, K; Takenaka, K | 1 |
| Prescott, LM | 1 |
| Rubin, M | 1 |
| Gupta, S; Jaffe, M; Piraka, C | 1 |
| Cainelli, F; Concia, E; Longhi, MS; Vento, S | 1 |
| Heathcote, EJ; Hoofnagle, JH; Lok, AS | 1 |
| Albayrak, D; Dagdemir, A; Dilber, C; Kalayci, AG | 1 |
| Cahlin, C; Friman, S; Olausson, M | 2 |
| Han, SH; Jensen, D; Keeffe, EB; Lok, AS; Luketic, V; Teo, EK; Terrault, N | 1 |
| Gładysz, A; Inglot, M; Jander, A; Jobs, K; Latoszyńska, J; Makulska, I; Pietrzyk, J; Rajkowski, T; Szczepańska, M; Szprynger, K; Zachwieja, J; Zachwieja, K; Zurowska, A; Zwolińska, D | 1 |
| Delaney, WE; Locarnini, S; Shaw, T | 1 |
| Arnaout, WS; Chan, CK; Colquhoun, SD; Fong, TL; Geller, SA; Khanafshar, E; Nichols, WS; Vierling, JM; Yu, AS | 1 |
| Chang, TT; Cheng, PN; Jen, CM; Kao, AW; Young, KC | 1 |
| Bahr, MJ; Klempnauer, J; Manns, MP; Rosenau, J; Tillmann, HL; Trautwein, C | 1 |
| Anschuetz, G; Atkins, M; Barrett, CA; Bassendine, M; Burra, P; Caccamo, L; de Man, RA; Iemmolo, RM; Lopes, AR; Naoumov, NV; O'Grady, JG; Portmann, BC; Williams, R | 1 |
| Barbui, AM; Ciancio, A; David, E; Debernardi-Venon, W; Franchello, A; Gentilcore, E; Marzano, A; Negro, F; Piantino, P; Rizzetto, M; Salizzoni, M; Smedile, A | 1 |
| Kuchimanchi, U; Rooney, G | 1 |
| Ciancio, A; Marzano, A; Negro, F; Rizzetto, M; Salizzoni, M | 1 |
| Aydogdu, S; Selimoglu, MA; Unal, F; Yagci, RV; Yüce, G | 1 |
| Tanikawa, K | 1 |
| Bass, NM; Freise, C; Maslow, L; Terrault, NA; Yao, FY | 1 |
| Borrás-Cuesta, F; Condreay, L; Cullen, JM; Hervás-Stubbs, S; Lasarte, JJ; Prieto, J; Sarobe, P; Vivas, I | 1 |
| Chon, CY; Chung, HY; Han, KH; Kim, JH; Lee, CK; Lee, JS; Lee, KS; Moon, YM; Paik, YH; Ryu, WS | 1 |
| Raj, V | 1 |
| Armstrong, DR; Chu, CJ; Fontana, RJ; Lok, AS; Magee, JC; Merion, RM; Moore, C; Punch, JD; Su, GL | 1 |
| Aaron, L; Carnot, F; Pialoux, G | 1 |
| Chizzolini, C; Deléaval, P; Descombes, E; Hecker, E; Nicole, A; Pugin, P; Regamey, C; Schrago, G; Stadler, P | 1 |
| Chen, RW; Koskela, P; Lappalainen, M; Piiparinen, H; Sarna, S; Seppänen, M | 1 |
| Baruch, Y; Gelman, R; Green, J; Khankin, E; Nakhoul, F | 1 |
| Benhamou, Y; Bochet, M; Brosgart, C; Calvez, V; Fievet, MH; Fry, J; Gibbs, CS; Katlama, C; Namini, H; Poynard, T; Thibault, V; Vig, P | 1 |
| Hata, M; Ikegaya, S; Imamura, S; Kawahito, M; Kawai, Y; Tsutani, H; Ueda, T; Yoshida, A | 1 |
| Boyle, BA | 1 |
| Hasegawa, K; Hashimoto, E; Hayashi, N; Kanai, N; Naritomi, T; Ogawa, M; Takasaki, K; Taniai, M | 1 |
| Chung, RT; Kim, AY; Polsky, B | 1 |
| Leung, N | 1 |
| Chen, DS; Chen, PJ; Chou, NK; Chu, SH; Jen, YM; Kao, JH; Lai, MY; Lee, PH; Liu, CJ | 1 |
| Buffello-Le Guillou, D; Duclos-Vallée, JC; Dussaix, E; Féray, C; Petit, MA; Roche, B; Samuel, D | 1 |
| Alba, L; Antinori, A; Grisetti, S; Liuzzi, G; Sette, P; Zaccarelli, M | 1 |
| Bowden, S; Lau, GK; Lewin, SR; Locarnini, S; Perelson, AS; Ribeiro, RM; Walters, T | 1 |
| Chen, CH; Cheng, CH; Lee, WC; Lian, JD; Shu, KH; Wu, MJ | 1 |
| Bechstein, WO; Berg, T; Müller, AR; Naumann, U; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D; Steinmüller, T; Tullius, SG | 1 |
| Fabrizi, F; Lunghi, G; Martin, P | 1 |
| Cane, P; Gazzard, B; Matthews, GV; Nelson, M; Pillay, D; Ratcliffe, D | 1 |
| Berg, T; Hopf, U; Müller, AR; Neuhaus, P; Neuhaus, R; Radke, C; Rayes, N; Seehofer, D; Settmacher, U; Steinmüller, T | 1 |
| Motta, M; Pelizzari, A; Puoti, M; Rossi, G | 1 |
| Merle, P; Trépo, C; Zoulim, F | 1 |
| Balducci, M; Clementi, M; Manzin, A; Petrelli, E; Pieretti, C; Rocchi, MB | 1 |
| Agut, H; Aubron-Olivier, C; Katlama, C; Thibault, V | 1 |
| Hamaki, T; Kami, M; Kusumi, E; Miyakoshi, S; Morinaga, S; Mutou, Y; Ueyama, J | 1 |
| Aubron-Olivier, C; Benhamou, Y; Bernard, B; Di Martino, V; Poynard, T; Thabut, D; Thibault, V | 1 |
| Angelico, M; Araco, A; Casciani, CU; Di Paolo, D; Lionetti, R; Petrolati, A; Tisone, G; Trinito, MO; Zazza, S | 1 |
| Haran, M; Klepfish, A; Lurie, Y; Malnick, S; Shtalrid, M | 1 |
| Chan, TM; Ho, SK; Lai, KN; Moniri, K; Tang, S | 1 |
| Ayres, A; Bonacini, M; Gibbs, C; Kurz, A; Locarnini, S | 1 |
| Fontaine, H; Pol, S | 1 |
| Ramrakhiani, S; Sponseller, CA | 1 |
| de Man, RA; Niesters, HG; Pas, SD; van der Eijk, AA | 1 |
| Bock, CT; Klempnauer, J; Locarnini, S; Manns, MP; Tillmann, HL; Torresi, J; Trautwein, C | 1 |
| Haznedar, R; Yağci, M | 1 |
| Abensur, H; Araújo, MR; Haiashi, AR; Noronha, IL; Romão Junior, JE; Santos, FR | 1 |
| Huang, D; Liang, T; Liao Sy, SY; Lu Aw, AW; Shen, Y; Wang, W; Wu, J; Xu, X; Zhang, M; Zheng, S | 1 |
| Duan, Y; Liang, S; Wang, F; Yuan, G; Zhu, L | 1 |
| Lu, Z; Xu, X | 1 |
| Asaka, M; Chiba, K; Hashino, S; Hige, S; Izumiyama, K; Nozawa, A; Suzuki, S; Takahata, M | 1 |
| Buti, M; Cotrina, M; Esteban, R; Jardi, R; Rodriguez-Frias, F; Valdes, A | 1 |
| Grob, PJ; Reichen, J | 1 |
| Asaka, M; Chiba, K; Hashino, S; Hige, S; Izumiyama, K; Kondo, T; Nozawa, A; Suzuki, S; Yonezumi, M | 1 |
| Blazek, J; Dick, D; Eason, JD; Guo, L; Lipscomb, J; Loss, GE; Mason, AL; Perrillo, RP | 1 |
| Ben-Ari, Z; Daudi, N; Dinari, G; Klein, A; Mor, E; Shapira, R; Shouval, D; Tur-Kaspa, R | 1 |
| Andreani, T; Calmus, Y; Chazouillères, O; Poupon, R | 1 |
| Boyer, N; Castelneau, C; Marcellin, P | 1 |
| Nguyen, MH; Wright, TL | 1 |
| Cooper, DA; Dore, GJ | 1 |
| Brems, JJ; Holt, D; Thomas, R; Van Thiel, D | 1 |
| Chung, YH; Han, JM; Jung, S; Kwon, Y; Lee, HC; Lee, YJ; Lee, YS; Suh, DJ; Yu, E | 1 |
| Chan, WM; Fung, TT; Hui, PK; Lam, KM; Lau, CF; Loo, CK; Tung, YM; Yip, WC | 1 |
| Hasnain, SE; Kazim, SN; Khan, LA; Sarin, SK; Wakil, SM | 1 |
| Nakagawa, M; Sato, B; Simizu, Y; Suemura, M | 1 |
| Pramoolsinsup, C | 1 |
| Mancuso, A; Pagliaro, L | 1 |
| Araya, VR; Manzarbeitia, C; Munoz, SJ; Ortiz, JA; Reich, DJ; Rothstein, KD | 1 |
| Chesky, A; Demetris, AJ; Dodson, FS; Dvorchik, I; Fung, JJ; Gray, E; Joya-Vazquez, PP; Shakil, O; Vargas, HE | 1 |
| Choi, MS; Joh, JW; Kim, SJ; Koh, KC; Lee, JH; Lee, SK; Paik, SW; Park, SJ | 1 |
| Julander, JG; Morrey, JD; Sidwell, RW | 1 |
| Jurriaans, S; Lange, JM; Weel, J; Weverling, GJ; Wit, FW | 1 |
| Gillis, S; Hubert, A; Ilan, Y; Safadi, R; Shibolet, O; Shouval, D | 1 |
| Aulitzky, WE; Einsele, H; Henkes, M; Martin, S | 1 |
| Chang, CN; Cheng, YC; Skalski, V; Zhou, JH | 1 |
203 review(s) available for lamivudine and Hepatitis B Virus Infection
| Article | Year |
|---|---|
A review of non-nucleoside anti-hepatitis B virus agents.
Topics: Animals; Antiviral Agents; Biological Products; Hepatitis B; Hepatitis B virus; Humans; Small Molecule Libraries | 2014 |
Hepatitis B virus genetic multiplicity and the associated HBV lamivudine resistance mutations in HBV/HIV co-infection in Western Kenya: A review article.
Topics: Anti-Retroviral Agents; Coinfection; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Kenya; Lamivudine; Mutation | 2022 |
Adefovir for lamivudine-resistant hepatitis B.
Topics: Adenine; Drug Resistance, Viral; Hepatitis B; Humans; Lamivudine; Organophosphonates | 2022 |
Lamivudine vs placebo or no treatment in preventing the transmission of hepatitis B virus during pregnancy: a systematic review and meta-analysis.
Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic | 2020 |
Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Genotype; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Randomized Controlled Trials as Topic; Reproducibility of Results; Tenofovir; Treatment Outcome; Viral Load | 2021 |
Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
Topics: Acute Disease; Antiviral Agents; Disease Progression; Guanine; Hepatic Encephalopathy; Hepatitis B; Hepatitis C, Chronic; Humans; Immunization, Passive; Interferons; Lamivudine; Network Meta-Analysis; Odds Ratio; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors | 2017 |
Antiretroviral therapy for pregnant women living with HIV or hepatitis B: a systematic review and meta-analysis.
Topics: Adult; Anti-Retroviral Agents; Drug Combinations; Emtricitabine; Female; Hepatitis B; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Ritonavir; Tenofovir; Young Adult; Zidovudine | 2017 |
Prophylactic effect of lamivudine on chemotherapy-induced hepatitis B virus reactivation in patients with solid tumour: A meta-analysis.
Topics: Anti-HIV Agents; Antiviral Agents; Hepatitis B; Humans; Lamivudine; Neoplasms; Retrospective Studies; Virus Activation | 2018 |
Management of HBV reactivation in non-oncological patients.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Virus Activation | 2018 |
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis.
Topics: Alanine Transaminase; Antiviral Agents; Coinfection; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Lamivudine; RNA, Viral; Tenofovir; Treatment Outcome | 2018 |
Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis.
Topics: Adenine; Adult; Aged; Antiviral Agents; Coinfection; Emtricitabine; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Network Meta-Analysis; Organophosphonates; Tenofovir; Treatment Outcome; Young Adult | 2018 |
HIV/HBV coinfection in children and antiviral therapy.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Coinfection; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Young Adult | 2013 |
Prevention of recurrent hepatitis B infection after liver transplantation.
Topics: Adaptive Immunity; Administration, Oral; Adoptive Transfer; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Viral; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Secondary Prevention; Treatment Outcome; Virus Activation | 2013 |
Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis.
Topics: Adult; Aged; Antiviral Agents; Bilirubin; Biomarkers; Chi-Square Distribution; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Odds Ratio; Prothrombin Time; Serum Albumin; Serum Albumin, Human; Treatment Outcome; Viral Load | 2013 |
Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?
Topics: Adenine; Administration, Oral; Antiviral Agents; Carcinoma, Hepatocellular; Fibrosis; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Nucleosides; Organophosphonates; Telbivudine; Tenofovir; Thymidine | 2014 |
Postoperative therapy options for hepatocellular carcinoma.
Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Disease-Free Survival; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Liver Neoplasms; Neoplasm Recurrence, Local; Postoperative Care; Radiotherapy, Adjuvant; Survival Rate | 2014 |
HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.
Topics: Animals; Combined Modality Therapy; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications | 2016 |
Prophylactic lamivudine to improve the outcome of HBsAg-positive lymphoma patients during chemotherapy: a systematic review and meta-analysis.
Topics: Antineoplastic Agents; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Lymphoma; Treatment Outcome | 2015 |
Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence.
Topics: Adenine; Anti-HIV Agents; Breast Feeding; Disease Transmission, Infectious; Female; Hepatitis B; Humans; Infant, Newborn; Lamivudine; Organophosphonates; Pregnancy; Tenofovir | 2015 |
The efficacy of lamivudine prophylaxis against hepatitis B reactivation in breast cancer patients undergoing chemotherapy: a meta-analysis.
Topics: Antiviral Agents; Breast Neoplasms; Drug Therapy; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Treatment Outcome; Virus Activation | 2015 |
Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Prognosis | 2015 |
Prophylactic Effect of Lamivudine for Chemotherapy-Induced Hepatitis B Reactivation in Breast Cancer: A Meta-Analysis.
Topics: Antineoplastic Agents; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Female; Hepatitis B; Humans; Lamivudine; Reverse Transcriptase Inhibitors | 2015 |
Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation.
Topics: Antiviral Agents; Donor Selection; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Risk Factors; Tissue Donors; Treatment Outcome; Vaccination; Waiting Lists | 2015 |
Prophylactic managements of hepatitis B viral infection in liver transplantation.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Risk Factors; Secondary Prevention; Tissue Donors | 2016 |
Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation.
Topics: Adenine; Antineoplastic Agents; Antiviral Agents; Controlled Clinical Trials as Topic; Guanine; Hepatitis B; Hepatitis B virus; Host-Pathogen Interactions; Humans; Lamivudine; Organophosphonates; Telbivudine; Thymidine; Virus Activation | 2016 |
Comparison of entecavir and lamivudine in preventing HBV reactivation in lymphoma patients undergoing chemotherapy: a meta-analysis.
Topics: Antineoplastic Agents; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma; Treatment Outcome | 2016 |
Coexistence of acquired hemophilia A and epidermolysis bullosa acquisita: Two case reports and published work review.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Biopsy; China; Collagen Type VII; Cyclosporine; Epidermolysis Bullosa Acquisita; Esophageal Diseases; Factor VIII; Gastrointestinal Hemorrhage; Glucocorticoids; Hematemesis; Hemophilia A; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Prednisone; Reverse Transcriptase Inhibitors; Skin | 2017 |
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature.
Topics: Antiviral Agents; Graft Survival; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver; Liver Failure; Liver Transplantation; Risk; Tissue Donors | 2016 |
Update on occult hepatitis B virus infection.
Topics: Antiviral Agents; Coinfection; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Interferons; Lamivudine; Liver Cirrhosis; Liver Transplantation; Mutation; Occupational Exposure; Prevalence; Renal Dialysis; RNA Splicing; Viral Load | 2016 |
Antiviral therapies for managing viral hepatitis in lymphoma patients.
Topics: Antiviral Agents; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis C; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Rituximab; Tenofovir; Virus Activation | 2017 |
Hepatitis B core-related antigen assay is useful for monitoring the antiviral effects of nucleoside analogue therapy.
Topics: Antiviral Agents; Biomarkers; Drug Resistance, Viral; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Treatment Outcome | 2008 |
[Management of hepatitis B virus reactivation during chemotherapy or immunosuppressive therapy].
Topics: Antineoplastic Agents; Antiviral Agents; Diagnosis, Differential; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Risk Factors; Virus Activation | 2008 |
Hepatitis B and liver transplantation: 2008 update.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B Vaccines; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine | 2009 |
Liver transplantation for hepatitis B: what is the best hepatitis B immune globulin/antiviral regimen?
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Immunoglobulins, Intravenous; Injections, Intramuscular; Lamivudine; Liver Transplantation | 2008 |
Hepatitis B immune globulin and HBV-related liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Immunotherapy; Lamivudine; Liver Transplantation; Recurrence; Treatment Outcome; Virology | 2008 |
Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis.
Topics: Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Mutation; Research Design; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome | 2009 |
[Interferon in hepatitis B].
Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Genotype; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Multicenter Studies as Topic; Nucleosides; Organophosphonates; Polyethylene Glycols; Pyrimidinones; Randomized Controlled Trials as Topic; Recombinant Proteins; Telbivudine; Thymidine; Treatment Outcome | 2008 |
[Hepatitis B in patients with HIV infection].
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Comorbidity; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; HIV; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Virus Replication | 2008 |
Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature.
Topics: Adolescent; Biopsy; DNA, Viral; Glomerulosclerosis, Focal Segmental; Hepatitis B; Hepatitis B Antigens; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunohistochemistry; Kidney; Lamivudine; Male; Nephrotic Syndrome; Proteinuria; Treatment Outcome | 2009 |
Hepatitis B therapy in children.
Topics: Adenine; Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Therapy, Combination; Hepatitis B; Humans; Infant; Infant, Newborn; Interferon-alpha; Lamivudine; Organophosphonates; Treatment Outcome | 2009 |
Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues.
Topics: Adenine; Administration, Oral; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Graft Survival; Guanine; Hepatitis B; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Nucleosides; Nucleotides; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome | 2009 |
Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature.
Topics: Aged; Antirheumatic Agents; Biological Products; Chronic Disease; Contraindications; Female; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Premedication; Reverse Transcriptase Inhibitors; Rheumatic Diseases; Tumor Necrosis Factor-alpha; Virus Activation; Virus Replication | 2009 |
Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance.
Topics: Antiviral Agents; Clinical Trials as Topic; Decision Support Techniques; Hepatitis B; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lamivudine; Lymphoma; Models, Biological; Reverse Transcriptase Inhibitors; Treatment Outcome | 2009 |
The option of liver transplantation for hepatitis B: where are we?
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Postoperative Complications; Practice Guidelines as Topic; Secondary Prevention; Viral Load | 2009 |
Liver transplantation for hepatitis B virus. Pre-emptive and peri-operative prophylaxis.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Perioperative Care; Postoperative Complications; Secondary Prevention; Treatment Outcome | 2009 |
[Reactivation of hepatitis B virus in patients with hematological neoplasms].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antineoplastic Agents; Antiviral Agents; Female; Graft vs Host Disease; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Male; Risk Factors; Sex Factors; Transplants; Virus Activation | 2009 |
Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis.
Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Middle Aged; Organophosphonates; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome | 2010 |
Liver grafts from anti-hepatitis B core positive donors: a systematic review.
Topics: Algorithms; Antiviral Agents; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Transplantation; Recurrence; Risk Factors; Tissue Donors; Treatment Outcome | 2010 |
[Management and treatment of pregnant women with hepatitis B].
Topics: Antiviral Agents; Female; Hepatitis B; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Viral Load | 2009 |
[Anti-viral treatment for liver cirrhosis].
Topics: Hepatitis B; Hepatitis C; Humans; Interferons; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Reverse Transcriptase Inhibitors | 2010 |
[Advance in clinical studies of the kinetics of hepatitis B virus].
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-alpha; Kinetics; Lamivudine; Models, Statistical; Viral Load | 2010 |
Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.
Topics: Adrenal Cortex Hormones; Antiviral Agents; Glomerulonephritis; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferons; Lamivudine; Proteinuria; Treatment Outcome | 2010 |
Is response to antiviral treatment influenced by hepatitis B virus genotype?
Topics: Antiviral Agents; Genotype; Hepatitis B; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Recombinant Proteins; Treatment Outcome | 2010 |
Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation | 2010 |
Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.
Topics: Adenine; Antiviral Agents; Asia; Guanine; Hepatitis B; Hepatitis B virus; Humans; Interferons; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir | 2010 |
HIV-HBV coinfection among South African patients receiving antiretroviral therapy.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Prevalence; Reverse Transcriptase Inhibitors; South Africa | 2010 |
Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: a systematic review.
Topics: Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Risk Assessment; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome | 2010 |
[Hepatitis B virus (HBV) infection and hepatocarcinogenesis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Epigenesis, Genetic; Hepatitis B; Hepatitis B Surface Antigens; Humans; Interferons; Lamivudine; Liver Neoplasms; Oncogenes; Population Surveillance; Primary Prevention; Protein Precursors; Secondary Prevention; Trans-Activators; Viral Regulatory and Accessory Proteins | 2010 |
Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis.
Topics: Carrier State; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Models, Theoretical; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors | 2010 |
Impact of immunosuppression and chemotherapy on reactivation of viral hepatitis.
Topics: Antiviral Agents; Hepacivirus; Hepatitis A; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Hepatitis Delta Virus; Humans; Immunosuppression Therapy; Lamivudine; Recurrence; Virus Activation | 2010 |
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.
Topics: Adenine; Antiviral Agents; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Randomized Controlled Trials as Topic; Secondary Prevention | 2010 |
Review of the use of hepatitis B core antibody-positive kidney donors.
Topics: Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Liver; Patient Selection; Reverse Transcriptase Inhibitors; Risk Assessment; Tissue Donors; Transaminases; Viral Load | 2010 |
Therapy with nucleos(t)ide analogues: current role in dialysis patients.
Topics: Antiviral Agents; Hepatitis B; Humans; Interferons; Kidney Failure, Chronic; Lamivudine; Nucleosides; Nucleotides; Renal Dialysis; Reverse Transcriptase Inhibitors | 2010 |
Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern.
Topics: Antiviral Agents; Australia; DNA Mutational Analysis; Drug Resistance, Viral; Genotype; Germany; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation | 2010 |
Interferon and lamivudine combination therapy versus lamivudine monotherapy for hepatitis B e antigen-negative hepatitis B treatment: a meta-analysis of randomized controlled trials.
Topics: Antiviral Agents; Drug Carriers; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Randomized Controlled Trials as Topic; Recombinant Proteins; Reverse Transcriptase Inhibitors | 2010 |
Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature.
Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Greece; Hepatitis B; Hepatitis C; Humans; Inflammatory Bowel Diseases; Interferon-alpha; Lamivudine; Male; Middle Aged; Organophosphonates; Prevalence; Retrospective Studies; Ribavirin; Tenofovir; Treatment Outcome | 2010 |
The difficulties of managing severe hepatitis B virus reactivation.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Recurrence; Virus Activation | 2011 |
The impact of human immunodeficiency virus on viral hepatitis.
Topics: Adenine; Antiviral Agents; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis C; Hepatitis Viruses; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine | 2011 |
An overview of treatment response rates to various anti-viral drugs in Pakistani hepatitis B virus infected patients.
Topics: Antiviral Agents; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Pakistan; Polyethylene Glycols; Recombinant Proteins | 2011 |
Hepatitis B immunoglobulin and/or nucleos(t)ide analogues for prophylaxis against hepatitis b virus recurrence after liver transplantation: a systematic review.
Topics: Adenine; Antiviral Agents; Chi-Square Distribution; Drug Therapy, Combination; Evidence-Based Medicine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Risk Assessment; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome | 2011 |
Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding.
Topics: Adenine; Antiviral Agents; Breast Feeding; Female; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Telbivudine; Tenofovir; Thymidine | 2011 |
Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation.
Topics: Antibiotic Prophylaxis; Antiviral Agents; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Risk Factors; Virus Activation | 2011 |
Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients.
Topics: Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Disease Management; DNA, Viral; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunity, Cellular; Immunosuppression Therapy; Lamivudine; Opportunistic Infections; Transplantation Conditioning; Virus Activation; Virus Replication | 2011 |
Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.
Topics: Antiviral Agents; Cost of Illness; Cost-Benefit Analysis; Health Care Costs; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Primary Prevention; Quality-Adjusted Life Years; Taiwan | 2011 |
A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus.
Topics: Antiviral Agents; Databases, Factual; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load | 2011 |
Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?
Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Interferons; Lamivudine; Liver Failure, Acute; Organophosphonates; Tenofovir | 2012 |
[Pharmacological treatment of acute hepatitis B].
Topics: Acute Disease; Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Lamivudine; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Spain; Telbivudine; Tenofovir; Thymidine; Treatment Outcome | 2012 |
Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis.
Topics: Adenine; Administration, Oral; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Pyrimidinones; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Time Factors; Treatment Outcome; Viral Load | 2012 |
Influence of anti-HBc positive organ donor in lung donor selection.
Topics: Antiviral Agents; Donor Selection; Follow-Up Studies; gamma-Globulins; Health Care Surveys; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Informed Consent; Lamivudine; Lung Transplantation; Organizational Policy; Practice Patterns, Physicians'; Preoperative Care; Spain; Tissue Donors; Vaccination | 2012 |
A meta-analysis of nucleos(t)ide analogues in patients with decompensated cirrhosis due to hepatitis B.
Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Nucleosides; Nucleotides; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine | 2013 |
Hepatitis B virus infection in hemodialysis patients.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B Vaccines; Humans; Interferon-alpha; Kidney Failure, Chronic; Lamivudine; Prognosis; Renal Dialysis; Risk Factors | 2002 |
Prevention of recurrent hepatitis B post-liver transplantation.
Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention; Viral Hepatitis Vaccines | 2002 |
Use of hepatitis B core antibody-positive donors for liver transplantation.
Topics: Hepatitis B; Hepatitis B Antibodies; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Tissue Donors | 2002 |
The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus.
Topics: DNA-Directed DNA Polymerase; Drug Resistance, Viral; Genes, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors | 2002 |
Prophylaxis and treatment of recurrent hepatitis B after liver transplantation.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Immunization; Immunoglobulins; Lamivudine; Liver Transplantation; Preventive Medicine; Reverse Transcriptase Inhibitors; Secondary Prevention | 2003 |
Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era.
Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Nucleosides; Organophosphonates; Postoperative Complications; Recurrence; Time Factors; Transplantation Immunology | 2003 |
Management of patients with decompensated HBV cirrhosis.
Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; Disease Progression; Drug Resistance; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Organophosphonates; Prognosis; Reverse Transcriptase Inhibitors; Risk Factors | 2003 |
Lamivudine resistant occult HBV: implications for public health?
Topics: Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Public Health; Reverse Transcriptase Inhibitors | 2003 |
[Treatment of hepatitis B].
Topics: Adenine; Antiviral Agents; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Treatment Outcome | 2002 |
[Drug therapy of hepatitis B and C].
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Ribavirin | 2003 |
Pediatric issues in new therapies for hepatitis B and C.
Topics: Adolescent; Adult; Age Factors; Antiviral Agents; Child; Child, Preschool; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Reverse Transcriptase Inhibitors | 2003 |
Towards an improved and cost-saving prophylaxis of hepatitis B virus recurrence after liver transplantation?
Topics: Cost Control; Drug Costs; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Care; Preventive Medicine; Reverse Transcriptase Inhibitors; Secondary Prevention | 2003 |
Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with hemato-oncological neoplasias treated with chemotherapy.
Topics: Antineoplastic Agents; Chronic Disease; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Virus Activation | 2003 |
[Hepatotoxicity of chemotherapy].
Topics: Antineoplastic Agents; Antiviral Agents; Chemical and Drug Induced Liver Injury; Hematologic Neoplasms; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Liver Diseases; Neoplasms; Reverse Transcriptase Inhibitors | 2003 |
[Hepatitis: associated diseases. Risk groups -- prevention -- treatment].
Topics: Adenine; Adult; Antiviral Agents; Child; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; Humans; Infant; Infant, Newborn; Interferons; Lamivudine; Liver Cirrhosis; Male; Mutation; Organophosphonates; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Time Factors | 2003 |
Early detection of hepatitis B drug resistance: implications for patient management.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors | 2003 |
Current issues and treatment of fulminant hepatic failure including transplantation in Hong Kong and the Far East.
Topics: Asia, Eastern; Hepatitis B; Hong Kong; Humans; Immunotherapy, Adoptive; Lamivudine; Liver Failure; Liver Transplantation; Reverse Transcriptase Inhibitors | 2003 |
Treatment of hepatitis B reinfection after liver transplantation.
Topics: Drug Therapy, Combination; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Interferon-alpha; Lamivudine; Liver Transplantation; Recurrence; Reverse Transcriptase Inhibitors | 2003 |
Treatment modalities for hepatitis B viral infection and resistance to antiviral therapy.
Topics: Antiviral Agents; Drug Design; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation | 2003 |
Lamivudine prophylaxis for chemotherapy induced reactivation hepatitis B: a case report and review.
Topics: Adult; Antineoplastic Protocols; Female; Hepatitis B; Humans; Lamivudine; Leukemia, Myeloid, Acute; Reverse Transcriptase Inhibitors | 2003 |
Doctor to patient transmission of hepatitis B virus: implications of HBV DNA levels and potential new solutions.
Topics: Adenine; Antiviral Agents; DNA, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Infectious Disease Transmission, Professional-to-Patient; Interferon-alpha; Lamivudine; Organophosphonates; Organophosphorus Compounds; Physicians; Risk Factors; Risk Management; Tenofovir; Viral Load | 2003 |
Chronic viral hepatitis: always be current!
Topics: Adenine; Adolescent; Adult; Antiviral Agents; Child; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Immunization Schedule; Infant, Newborn; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Prevalence; Risk Factors; Serologic Tests; Treatment Outcome; United States; Viral Hepatitis Vaccines | 2003 |
Viral hepatitis B.
Topics: Adenine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Genotype; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Viral Load | 2003 |
Results of lamivudine therapy for HBe antigen positive hepatitis (in the West).
Topics: Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; North America; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Treatment Outcome | 2003 |
Hepatitis B virus resistance to antivirals: clinical implications and management.
Topics: Antiviral Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Prognosis; Reverse Transcriptase Inhibitors | 2003 |
Management of the patient with hepatitis B virus-related cirrhosis.
Topics: Adenine; Antiviral Agents; Hepatitis B; Humans; Interferons; Lamivudine; Liver Cirrhosis; Nucleosides; Organophosphonates; Reverse Transcriptase Inhibitors | 2003 |
Treatment of recurrence of hepatitis B in transplant patients.
Topics: 2-Aminopurine; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention | 2003 |
Hepatitis B.
Topics: Acute Disease; Antiviral Agents; Carcinoma, Hepatocellular; Chronic Disease; Disease Progression; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Mass Screening; Patient Selection; Recombinant Proteins; Reverse Transcriptase Inhibitors; Risk Factors; Sexually Transmitted Diseases; Substance Abuse, Intravenous; United States; Vaccination | 2004 |
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Polyethylene Glycols; Recombinant Proteins | 2004 |
Hepatitis B virus infection--natural history and clinical consequences.
Topics: Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Neoplasms; Viremia; Virus Replication | 2004 |
Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials.
Topics: DNA, Viral; Hepatitis B; Humans; Kidney Transplantation; Lamivudine; MEDLINE; Postoperative Complications | 2004 |
PGS consensus statement on management of hepatitis B virus infection--2003.
Topics: Antiviral Agents; Carrier State; Disease Transmission, Infectious; Hepatitis B; Hepatitis B Antigens; Hepatitis B Vaccines; Humans; Interferon-alpha; Lamivudine; Pakistan; Prevalence; Reverse Transcriptase Inhibitors | 2004 |
Molecular virology of hepatitis B virus.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Transcription, Genetic; Viral Proteins; Virus Replication | 2004 |
Hepatitis B virus kinetics and mathematical modeling.
Topics: Adenine; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatocytes; Lamivudine; Models, Biological; Organophosphonates; Reverse Transcriptase Inhibitors; Viral Load; Virion | 2004 |
HBV infection in patients with end-stage renal disease.
Topics: Antiviral Agents; Comorbidity; Cross Infection; Glomerulonephritis; Hepatitis B; Humans; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Renal Dialysis; Universal Precautions; Vaccination | 2004 |
The role of interferon therapy in hepatitis B.
Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Risk Assessment; Risk Factors; Treatment Outcome | 2004 |
Current antiviral therapy for chronic hepatitis B.
Topics: Adenine; Antiviral Agents; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors | 2004 |
Evolving strategies to prevent HBV recurrence.
Topics: Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis Antibodies; Hepatitis B; Hepatitis B Core Antigens; Hepatitis D; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Preoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention; Survival Analysis; Tissue Donors | 2004 |
[Hepatitis B (acute and chronic)].
Topics: Acute Disease; Adenine; Adolescent; Adult; Antiviral Agents; Child; Diagnosis, Differential; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male; Organophosphonates; Prognosis; Reverse Transcriptase Inhibitors; Risk Factors; Time Factors | 2004 |
[Hepatitis B viral mutation and its clinical significance].
Topics: Antiviral Agents; Genotype; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Treatment Outcome | 2004 |
[Detection of lamivudine-resistant hepatitis B virus].
Topics: Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Nucleic Acid Amplification Techniques; Plasmids; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Inhibitors | 2004 |
[Advances in the treatment of acute hepatitis B].
Topics: Acute Disease; Anticoagulants; Antiviral Agents; Carrier State; Clinical Trials as Topic; Diagnosis, Differential; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Guanine; Hepatitis B; Humans; Interferons; Lamivudine | 2004 |
[Recent advances in the treatment of fulminant hepatitis B].
Topics: Acute Disease; Antiviral Agents; Carrier State; Cyclosporine; Drug Therapy, Combination; Guanine; Hemodiafiltration; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Liver Failure, Acute; Liver Transplantation; Methylprednisolone; Plasma Exchange; Prognosis; Pulse Therapy, Drug | 2004 |
[Current status of treatment for HBV-related cirrhosis].
Topics: Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Interferon-alpha; Interferon-beta; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Risk; Treatment Outcome | 2004 |
[Liver transplantation for hepatitis B virus cirrhosis].
Topics: Biomarkers; Brain Death; Combined Modality Therapy; DNA, Viral; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Living Donors; Preoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention | 2004 |
Hepatitis B and hepatitis C viruses in liver transplantation.
Topics: Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Immunosuppression Therapy; Lamivudine; Liver Transplantation; Reoperation; Vaccination | 2004 |
[Treatment of hepatitis B].
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Transplantation; Nucleosides; Viral Load | 2004 |
Management of hepatitis B in liver transplant patients.
Topics: Antiviral Agents; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications; Recurrence; Risk Factors | 2005 |
Lamivudine in the treatment of HBV-related liver disease after renal transplantation: an update.
Topics: Antiviral Agents; Graft Survival; Hepatitis B; Humans; Interferons; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Survival Analysis | 2005 |
[Prevention and treatment of hepatitis B virus infection after liver transplantation].
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Survival | 2005 |
Prevention of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoprevention; Disease Progression; Disease Susceptibility; Hepatitis B; Humans; Interferons; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Reverse Transcriptase Inhibitors; Secondary Prevention; Vaccination | 2005 |
Reactivation of hepatitis B virus with rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibodies, Viral; Antineoplastic Agents; Antiviral Agents; Autoimmune Diseases; Hepatitis B; Hepatitis B virus; Humans; Kinetics; Lamivudine; Lymphoma, Non-Hodgkin; Rituximab | 2005 |
Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Treatment Outcome; Virulence | 2005 |
[Diagnostic tests: HBV-DNA].
Topics: Antiviral Agents; Biomarkers; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Monitoring, Physiologic; Nucleic Acid Amplification Techniques | 2005 |
Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation.
Topics: Antibiotic Prophylaxis; Antiviral Agents; Hepatitis B; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Recurrence | 2005 |
Prevention of hepatitis B recurrence after liver transplantation.
Topics: Antiviral Agents; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence | 2005 |
Therapeutic implications of hepatitis B virus genotypes.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Genes, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver Neoplasms | 2005 |
[Prophylaxis and therapy of hepatitis B after liver transplantation].
Topics: Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence | 2005 |
Understanding hepatitis B.
Topics: Acute Disease; Adenine; Algorithms; Antiviral Agents; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Organophosphonates; Recombinant Proteins | 2005 |
Lamivudine treatment of decompensated hepatitis B virus-related cirrhosis.
Topics: Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome; Virus Replication | 2006 |
Hepatitis B virus genotypes and response to antiviral therapy.
Topics: Adenine; Antiviral Agents; Genotype; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Organophosphonates | 2006 |
Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Nucleotides; Organophosphonates; Recurrence; Tenofovir | 2006 |
Hepatitis B: the pathway to recovery through treatment.
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors | 2006 |
Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
Topics: Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Deoxycytidine; Drug Combinations; Emtricitabine; Guanine; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Organophosphonates; Preventive Medicine; Tenofovir | 2006 |
[Therapy of hepatitis B virus infection].
Topics: Adenine; Antiviral Agents; Drug Antagonism; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Forecasting; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Cirrhosis; Organophosphonates; Polyethylene Glycols; Prognosis; Recombinant Proteins; Reverse Transcriptase Inhibitors; Time Factors | 2006 |
[Managing lamivudine resistance in liver transplantation for hepatitis B liver disease].
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Organophosphonates; Practice Guidelines as Topic; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome | 2006 |
[Impact of resistance to analogue antivirals and therapeutic strategies in situations of dialysis, kidney transplantation, vasculitis, and preemptive treatments in immunosuppressed patients].
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Humans; Immunocompromised Host; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Organophosphonates; Renal Dialysis; Reverse Transcriptase Inhibitors; Treatment Outcome; Vasculitis | 2006 |
Hepatitis B virus: something old, something new.
Topics: Adolescent; Adult; Antiviral Agents; Carrier State; Child; Child, Preschool; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Interferon-alpha; Lamivudine | 2007 |
Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; CD4 Lymphocyte Count; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; HIV Seropositivity; Humans; Lamivudine; Middle Aged; Organophosphonates; Tenofovir | 2007 |
[Drugs for hepatitis B and C infection].
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Mutation; Oligopeptides; Organophosphonates; Proline; Ribavirin; Serine Proteinase Inhibitors | 2007 |
[Mechanisms of drug resistance in hepatitis viruses B and C].
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Gene Products, pol; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Interferons; Lamivudine; Mutation; Organophosphonates; Ribavirin; Viral Nonstructural Proteins | 2007 |
Drug resistance in antiviral treatment for infections with hepatitis B and C viruses.
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Organophosphonates | 2007 |
Entecavir is a potent anti-HBV drug superior to lamivudine: experience from clinical trials in China.
Topics: Antiviral Agents; China; Drug Resistance, Viral; Guanine; Hepatitis B; Humans; Lamivudine; Randomized Controlled Trials as Topic | 2007 |
Liver transplantation using hepatitis B core antibody-positive grafts: review and university of Tokyo experience.
Topics: Disease Transmission, Infectious; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Japan; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Risk Factors; Tissue Donors; Universities | 2007 |
Interferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trials.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; Humans; Interferon-alpha; Lamivudine; Polyethylene Glycols; Randomized Controlled Trials as Topic | 2007 |
Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis.
Topics: Databases, Bibliographic; Drug Therapy; Hepatitis B; Humans; Lamivudine; Secondary Prevention | 2008 |
[Attention-getting sexually transmitted diseases: Hepatitis B].
Topics: Adenine; Adenosine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Genotype; Guanine; Guanosine; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Sexually Transmitted Diseases, Viral | 2007 |
Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta-analysis.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis.
Topics: Adult; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Orthohepadnavirus; Secondary Prevention; Treatment Outcome | 2008 |
New nucleoside analogues for chronic hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Chronic Disease; Drug Evaluation, Preclinical; Famciclovir; Hepatitis B; Humans; Lamivudine; Nucleosides; Zalcitabine | 1995 |
New developments in antiviral therapy for chronic hepatitis B infection.
Topics: 2-Aminopurine; Antiviral Agents; Arabinofuranosyluracil; Clinical Trials as Topic; Famciclovir; Hepatitis B; Hepatitis, Chronic; Humans; Interferon-alpha; Lamivudine; Treatment Outcome; Zalcitabine | 1995 |
Treatment of posttransplantation hepatitis B.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Ganciclovir; Hepatitis B; Humans; Lamivudine; Liver Transplantation | 1997 |
Clinical pharmacokinetics of lamivudine.
Topics: Absorption; Age Factors; Anti-HIV Agents; Child; Clinical Trials as Topic; Drug Interactions; Female; Hepatitis B; Humans; Infant, Newborn; Lamivudine; Maternal-Fetal Exchange; Pregnancy; Renal Insufficiency; Reverse Transcriptase Inhibitors | 1999 |
[New management of hepatitis B virus].
Topics: 2-Aminopurine; Adrenal Cortex Hormones; Antiviral Agents; Famciclovir; Germanium; Hepatitis B; Humans; Immunologic Factors; Interferons; Interleukin-12; Lamivudine; Organometallic Compounds; Propionates; Reverse Transcriptase Inhibitors; Thymosin | 1999 |
Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature.
Topics: Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Middle Aged; Reverse Transcriptase Inhibitors | 1999 |
Lamivudine therapy for hepatitis B infection.
Topics: DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Secondary Prevention; Transaminases; Treatment Outcome; Virus Replication | 1999 |
Update on prevention and treatment of viral hepatitis in children.
Topics: Child; Female; Hepatitis A; Hepatitis B; Hepatitis C; Humans; Infectious Disease Transmission, Vertical; Interferons; Lamivudine; Male; Viral Hepatitis Vaccines | 1999 |
Preclinical aspects of lamivudine and famciclovir against hepatitis B virus.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine | 1999 |
[Hepatitis B: when to use lamivudine?].
Topics: Antiviral Agents; Hepatitis B; Humans; Interferon-alpha; Lamivudine | 2000 |
Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
Topics: Administration, Oral; Animals; Disease Models, Animal; DNA, Viral; Dose-Response Relationship, Drug; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B Virus, Woodchuck; Humans; Interferon-alpha; Lamivudine; Mice; Mice, Transgenic; Polymerase Chain Reaction; Sex Factors; Time Factors; Viral Load; Virus Replication; Zidovudine | 1998 |
Lamivudine for treating active hepatitis B in renal transplant recipients: a case report.
Topics: Hepatitis B; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors | 2000 |
Lamivudine for hepatitis B in clinical practice.
Topics: Antiviral Agents; Controlled Clinical Trials as Topic; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Treatment Outcome; Virus Replication | 2000 |
Development of resistance and perspectives for future therapies against hepatitis B infections: lessons to be learned from HIV.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Microbial Sensitivity Tests; Prognosis; Reverse Transcriptase Inhibitors; Treatment Outcome | 1999 |
Doctor-to-patient transmission of viral hepatitis B: is it a problem, is there a solution?
Topics: Antiviral Agents; DNA, Viral; General Surgery; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Infectious Disease Transmission, Professional-to-Patient; Lamivudine; Practice Guidelines as Topic; Risk Factors | 2000 |
[Therapy of problem cases in hepatitis B].
Topics: Antiviral Agents; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Liver; Liver Function Tests; Liver Transplantation | 2000 |
Transplantation in the hepatitis B patient and current therapies to prevent recurrence.
Topics: Adult; Female; Hepatitis B; Hepatitis B Vaccines; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Reverse Transcriptase Inhibitors; Risk Factors; Secondary Prevention; Survival Analysis | 2000 |
Posttransplantation: emerging and future therapies.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Ganciclovir; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Nucleosides; Postoperative Care; Risk Factors; Secondary Prevention; Survival Analysis | 2000 |
Drug-resistant viral hepatitis.
Topics: Amantadine; Antiviral Agents; Drug Resistance, Microbial; Hepacivirus; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Ribavirin | 2000 |
Hepatitis B immune globulin: the US experience.
Topics: Antiviral Agents; Graft Survival; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Incidence; Lamivudine; Liver Cirrhosis; Liver Transplantation; Mutation; Patient Selection; Time Factors; Transplantation, Homologous; Treatment Failure; Treatment Outcome; United States; Virus Replication | 2000 |
Antiviral therapy to prevent and treat hepatitis B virus infection in hepatic allografts.
Topics: 2-Aminopurine; Antiviral Agents; Drug Combinations; Drug Resistance, Microbial; Famciclovir; Ganciclovir; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Survival Rate; Transplantation, Homologous | 2000 |
Current topics in hepatitis B.
Topics: Antiviral Agents; Blood Donors; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Interferon-alpha; Lamivudine; Mutation; Reverse Transcriptase Inhibitors | 2000 |
Posttransplantation prevention and treatment of recurrent hepatitis B.
Topics: Antiviral Agents; Drug Resistance; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence | 2000 |
Hepatitis B and C in the liver transplant recipient.
Topics: Graft Enhancement, Immunologic; Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Reverse Transcriptase Inhibitors; Risk Factors | 2000 |
Hepatitis B--an important public health issue.
Topics: Antiviral Agents; Carrier State; Endemic Diseases; Hepatitis B; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Diseases; Public Health | 2001 |
Molecular anatomy and pathophysiologic implications of drug resistance in hepatitis B virus infection.
Topics: Drug Resistance, Microbial; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Virus Replication | 2001 |
Management of hepatitis B: 2000--summary of a workshop.
Topics: Animals; Disease Models, Animal; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Recurrence | 2001 |
Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
Topics: 2-Aminopurine; Adenine; Amino Acid Sequence; Animals; Anti-HIV Agents; Antimetabolites; Antiviral Agents; Biological Availability; Cell Line; Clinical Trials as Topic; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Viral; Drug Therapy, Combination; Enzyme Inhibitors; Famciclovir; Gene Products, pol; Hepatitis B; Hepatitis B virus; Hepatitis Viruses; Hepatitis, Animal; HIV; Humans; Lamivudine; Models, Animal; Molecular Sequence Data; Molecular Structure; Nucleosides; Organophosphonates; Sequence Alignment; Sequence Homology, Amino Acid; Species Specificity; Virus Replication | 2001 |
Transmission of hepatitis B infection from hepatitis B core antibody--positive livers: background and prevention.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Transplantation; Tissue Donors | 2001 |
Liver transplantation and hepatitis B virus infection: the situation seems to be under control, but the virus is still there.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Risk Factors | 2001 |
Treatment of hepatitis B.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Treatment Outcome | 2001 |
Lamivudine therapy for severe acute hepatitis B virus infection after renal transplantation: case report and literature review.
Topics: Hepatitis B; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors | 2001 |
Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin's lymphoma: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cyclophosphamide; Doxorubicin; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors | 2001 |
Treatment of HBV-related liver disease in the dialysis population: reality and promises.
Topics: Antiviral Agents; Genome, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompetence; Interferon-alpha; Kidney Diseases; Lamivudine; Renal Dialysis; Virus Replication | 2001 |
[HVB and HVC infections in nephrology].
Topics: Antiviral Agents; Comorbidity; Contraindications; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Interferon-alpha; Kidney Diseases; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Postoperative Complications; Renal Dialysis; Ribavirin; Vaccination; Viral Hepatitis Vaccines; Viremia | 2001 |
Current management strategies for hepatitis B in the elderly.
Topics: Aged; Antiviral Agents; Hepatitis B; Humans; Interferon-alpha; Lamivudine | 2001 |
[Prevention and treatment of viral hepatitis in renal insufficiency conditions].
Topics: Antiviral Agents; Biopsy; Comorbidity; Contraindications; Cryoglobulinemia; Female; Graft Rejection; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Liver; Male; Renal Dialysis; Ribavirin; Severity of Illness Index | 2001 |
Treatment of hepatitis B and C following liver transplantation.
Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Disease Progression; Drug Resistance; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Interferon-alpha; Lamivudine; Liver Transplantation; Organophosphonates; Prognosis; Ribavirin; Secondary Prevention; Survival Rate | 2002 |
[Hepatic transplantation and HBV reinfection].
Topics: Antiviral Agents; Chemoprevention; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Ribavirin; Secondary Prevention | 2002 |
[Risks and precautions for the use of lamivudine in patients with chronic hepatitis B virus infection].
Topics: DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine | 2002 |
[New management strategies for hepatitis B].
Topics: Adenine; Antiviral Agents; Arabinofuranosyluracil; Deoxycytidine; Emtricitabine; Guanine; Hepatitis B; Humans; Lamivudine; Organophosphonates | 2002 |
Therapeutic advances in the management of hepatitis B and hepatitis C.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Ribavirin | 2001 |
The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses.
Topics: Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Hepatitis B; Hepatitis C; HIV Infections; Humans; Lamivudine; Liver; Ribavirin; Viremia | 2001 |
Management of viral hepatitis B.
Topics: Adjuvants, Immunologic; Antiviral Agents; Forecasting; Genetic Variation; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Nucleosides; Reverse Transcriptase Inhibitors | 2002 |
137 trial(s) available for lamivudine and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Randomized Controlled Study of Tenofovir versus Lamivudine Followed by Tenofovir in Severe Exacerbation of Hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Tenofovir; Treatment Outcome | 2022 |
New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings.
Topics: Adult; Alanine Transaminase; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Emtricitabine; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Retrospective Studies; Uganda; Zimbabwe | 2021 |
Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen-positive graft.
Topics: Adult; Allografts; Antibiotic Prophylaxis; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Incidence; Lamivudine; Liver; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Serologic Tests; Treatment Outcome; Vaccination | 2017 |
Clinical effect of lamivudine in treating liver function lesion caused by hepatitis B combined with Anti-TB drugs.
Topics: Adult; Aged; Antitubercular Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B; Humans; Isoniazid; Lamivudine; Liver; Liver Function Tests; Male; Middle Aged; Rifampin; Treatment Outcome; Tuberculosis; Withholding Treatment; Young Adult | 2018 |
Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates.
Topics: Adenine; Adult; Aged; Antiviral Agents; Biomarkers; Disease-Free Survival; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Kaplan-Meier Estimate; Lamivudine; Liver Transplantation; Male; Middle Aged; New South Wales; New Zealand; Organophosphonates; Prospective Studies; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome; Victoria; Viral Load; Young Adult | 2013 |
Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy.
Topics: Adult; Alanine Transaminase; Anti-Retroviral Agents; CD4-Positive T-Lymphocytes; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; HIV Infections; HIV-1; Humans; Kaplan-Meier Estimate; Kenya; Lamivudine; Logistic Models; Prevalence; Proportional Hazards Models; Prospective Studies; Sex Workers; Treatment Outcome | 2013 |
Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis.
Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; Chi-Square Distribution; China; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Kaplan-Meier Estimate; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Time Factors; Treatment Outcome; Viral Load | 2013 |
De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis.
Topics: Adenine; Adult; Alanine Transaminase; Analysis of Variance; Antiviral Agents; Biomarkers; Chi-Square Distribution; China; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Prospective Studies; Time Factors; Treatment Outcome | 2013 |
Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double-blinded multicentre trial.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Bilirubin; DNA, Viral; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Middle Aged; Placebos; Prospective Studies; Treatment Outcome | 2014 |
Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy.
Topics: Adenine; Alanine Transaminase; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Organophosphonates; Polymerase Chain Reaction; Treatment Outcome; Ultrasonography; Viral Load | 2014 |
Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy: the efficacy of preemptive lamivudine and identification of risk factors.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Virus Activation | 2014 |
Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Vincristine; Young Adult | 2014 |
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Biomarkers; Biopsy; DNA, Circular; DNA, Viral; Double-Blind Method; Down-Regulation; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Linear Models; Liver; Male; Middle Aged; Time Factors; Treatment Outcome; Viral Load; Young Adult | 2015 |
Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China.
Topics: Adolescent; Adult; Anti-Retroviral Agents; China; Coinfection; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Virus Replication; Young Adult | 2015 |
A comparison of lamivudine vs entecavir for prophylaxis of hepatitis B virus reactivation in allogeneic hematopoietic stem cell transplantation recipients: a single-institutional experience.
Topics: Adolescent; Adult; Allografts; Female; Follow-Up Studies; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Virus Activation | 2016 |
Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Cross-Sectional Studies; Female; Ghana; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Tenofovir; Viral Load; Viremia; Young Adult | 2016 |
Evidence of long-term suppression of hepatitis B virus DNA by tenofovir as rescue treatment in patients coinfected by HIV.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tenofovir; Time Factors; Treatment Outcome; Virus Replication | 2008 |
[Lamivudine and adefovir dipivoxil combination treatment for liver cirrhosis patients with CHB].
Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates | 2008 |
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies; Tenofovir; Thailand; Treatment Outcome; Zidovudine | 2008 |
A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis.
Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Patient Selection; Postoperative Complications; Viral Load | 2008 |
[Effect of high viral hepatitis B virus DNA loads on vertical transmission of hepatitis B virus in late-pregnant women].
Topics: Administration, Oral; Adult; Antiviral Agents; DNA, Viral; Double-Blind Method; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Viral Load | 2008 |
Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience.
Topics: Anti-HIV Agents; Antineoplastic Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Neoplasms; Retrospective Studies; Treatment Outcome; Virus Activation | 2009 |
Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.
Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Treatment Outcome | 2008 |
Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biopsy; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Lamivudine; Liver; Male; Middle Aged; Models, Biological; Organophosphonates; Prospective Studies; Tenofovir; Viral Load; Young Adult | 2009 |
Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.
Topics: Adult; Antibodies, Viral; Antiviral Agents; Chemoprevention; Double-Blind Method; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Placebos; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome | 2009 |
Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Phylogeny; RNA-Directed DNA Polymerase; Treatment Outcome | 2009 |
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cross-Sectional Studies; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Viral Load | 2009 |
Lamivudine for the prevention of hepatitis B virus reactivation after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with advanced or relapsed non-Hodgkin's lymphoma single institution experience.
Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Incidence; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Transplantation, Autologous; Young Adult | 2009 |
Adefovir plus lamivudine are more effective than adefovir alone in lamivudine-resistant HBeAg- chronic hepatitis B patients: a 4-year study.
Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Time Factors; Treatment Outcome; Viral Load; Young Adult | 2010 |
The study of efficacy of lamivudine in patients with severe acute hepatitis B.
Topics: Acute Disease; Adult; Aged; Anti-HIV Agents; Bilirubin; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Proportional Hazards Models | 2010 |
Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
Topics: Adult; Aged; Blood Donors; DNA, Viral; Female; Graft vs Host Disease; Hematologic Neoplasms; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Stem Cell Transplantation; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Virus Activation; Young Adult | 2010 |
Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; DNA, Viral; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Factors; Rituximab; Virus Activation | 2010 |
[Analysis of the prophylactic effect of nucleosides against reactivation of HBV in HBsAg-positive patients with non-hepatic tumors after chemotherapy].
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lung Neoplasms; Lymphoma; Male; Middle Aged; Nucleosides; Pyrimidinones; Retrospective Studies; Telbivudine; Thymidine; Virus Activation | 2010 |
Preventing chemotherapy-induced hepatitis B reactivation in breast cancer patients: a prospective comparison of prophylactic versus deferred preemptive lamivudine.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Cohort Studies; DNA, Viral; Drug Administration Schedule; Feasibility Studies; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Retrospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Virus Activation | 2011 |
Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Chemoprevention; China; Female; Guanine; Hepatitis B; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Treatment Outcome; Virus Activation; Young Adult | 2011 |
Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.
Topics: Adolescent; Adult; Antigens, Surface; Chronic Disease; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunity, Cellular; Interferon-gamma; Lamivudine; Male; Medication Adherence; Safety; Serologic Tests; Vaccination; Vaccines, DNA; Vaccinia virus; Viral Load; Viral Proteins; Young Adult | 2011 |
A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Female; Hepatitis Antigens; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Middle Aged; Prospective Studies; Secondary Prevention; Treatment Outcome; Virus Activation | 2011 |
Efficacy of peripartum antiviral treatment for hepatic failure due to hepatitis B virus.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Humans; Infant, Newborn; Lamivudine; Liver Failure; Maternal Mortality; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Time Factors; Treatment Outcome; Uterine Diseases; Virus Replication; Young Adult | 2011 |
HBV lamivudine resistance among hepatitis B and HIV coinfected patients starting lamivudine, stavudine and nevirapine in Kenya.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Kenya; Lamivudine; Male; Nevirapine; Stavudine; Treatment Outcome; Viral Load | 2011 |
Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients.
Topics: Adenine; Adult; Age Factors; Aged; Creatine; Drug Resistance, Viral; Drug Therapy, Combination; Female; Greece; Hepatitis B; Hepatitis B e Antigens; Humans; Kidney; Lamivudine; Linear Models; Male; Middle Aged; Organophosphonates | 2011 |
Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis.
Topics: Adult; Aged; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Multivariate Analysis; Republic of Korea; Viremia | 2012 |
The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Chemoprevention; Cohort Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Immunotherapy; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies | 2012 |
Treatment response and evolution of HBV resistance during lamivudine plus adefovir or entecavir therapy in patients with adefovir-resistant mutants.
Topics: Adenine; Adult; Aged; Antiviral Agents; Base Sequence; Cloning, Molecular; DNA, Viral; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates | 2012 |
Safety and efficacy of subcutaneous hepatitis B immunoglobulin after liver transplantation: an open single-arm prospective study.
Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Humans; Immunoglobulins; Injections, Subcutaneous; Lamivudine; Liver Transplantation; Male; Middle Aged; Prospective Studies; Quality of Life; Self Administration; Treatment Outcome | 2013 |
Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B (ACE study): a 2-year follow-up randomized controlled trial.
Topics: Adenine; Adult; Analysis of Variance; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Immunoassay; Lamivudine; Male; Middle Aged; Oligonucleotides; Organophosphonates; Prospective Studies; Republic of Korea; Reverse Transcriptase Inhibitors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Treatment Outcome | 2013 |
[Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation].
Topics: Adult; Antiviral Agents; Chemoprevention; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Postoperative Complications | 2002 |
Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: a pilot study.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Pilot Projects; Recombinant Proteins | 2002 |
Oral ganciclovir for treatment of lamivudine-resistant hepatitis B virus infection: a pilot study.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Antiviral Agents; Drug Resistance, Viral; Female; Ganciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Pilot Projects | 2002 |
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
Topics: Adult; DNA, Viral; Drug Resistance, Viral; Female; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Reverse Transcriptase Inhibitors; Transplantation, Homologous; Treatment Outcome; Virus Replication | 2002 |
Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantation.
Topics: Alanine Transaminase; Cohort Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Preoperative Care; Reverse Transcriptase Inhibitors; Severity of Illness Index; Virus Replication; Waiting Lists | 2002 |
[Therapeutic efficacy of lamivudine in patients with hepatitis B virus-related decompensated cirrhosis in Korea].
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged | 2002 |
Lamivudine therapy in renal allograft recipients with hepatitis B virus infection.
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Postoperative Complications; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Virus Activation | 2003 |
[Effect of single-using or combined-using lamivudine/interferon-alpha 1b on serum markers in patients with hepatitis B].
Topics: Adolescent; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged | 2003 |
A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation.
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome; Virus Replication | 2003 |
Interruption of HBV intrauterine transmission: a clinical study.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Incidence; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy | 2003 |
Trial of lamivudine in hepatitis B surface antigen carriers with persistent hepatitis B core IgM antibody.
Topics: Adult; Carrier State; Enzyme-Linked Immunosorbent Assay; Female; Headache; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulin M; Iraq; Lamivudine; Male; Middle Aged; Nausea; Reverse Transcriptase Inhibitors; Treatment Outcome | 2003 |
Reconstitution of hepatitis B virus (HBV)-specific T cell responses with treatment of human immunodeficiency virus/HBV coinfection.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Hepatitis B; Hepatitis B virus; HIV Seropositivity; HIV-1; Humans; Lamivudine; Species Specificity; T-Lymphocytes; Viral Load | 2003 |
Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Time Factors; Virus Activation | 2003 |
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.
Topics: Adult; Age Distribution; Aged; Carrier State; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Incidence; Lamivudine; Male; Middle Aged; Neoplasm Staging; Neoplasms; Primary Prevention; Probability; Prognosis; Reference Values; Risk Assessment; Secondary Prevention; Serologic Tests; Sex Distribution; Survival Analysis; Treatment Outcome | 2004 |
Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; DNA, Viral; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged | 2004 |
No benefit to continue lamivudine therapy after emergence of YMDD mutations.
Topics: Adolescent; Adult; Amino Acid Motifs; Antiviral Agents; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Treatment Outcome | 2004 |
Lamivudine facilitates optimal chemotherapy in hepatitis B virus-infected children with hematological malignancies: a preliminary report.
Topics: Adolescent; Antineoplastic Agents; Antiviral Agents; Child; Child, Preschool; Drug Synergism; Female; Hematologic Neoplasms; Hepatitis B; Humans; Immunosuppression Therapy; Lamivudine; Male; Remission Induction; Treatment Outcome; Virus Activation | 2004 |
Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa.
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Drug Administration Schedule; Female; Hepatitis B; Humans; Lamivudine; Male; Methylprednisolone; Plasma Exchange; Polyarteritis Nodosa; Prednisone; Reverse Transcriptase Inhibitors; Treatment Outcome | 2004 |
A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
Topics: Adolescent; Adult; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Male; Polymerase Chain Reaction; Probability; Prospective Studies; Severity of Illness Index; Statistics, Nonparametric; Transaminases; Treatment Outcome; Viral Load | 2004 |
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance.
Topics: Adult; Carcinoma, Hepatocellular; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Risk Assessment | 2004 |
Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus.
Topics: Adenine; Adult; Anti-HIV Agents; Drug Therapy, Combination; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir | 2004 |
The management of hepatitis B virus/HIV-1 co-infected patients starting their first HAART regimen. Treating two infections for the price of one drug?
Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Aspartate Aminotransferases; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Liver; Male; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome | 2004 |
Lamivudine treatment for acute severe hepatitis B: a pilot study.
Topics: Acute Disease; Adult; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis B; Humans; Immunocompromised Host; Lamivudine; Male; Pilot Projects; Polymerase Chain Reaction; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2004 |
Lamivudine in prevention and treatment of recurrent HBV after liver transplantation.
Topics: Adult; Female; Follow-Up Studies; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome | 2004 |
Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis.
Topics: Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Time Factors | 2004 |
Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation.
Topics: Adolescent; Adult; Combined Modality Therapy; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome | 2004 |
Genotypic resistance of hepatitis B virus to lamivudine in renal transplant recipients.
Topics: Adult; Base Sequence; DNA Primers; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Mutation | 2005 |
[Anti-viral therapy using lamivudine and thymosin is helpful to prevent recurrence in hepatocellular carcinoma with coexisting active hepatitis B].
Topics: Adult; Aged; Carcinoma, Hepatocellular; DNA, Viral; Female; Hepatectomy; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Postoperative Period; Reverse Transcriptase Inhibitors; Survival Rate; Thymalfasin; Thymosin | 2005 |
Character of HBV (hepatitis B virus) polymerase gene rtM204V/I and rtL180M mutation in patients with lamivudine resistance.
Topics: China; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Genetic Predisposition to Disease; Genetic Testing; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Polymorphism, Genetic; Risk Assessment; Risk Factors | 2005 |
Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; Cisplatin; Female; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Male; Middle Aged; Nasopharyngeal Neoplasms; Radiotherapy, Adjuvant; Virus Activation | 2005 |
Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis.
Topics: Adult; DNA, Viral; Drug Administration Schedule; Female; Follow-Up Studies; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome | 2005 |
Adefovir dipivoxil alone or in combination with ongoing lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Antiviral Agents; Drug Combinations; Drug Resistance, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Treatment Outcome | 2005 |
Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; DNA, Viral; Drug Therapy, Combination; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Premedication; Prospective Studies; Serologic Tests; Treatment Outcome; Virus Activation | 2005 |
Lamivudine treatment in patients with HBV-related hepatocellular carcinoma--using an untreated, matched control cohort.
Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local | 2005 |
Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients.
Topics: Adult; Antiviral Agents; Biopsy; Female; Hepatitis B; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome | 2005 |
Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients.
Topics: Adult; Antiviral Agents; Drug Resistance; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Premedication; Viral Load; Virus Activation | 2006 |
Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anthracyclines; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relationship, Drug; Female; Hepatitis B; Hepatitis B virus; Hodgkin Disease; Humans; Incidence; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Primary Prevention; Prognosis; Survival Rate; Treatment Outcome | 2006 |
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Bilirubin; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure, Acute; Male; Middle Aged; Prothrombin Time | 2006 |
A multiphase model of the dynamics of HBV infection in HBeAg-negative patients during pegylated interferon-alpha2a, lamivudine and combination therapy.
Topics: Antiviral Agents; DNA, Viral; Double-Blind Method; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Models, Biological; Polyethylene Glycols; Recombinant Proteins; Time Factors; Viral Load | 2006 |
Changes in viral loads of lamivudine-resistant mutants and evolution of HBV sequences during adefovir dipivoxil therapy.
Topics: Adenine; Adult; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Viral; Evolution, Molecular; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Viral; Hepatitis B; Hepatitis B virus; Humans; Interferons; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; RNA-Directed DNA Polymerase; Viral Load | 2006 |
The effectiveness of lamivudine treatment in cirrhotic patients with HBV precore mutations: a prospective, open-label study.
Topics: Adult; Aged; Antiviral Agents; Biomarkers; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Prospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index; Survival Analysis; Treatment Outcome; Virus Replication | 2006 |
Lamivudine and high-dose interferon alpha 2a combination treatment in naïve HBeAg-positive immunoactive chronic hepatitis B in children: an East Mediterranean center's experience.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Recombinant Proteins; Reverse Transcriptase Inhibitors; Treatment Outcome; Turkey | 2007 |
A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues.
Topics: 2-Aminopurine; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Chronic Disease; Famciclovir; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Nucleosides; Pilot Projects; Prospective Studies; Virus Activation | 2006 |
Sequential treatment with lamivudine and interferon-alpha monotherapies in hepatitis B e antigen-negative Chinese patients and its suppression of lamivudine-resistant mutations.
Topics: Adult; Antiviral Agents; China; Drug Administration Schedule; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Recombinant Proteins; Reverse Transcriptase Inhibitors | 2006 |
Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present.
Topics: Antiviral Agents; Cells, Cultured; DNA-Directed DNA Polymerase; DNA, Viral; Double-Blind Method; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Plasmids; Treatment Outcome; Virus Replication | 2007 |
A randomized controlled trial of lamivudine to treat acute hepatitis B.
Topics: Acute Disease; Adolescent; Adult; Aged; Bilirubin; Child; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunocompetence; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Outcome | 2007 |
Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients.
Topics: Child; Child, Preschool; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Vaccines; Humans; Infant; Lamivudine; Liver Transplantation; Living Donors; Male; Treatment Outcome; Vaccination | 2007 |
Efficacy of adefovir dipivoxil in the treatment of lamivudine-resistant hepatitis B virus genotype C infection.
Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates | 2007 |
Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation.
Topics: Dose-Response Relationship, Drug; Follow-Up Studies; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunotherapy; Lamivudine; Liver Transplantation; Secondary Prevention; Time Factors | 2007 |
Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Viral Load | 2007 |
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Kidney Diseases; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Secondary Prevention; Waiting Lists | 2007 |
[The study of the different medicating ways and the formula for intravenous loading dosage of hepatitis B immunoglobulin in liver transplantation].
Topics: Alanine Transaminase; Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Linear Models; Liver Transplantation; Secondary Prevention; Treatment Outcome | 2006 |
[Lamivudine therapy in patients with severe acute hepatitis B].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Male; Middle Aged | 2007 |
Hepatitis B vaccination after living donor liver transplantation.
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Vaccines; Humans; Immunization Schedule; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Living Donors; Male; Prospective Studies; Time Factors; Treatment Outcome | 2007 |
Adherence to Lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hepatitis B virus recurrence.
Topics: Disease-Free Survival; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Secondary Prevention; Time Factors | 2007 |
Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients.
Topics: Adenine; Adult; Aged; Antiviral Agents; Disease Progression; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Organophosphonates; Risk Factors; Survival Analysis; Treatment Outcome | 2007 |
[Liver transplantation for chronic hepatitis B patients with lamivudine monotherapy or lamivudine combined with individualized low-dose hepatitis B immunoglobulin treatment].
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Secondary Prevention | 2007 |
[A clinical analysis of HBV reactivation in patients with malignant tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Neoplasms; Virus Activation | 2007 |
Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients.
Topics: Adult; Antiviral Agents; DNA, Circular; Female; Gene Expression Regulation; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Recombinant Proteins; Time Factors | 2008 |
A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial.
Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Secondary Prevention; Survival Analysis; Treatment Outcome | 2008 |
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B.
Topics: Adenine; Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates | 2008 |
The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis.
Topics: Adult; Aged; Anti-HIV Agents; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged | 2008 |
Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment.
Topics: Adult; Antiviral Agents; Biomarkers; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoassay; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Polyethylene Glycols; Recombinant Proteins; Viral Load | 2008 |
Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Circular; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunohistochemistry; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Risk Assessment; Risk Factors; Secondary Prevention; Sequence Analysis, DNA; Time Factors; Treatment Outcome; Viral Load; Virus Replication | 2008 |
Hepatitis B immunoglobulin and Lamivudine improve hepatitis B-related outcomes after liver transplantation: meta-analysis.
Topics: Adult; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Orthohepadnavirus; Secondary Prevention; Treatment Outcome | 2008 |
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis-B surface antigen (HBSAG) seropositive cancer patients undergoing cytotoxic chemotherapy.
Topics: Adult; Antineoplastic Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Neoplasms; Prevalence; Treatment Outcome; Virus Activation | 2008 |
A preliminary trial of lamivudine for chronic hepatitis B infection.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; Chronic Disease; DNA, Viral; Double-Blind Method; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Zalcitabine | 1995 |
Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Virus Replication; Zalcitabine | 1995 |
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis.
Topics: DNA, Viral; Fibrosis; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Failure; Liver Transplantation; Recurrence | 1996 |
Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.
Topics: Adolescent; Adult; Antiviral Agents; Carrier State; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Single-Blind Method | 1997 |
[Therapy of chronic hepatitis B virus infection with the nucleoside analog lamivudine].
Topics: Administration, Oral; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Hepatitis B; Hepatitis, Chronic; Humans; Lamivudine; Reverse Transcriptase Inhibitors | 1996 |
Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine.
Topics: Adolescent; Adult; Antiviral Agents; Chronic Disease; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Male; Middle Aged | 1997 |
Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B.
Topics: Adult; Biopsy; Breath Tests; Chronic Disease; Female; Hepatitis B; Humans; Lamivudine; Liver; Liver Diseases, Alcoholic; Male; Microscopy, Electron; Middle Aged; Mitochondria, Liver | 1997 |
Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Asia; DNA, Viral; Dose-Response Relationship, Drug; Ethnicity; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Time Factors | 1997 |
Efficacy and safety of lamivudine on replication of recurrent hepatitis B after cadaveric renal transplantation.
Topics: Antiviral Agents; Cyclosporine; Female; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Function Tests; Male; Middle Aged; Pilot Projects; Virus Replication | 1997 |
Quantitative assessment of hepatitis B virus DNA during a 24-week course of lamivudine therapy.
Topics: Antiviral Agents; DNA, Viral; Drug Administration Schedule; Hepatitis B; Humans; Lamivudine; Polymerase Chain Reaction | 1998 |
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.
Topics: Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Division; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis, Chronic; Humans; Lamivudine; Male | 1998 |
High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Polymerase Chain Reaction; Prognosis; Recurrence; Treatment Failure; Virus Replication | 1999 |
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.
Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications | 1999 |
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy.
Topics: Adolescent; Adult; Alanine Transaminase; Antiviral Agents; Conserved Sequence; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation | 1999 |
Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee.
Topics: Acetamides; Acetophenones; Adult; Aged; Anti-HIV Agents; Antiviral Agents; Disease Progression; Disease-Free Survival; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Placebos; Retrospective Studies; Time Factors | 1999 |
A study of the pharmacokinetic interaction between lamivudine and alpha interferon.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Area Under Curve; Drug Combinations; Half-Life; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Male; Metabolic Clearance Rate | 2000 |
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; HIV; Humans; Lamivudine; Liver; Liver Transplantation; Prospective Studies; Reverse Transcriptase Inhibitors | 2000 |
Twelve months of lamivudine treatment for chronic hepatitis B virus infection in renal transplant recipients.
Topics: Adult; Anti-HIV Agents; Chronic Disease; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Time Factors | 2000 |
Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: comparison with salvage treatment after hepatic dysfunction with HBV recurrence.
Topics: DNA, Viral; Female; Graft Rejection; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Diseases; Male; Recurrence; Reverse Transcriptase Inhibitors; Salvage Therapy | 2001 |
Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence | 2001 |
Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients.
Topics: Adolescent; Adult; Alanine Transaminase; Anti-Inflammatory Agents; Antilymphocyte Serum; Bilirubin; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Failure; Male; Methylprednisolone; Middle Aged; Prothrombin Time; Treatment Outcome; Virus Activation | 2001 |
Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.
Topics: Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Treatment Failure; Vaccines, Synthetic | 2002 |
Hepatitis B viral genotypes and lamivudine resistance.
Topics: Adult; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors | 2002 |
[Prevention and treatment of HBV reinfection following liver transplantation].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Biopsy; DNA, Viral; Drug Combinations; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Care; Preoperative Care; Recurrence | 2002 |
Is lamivudine with 1-week HBlg as effective as long-term high-dose HBlg in HBV prophylaxis after liver transplantation?
Topics: Adult; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Prospective Studies; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Survival Rate; Time Factors | 2002 |
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Middle Aged; Opportunistic Infections; Treatment Outcome; Virus Activation | 2002 |
832 other study(ies) available for lamivudine and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Isolation and biological evaluation of filiformin, plakortide F, and plakortone G from the Caribbean sponge Plakortis sp.
Topics: Animals; Antimalarials; Bromobenzenes; Chromatography, High Pressure Liquid; Colonic Neoplasms; Dioxanes; Gas Chromatography-Mass Spectrometry; Hepatitis B; HIV; Humans; Jamaica; Lactones; Leukemia P388; Lung Neoplasms; Mice; Molecular Structure; Mycobacterium tuberculosis; Neoplasms, Unknown Primary; Nuclear Magnetic Resonance, Biomolecular; Plasmodium berghei; Plasmodium falciparum; Porifera; Spectrometry, Mass, Electrospray Ionization; Tumor Cells, Cultured | 2001 |
Synthesis and in vitro anti-hepatitis B and C virus activities of ring-expanded ('fat') nucleobase analogues containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring system.
Topics: Antiviral Agents; Benzazepines; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Imidazoles; Nucleosides; Virion | 2005 |
Synthesis and in vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives.
Topics: Antiviral Agents; Benzodiazepines; Cell Line, Tumor; Chemistry, Pharmaceutical; Chlorine; Drug Design; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; In Vitro Techniques; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Molecular Structure; Structure-Activity Relationship | 2008 |
Synthesis and the biological evaluation of arylnaphthalene lignans as anti-hepatitis B virus agents.
Topics: Cell Line, Tumor; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lignans; Promoter Regions, Genetic; Structure-Activity Relationship; Viral Core Proteins; Virus Replication | 2010 |
Orally bioavailable anti-HBV dinucleotide acyloxyalkyl prodrugs.
Topics: Administration, Oral; Animals; Antiviral Agents; Cell Line; Female; Hepatitis B; Hepatitis B virus; Humans; Male; Mice; Mice, Transgenic; Mutation; Nucleotides; Prodrugs; Rats; Rats, Sprague-Dawley | 2010 |
Heat stress cognate 70 host protein as a potential drug target against drug resistance in hepatitis B virus.
Topics: 3' Untranslated Regions; Alkaloids; Antiviral Agents; Down-Regulation; Drug Design; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Hepatocytes; HSC70 Heat-Shock Proteins; Humans; In Vitro Techniques; Quinolizines; RNA, Small Interfering; Virus Replication | 2010 |
Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus.
Topics: Antiviral Agents; Benzimidazoles; Cell Line, Tumor; Cell Survival; Hepatitis B; Hepatitis B virus; Humans; Structure-Activity Relationship | 2010 |
Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus.
Topics: Antiviral Agents; Cell Survival; DNA, Viral; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Structure-Activity Relationship; Tryptamines | 2011 |
Synthesis and biological evaluation of novel homochiral carbocyclic nucleosides from 1-amino-2-indanols.
Topics: Animals; Antiviral Agents; Bovine Virus Diarrhea-Mucosal Disease; Cattle; Cell Line; Chlorocebus aethiops; Diarrhea Viruses, Bovine Viral; Dogs; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Herpes Simplex; Herpesvirus 1, Human; Humans; Indans; Nucleosides; Stereoisomerism; Vero Cells | 2012 |
A new class of pyrimidine nucleosides: inhibitors of hepatitis B and C viruses.
Topics: Antiviral Agents; Cell Line, Tumor; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Liver; Pyrimidine Nucleosides | 2012 |
Synthesis and biological evaluation of nucleoside analogues than contain silatrane on the basis of the structure of acyclovir (ACV) as novel inhibitors of hepatitis B virus (HBV).
Topics: Acyclovir; Animals; Antiviral Agents; Bridged Bicyclo Compounds, Heterocyclic; Female; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Organosilicon Compounds; Purine Nucleosides; Random Allocation | 2013 |
Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
Topics: Amides; Antiviral Agents; Cell Line; Diterpenes, Kaurane; DNA Replication; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; NF-kappa B | 2015 |
Synthesis and biological evaluation of 4-substituted fluoronucleoside analogs for the treatment of hepatitis B virus infection.
Topics: Animals; Antiviral Agents; Cell Line, Tumor; Cytidine; DNA Replication; DNA, Viral; Ducks; Hepatitis B; Hepatitis B virus; Humans; Leukocyte Count; Mice; Models, Molecular; Mutagenicity Tests; Nucleosides; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Toxicity Tests, Acute | 2015 |
Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
Topics: Animals; Antiviral Agents; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Ducks; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatitis B Virus, Duck; Humans; Models, Molecular; Molecular Structure; Monosaccharides; Nucleosides; Structure-Activity Relationship; Triazoles; Virus Replication | 2018 |
Junceellolide B, a novel inhibitor of Hepatitis B virus.
Topics: Antiviral Agents; Cell Line; Diterpenes; DNA Replication; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans | 2020 |
Synthesis and evaluation of new phenyl acrylamide derivatives as potent non-nucleoside anti-HBV agents.
Topics: Acrylamide; Antiviral Agents; Drug Design; Drug Resistance; Gene Expression Regulation; Guanine; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Lamivudine; Molecular Docking Simulation; Mutation; Protein Binding; Protein Conformation; Structure-Activity Relationship; Virus Replication | 2021 |
Effectiveness of prophylactic antiviral therapy in reducing HBV reactivation for HBsAg-positive recipients following allogeneic hematopoietic stem cell transplantation: a multi-institutional experience from an HBV endemic area.
Topics: Adult; Antiviral Agents; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Transplantation, Homologous; Virus Activation; Young Adult | 2022 |
Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy.
Topics: Adult; Coinfection; Emtricitabine; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Lamivudine; Male; Retrospective Studies; RNA | 2022 |
A small molecule targeting hepatitis B surface antigen inhibits clinically relevant drug-resistant hepatitis B virus.
Topics: Antiviral Agents; Drug Resistance, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; RNA-Directed DNA Polymerase | 2022 |
Association of Pre-S/S and Polymerase Mutations with Acute and Chronic Hepatitis B Virus Infections in Patients from Rio de Janeiro, Brazil.
Topics: Brazil; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Nucleotides; Phylogeny; Protein S | 2022 |
Antenatal hepatitis B virus sero-prevalence, risk factors, pregnancy outcomes and vertical transmission rate within 24 months after birth in a high HIV prevalence setting.
Topics: Child; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Mothers; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Risk Factors; Seroepidemiologic Studies; Tenofovir | 2023 |
Long-term observation on hepatitis B surface antigen seroclearance in therapy experienced HIV/HBV co-infected Chinese.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Asian People; China; Coinfection; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Tenofovir; Time Factors; Young Adult | 2020 |
Hepatitis B virus seroprevalence among HIV-infected patients receiving combination antiretroviral therapy three decades after universal neonatal hepatitis B immunization program in Taiwan.
Topics: Adult; Anti-Retroviral Agents; Biomarkers; CD4 Lymphocyte Count; Coinfection; Female; Hemochromatosis; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Immunization Programs; Lamivudine; Male; Retrospective Studies; Seroepidemiologic Studies; Syphilis; Taiwan; Tenofovir; Young Adult | 2021 |
Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center.
Topics: Adult; Aged; Antiviral Agents; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Latin America; Male; Middle Aged; Retrospective Studies; Rituximab; Seroconversion; Transplant Recipients; Virus Activation | 2020 |
Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumors.
Topics: Aged; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Hypothalamic Neoplasms; Immunosuppression Therapy; Lamivudine; Male; Middle Aged; Pituitary Neoplasms; Retrospective Studies; Steroids; Virus Activation | 2020 |
Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study.
Topics: Adult; Female; Hepatitis B; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Telbivudine | 2020 |
A Telomerase-Derived Peptide Exerts an Anti-Hepatitis B Virus Effect
Topics: Animals; Antiviral Agents; DNA Damage; DNA, Mitochondrial; Drug Synergism; Guanine; Heme Oxygenase-1; Hep G2 Cells; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon Regulatory Factor-3; Interferon Type I; Lamivudine; Membrane Proteins; Mice; Mice, Transgenic; Peptide Fragments; Phagosomes; Signal Transduction; Telomerase; Virus Replication | 2020 |
Nanopore sequencing from extraction-free direct PCR of dried serum spots for portable hepatitis B virus drug-resistance typing.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Nanopore Sequencing; Pharmaceutical Preparations; Polymerase Chain Reaction | 2020 |
Impact of Lamivudine-Based Antiretroviral Treatment on Hepatitis B Viremia in HIV-Coinfected South Africans.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Coinfection; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Tenofovir; Viral Load; Viremia; Young Adult | 2020 |
Trends in Liver Transplantation for Chronic Hepatitis B in an Era of Highly Potent Antiviral Therapies.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Treatment Outcome | 2021 |
Assessing the association between platelets and immune recovery in HIV/HBV co-infected patients: A long-term cohort in Asia.
Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Blood Platelets; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Cohort Studies; Cyclopropanes; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Immune Reconstitution; Lamivudine; Longitudinal Studies; Male; Platelet Count; Retrospective Studies; Tenofovir | 2020 |
Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.
Topics: Adolescent; Coinfection; Diagnostic Tests, Routine; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Persistent Infection; Phylogeny; Prevalence; Retrospective Studies; Senegal; Viremia | 2021 |
Complex genetic encoding of the hepatitis B virus on-drug persistence.
Topics: Antiviral Agents; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tenofovir | 2020 |
Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group.
Topics: Antiviral Agents; Case-Control Studies; China; DNA, Viral; Drug Administration Schedule; Female; Gestational Age; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; Humans; Immunoglobulins; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Telbivudine; Tenofovir; Treatment Outcome | 2020 |
Management of Hepatitis-B Virus Infection in Immunocompromised Children: A Single Center Experience.
Topics: Antiviral Agents; Child; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Herpesviridae Infections; Humans; Lamivudine; Retrospective Studies; Symptom Flare Up; Virus Activation | 2021 |
Heart Retransplantation From an Hepatitis B Core Antibody (Anti-HBcore)-Positive Donor: A Case Report.
Topics: Antiviral Agents; Graft Rejection; Heart Failure; Heart Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Reoperation; Risk Factors; Tissue Donors | 2021 |
Hepatitis B immunoglobulin (HBIG) combined with long-term entecavir prophylaxis for hepatitis B virus infection in allogeneic hematopoietic stem cell transplantation with hepatitis B surface antigen-positive donors.
Topics: Antiviral Agents; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Treatment Outcome | 2021 |
Understanding Hepatitis B Virus Dynamics and the Antiviral Effect of Interferon Alpha Treatment in Humanized Chimeric Mice.
Topics: Animals; Antiviral Agents; Child, Preschool; Disease Models, Animal; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Infant; Interferon-alpha; Kinetics; Lamivudine; Liver Transplantation; Male; Mice, SCID; Models, Theoretical; Polyethylene Glycols; Recombinant Proteins; Serum Albumin; Transplantation Chimera | 2021 |
Predominance of Hepatitis B Virus Genotype A Among Treated HIV Infected Patients Experiencing High Hepatitis B Virus Drug Resistance in Nairobi, Kenya.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Emtricitabine; Female; Genes, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Kenya; Lamivudine; Male; Middle Aged; Tenofovir; Viral Load; Young Adult | 2017 |
Impacts of HBV rtH55R polymerase substitution on viral replication and rtM204I/V resistance to nucleoside/nucleotide antiviral drugs.
Topics: Amino Acid Substitution; Antiviral Agents; Biomarkers; Cell Line; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation; RNA-Directed DNA Polymerase; Virus Replication | 2018 |
Post-transplant withdrawal of lamivudine results in fatal hepatitis flares in kidney transplant recipients, under immune suppression, with inactive hepatitis B infection.
Topics: Adult; Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Retrospective Studies | 2016 |
Is hepatitis B immune globulin still needed after liver transplantation for chronic hepatitis B?
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence | 2017 |
Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes.
Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Cross-Sectional Studies; Female; Gambia; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Mass Screening; Middle Aged; Practice Guidelines as Topic; Tenofovir; Treatment Outcome; Young Adult | 2017 |
Letter: role of tenofovir to prevent mother-to-child transmission of hepatitis B virus.
Topics: Child; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy Complications, Infectious; Tenofovir | 2017 |
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal.
Topics: Antibiotic Prophylaxis; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Male; Middle Aged; Virus Activation | 2017 |
Development of a digital droplet PCR assay to measure HBV DNA in patients receiving long-term TDF treatment.
Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Limit of Detection; Polymerase Chain Reaction; Sensitivity and Specificity; Seroconversion; Tenofovir; Viral Load; Virus Replication | 2017 |
Lamivudine versus entecavir in the rescue of chemotherapy-induced hepatitis B flare-up.
Topics: Aged; Antineoplastic Agents; Antiviral Agents; Female; Guanine; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Prognosis; Retrospective Studies | 2017 |
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Male; Middle Aged; Virus Activation; Young Adult | 2018 |
Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic history.
Topics: Alleles; Amino Acid Substitution; Computational Biology; DNA Barcoding, Taxonomic; Drug Resistance, Viral; Evolution, Molecular; Gene Frequency; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Virion | 2017 |
Comparing Efficacy of Lamivudine, Adefovir Dipivoxil, Telbivudine, and Entecavir in Treating Nucleoside Analogues Naïve for HBeAg-Negative Hepatitis B with Medium Hepatitis B Virus (HBV) DNA Levels.
Topics: Adenine; Adult; Alanine Transaminase; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Male; Multivariate Analysis; Nucleosides; Organophosphonates; Proportional Hazards Models; Telbivudine; Thymidine | 2017 |
Antiviral therapy for hepatitis B virus during second pregnancies.
Topics: Adult; Antiviral Agents; Female; Gravidity; Hepatitis B; Hepatitis B virus; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Tenofovir | 2018 |
Early Combination Therapy with Corticosteroid and Nucleoside Analogue Induces Rapid Resolution of Inflammation in Acute Liver Failure due to Transient Hepatitis B Virus Infection.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; Guanine; Hepatitis B; Hepatitis B virus; Humans; Inflammation; Lamivudine; Liver Failure, Acute; Male; Methylprednisolone; Middle Aged; Prednisolone; Retrospective Studies; Survival Rate; Time-to-Treatment | 2018 |
Utilization of hepatitis B core antibody positive grafts in living donor liver transplantation.
Topics: Adolescent; Adult; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk; Tenofovir; Transplants; Virus Activation; Young Adult | 2018 |
Involvement of multidrug resistance protein 4 in the hepatocyte efflux of lamivudine and entecavir.
Topics: Antiviral Agents; Biological Transport; Guanine; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Lamivudine; Multidrug Resistance-Associated Proteins | 2018 |
Successful Treatment of a South African Pediatric Case of Acute Liver Failure Caused by Perinatal Transmission of Hepatitis B.
Topics: Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Liver Failure, Acute; Male; Mothers; Perinatal Care; South Africa; Treatment Outcome | 2019 |
Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.
Topics: Adult; Africa, Western; AIDS-Related Opportunistic Infections; Anti-Retroviral Agents; Antiviral Agents; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Mutation; Promoter Regions, Genetic; Prospective Studies; Tenofovir | 2018 |
Hepatitis B Virus Serum DNA andRNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute Infection.
Topics: Biomarkers; DNA, Viral; Hepatitis B; Humans; Lamivudine; Nucleosides; RNA, Viral; Viral Load | 2018 |
Changes in Liver Tissue Trace Element Concentrations During Hepatitis B Viral Infection Treatment.
Topics: Adult; Antiviral Agents; Biopsy; Female; Fibrosis; Guanine; Hepatitis B; Humans; Lamivudine; Liver; Liver Function Tests; Male; Middle Aged; Telbivudine; Tenofovir; Trace Elements; Young Adult | 2019 |
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab.
Topics: Adult; Aged; Antibiotic Prophylaxis; Antiviral Agents; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Rituximab; Stem Cell Transplantation; Virus Activation; Young Adult | 2019 |
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Italy; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Rituximab; Treatment Outcome; Virus Activation | 2019 |
High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.
Topics: Adult; Anti-HIV Agents; China; Coinfection; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Multivariate Analysis; Mutation; Prevalence; Tenofovir; Viral Load | 2018 |
Response of hepatitis B virus to antiretroviral treatment containing lamivudine in HBsAg-positive and HBsAg-negative HIV-positive South African adults.
Topics: Adolescent; Adult; Anti-Retroviral Agents; Child; Cohort Studies; Coinfection; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; South Africa; Treatment Outcome; Viral Load; Young Adult | 2019 |
Rates of HBV, HCV, HDV and HIV type 1 among pregnant women and HIV type 1 drug resistance-associated mutations in breastfeeding women on antiretroviral therapy.
Topics: Adolescent; Adult; Anti-HIV Agents; Breast Feeding; Cameroon; Coinfection; Drug Resistance, Viral; Female; Health Knowledge, Attitudes, Practice; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Hepatitis C; Hepatitis C Antibodies; Hepatitis D; HIV Seroprevalence; HIV-1; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Nevirapine; Pregnancy; Pregnancy Complications, Infectious; Vaccination; Young Adult; Zidovudine | 2018 |
Lamivudine use in pregnant HBsAg-females effectively reduces maternal viremia.
Topics: Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Reverse Transcriptase Inhibitors; Vaccination; Viral Load; Viremia; Young Adult | 2019 |
Role of
Topics: Adult; Asian People; China; Female; Genetic Predisposition to Disease; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Outcome Assessment, Health Care; Peptide Termination Factors; Polymorphism, Single Nucleotide; Reverse Transcriptase Inhibitors | 2019 |
Entecavir and Low Genetic Barrier Antiviral Agents for Hepatocellular Carcinoma in Hepatitis B Viral Cirrhosis: Propensity Score Matching.
Topics: Adenine; Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; China; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Telbivudine | 2019 |
Early initiation of antiviral therapy contributes to a rapid and significant loss of serum HBsAg in infantile-onset hepatitis B.
Topics: Alanine Transaminase; Antiviral Agents; Child, Preschool; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Interferon-alpha; Lamivudine; Male; Prospective Studies; Time-to-Treatment; Treatment Outcome; Viral Load | 2019 |
High frequency of complex mutational patterns in lamivudine resistant hepatitis B virus isolates.
Topics: Adenine; Antiviral Agents; Codon, Nonsense; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation, Missense; Organophosphonates; RNA-Directed DNA Polymerase | 2013 |
Hepatitis B therapy, hepatocellular carcinoma and HBsAg mutants.
Topics: Adenine; Antiviral Agents; Carcinoma, Hepatocellular; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunohistochemistry; Lamivudine; Liver Neoplasms; Male; Middle Aged; Organophosphonates; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed | 2013 |
Forty-eight-week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis B-related cirrhosis.
Topics: Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Retrospective Studies; Telbivudine; Thymidine; Treatment Outcome; Young Adult | 2013 |
Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Immunization; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Spermatozoa; Viral Load | 2013 |
Prophylactic effect of antiretroviral therapy on hepatitis B virus infection.
Topics: Adenine; Adult; Alanine Transaminase; Anti-Retroviral Agents; Antibiotic Prophylaxis; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Organophosphonates; Retrospective Studies; Tenofovir | 2013 |
Adefovir is effective to promote development of immunity to donor origin hepatitis B virus in an allogeneic transplant recipient: a case report.
Topics: Adenine; Adult; Alanine Transaminase; Anemia, Aplastic; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; DNA, Viral; Donor Selection; Drug Resistance, Viral; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Living Donors; Male; Organophosphonates; Time Factors; Transplantation, Homologous; Treatment Outcome | 2013 |
Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: a 13-year experience.
Topics: Adult; Aged; DNA, Viral; Female; Follow-Up Studies; Graft Survival; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver; Liver Failure; Liver Transplantation; Male; Middle Aged; Time Factors; Tissue Donors; Treatment Outcome | 2013 |
Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
Topics: Adenine; Adult; Aged; Analysis of Variance; Antiviral Agents; Biomarkers; Chi-Square Distribution; DNA, Viral; Donor Selection; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Logistic Models; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Tenofovir; Time Factors; Tissue Donors; Treatment Outcome; Viral Load | 2013 |
HBV recurrence lowered by lamivudine/HBIG combination therapy in liver transplant patients: ten-year experience.
Topics: Adult; Aged; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; DNA, Viral; End Stage Liver Disease; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Secondary Prevention; Survival Analysis; Time Factors; Treatment Outcome | 2013 |
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy.
Topics: Adenine; Adult; Anti-Retroviral Agents; Coinfection; Cross-Sectional Studies; Deoxycytidine; Emtricitabine; Europe; Female; Guideline Adherence; Health Services Accessibility; Hepatitis B; HIV Infections; Humans; Infectious Disease Medicine; Italy; Lamivudine; Male; Multivariate Analysis; Organophosphonates; Practice Guidelines as Topic; Regression Analysis; Tenofovir; Treatment Outcome | 2013 |
Prognosis of 153 patients with decompensated hepatitis B virus-related cirrhosis is improved after 3-year continuous lamivudine treatment.
Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Prognosis; Retrospective Studies | 2013 |
Long-term effects of prophylactic and therapeutic lamivudine treatments in hepatitis B surface antigen-positive renal allograft recipients.
Topics: Adult; Allografts; Antiviral Agents; Biomarkers; Carcinoma, Hepatocellular; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Viral; Female; Graft Rejection; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Lamivudine; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Risk Factors; Taiwan; Time Factors; Transplant Recipients; Treatment Outcome; Virus Activation | 2014 |
Very late onset hepatitis-B virus reactivation following rituximab despite lamivudine prophylaxis: the need for continued vigilance.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Chemoprevention; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Rituximab; Virus Activation; Waldenstrom Macroglobulinemia | 2014 |
Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppression Therapy; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome | 2013 |
Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Mutation, Missense; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Viral Load; Young Adult | 2013 |
HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Prospective Studies; Reverse Transcriptase Inhibitors; South Africa; Tenofovir; Treatment Outcome; Zambia | 2013 |
Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults.
Topics: Adult; Antiviral Agents; Cohort Studies; Disease Progression; Female; Genotype; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Japan; Lamivudine; Male; Middle Aged; Risk Factors; Time Factors; Young Adult | 2014 |
Prophylactic effect of lamivudine-based antiretroviral therapy on incident hepatitis B virus infection among HIV-infected patients.
Topics: Anti-Retroviral Agents; Antibiotic Prophylaxis; Hepatitis B; HIV Infections; Humans; Incidence; Kaplan-Meier Estimate; Lamivudine | 2013 |
Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.
Topics: Adult; Age Factors; Antiviral Agents; Aspartic Acid; Carcinoma, Hepatocellular; China; DNA, Viral; Drug Therapy, Combination; End Stage Liver Disease; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Methionine; Middle Aged; Mutation; Retrospective Studies; Risk Factors; Secondary Prevention; Sex Factors; Tyrosine | 2014 |
Liver transplantation for HBsAg-positive recipients using grafts from HBsAg-positive deceased donors.
Topics: Adult; Aged; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Tissue Donors | 2013 |
Pre-emptive treatment of hepatitis B infection by lamivudine in two Tunisian renal transplant recipients.
Topics: Adult; Disease Progression; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Male; Reverse Transcriptase Inhibitors; Tunisia | 2013 |
Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations.
Topics: Antiviral Agents; Blood; DNA, Viral; Drug Resistance, Viral; Female; Genetic Variation; Hepatitis B; Hepatitis B virus; High-Throughput Nucleotide Sequencing; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Selection, Genetic; Treatment Outcome; Viral Load | 2014 |
Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B.
Topics: Administration, Oral; Adolescent; Adult; Antiviral Agents; Cohort Studies; Dihydropyridines; Female; Follow-Up Studies; Guanine; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Patient Compliance; Prospective Studies; Taiwan; Time Factors; Young Adult | 2014 |
Pretreatment HBsAg level and an early decrease in MELD score predict prognosis to lamivudine treatment for HBeAg-negative acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Male; Middle Aged; Prognosis; Retrospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index | 2014 |
Lamivudine compared with newer antivirals for prophylaxis of hepatitis B core antibody positive livers: a cost-effectiveness analysis.
Topics: Adenine; Antiviral Agents; Cohort Studies; Cost-Benefit Analysis; Decision Trees; Follow-Up Studies; Graft Survival; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Markov Chains; Organophosphonates; Prognosis; Quality-Adjusted Life Years; Survival Rate; Tenofovir | 2014 |
Mathematical models of the interrelated dynamics of hepatitis D and B.
Topics: Cell Proliferation; Coinfection; Computer Simulation; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Hepatocytes; Humans; Lamivudine; Models, Immunological; Virus Replication | 2014 |
Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in Cambodia.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cambodia; CD4 Lymphocyte Count; Coinfection; Cyclopropanes; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Liver; Logistic Models; Male; Middle Aged; Nevirapine; Proportional Hazards Models; Retrospective Studies; Stavudine; Treatment Outcome; Zidovudine | 2014 |
Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cost-Benefit Analysis; Cyclophosphamide; DNA, Viral; Doxorubicin; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Rituximab; Vincristine; Virus Activation | 2014 |
Case report: passive transfer of hepatitis B antibodies from intravenous immunoglobulin.
Topics: Antiviral Agents; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lamivudine; Lymphoma, Follicular; Male; Medical Errors; Middle Aged; Serologic Tests | 2014 |
[Relationship between effect of lamivudine in the treatment of cirrhotic patients with uncompensated hepatitis B with HBV genotypes and cytotoxic T lymphocyte].
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; T-Lymphocytes, Cytotoxic | 2013 |
Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cohort Studies; Coinfection; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Risk Factors; Tenofovir; Viral Load; Viremia | 2014 |
Hepatitis B and C seroprevalence in solid tumors - necessity for screening during chemotherapy.
Topics: DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Neoplasms; Retrospective Studies; RNA, Viral; Seroepidemiologic Studies | 2014 |
Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.
Topics: Adenine; Adult; Antibodies, Viral; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; Deoxycytidine; DNA, Viral; Emtricitabine; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Lamivudine; Logistic Models; Male; Middle Aged; Organophosphonates; Randomized Controlled Trials as Topic; Retrospective Studies; Tenofovir; United States | 2014 |
Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus.
Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; Female; Gastrointestinal Diseases; Hepatitis B; Hepatitis B virus; Humans; Incidence; Lamivudine; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prospective Studies; Tenofovir; Time Factors; Treatment Outcome; Viral Load | 2014 |
Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
Topics: Adult; Antiviral Agents; China; Donor Selection; End Stage Liver Disease; Female; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Patient Safety; Retrospective Studies; Seroepidemiologic Studies; Tissue Donors; Transplants; Treatment Outcome | 2014 |
Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy.
Topics: Adult; Anti-HIV Agents; Asymptomatic Diseases; Base Sequence; DNA, Viral; Female; Gene Products, pol; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; North America; Sequence Analysis, DNA; Viral Load | 2014 |
Entecavir treatment in kidney transplant recipients infected with hepatitis B.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Glomerular Filtration Rate; Guanine; Hepatitis B; Hepatitis B virus; Humans; Kidney Function Tests; Kidney Transplantation; Lamivudine; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Transplant Recipients | 2014 |
The impact of oral antiviral therapy on long-term survival of hepatitis B surface antigen-positive patients on haemodialysis.
Topics: Administration, Oral; Aged; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Male; Middle Aged; Proportional Hazards Models; Renal Dialysis; Retrospective Studies; Reverse Transcriptase Inhibitors; Survivors | 2014 |
HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogue therapy.
Topics: Adenine; Adult; Antiviral Agents; Biomarkers; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Male; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Time Factors; Treatment Outcome; Viral Load | 2014 |
Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus.
Topics: Adenine; Adult; Aged; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Odds Ratio; Organophosphonates; Retrospective Studies; Severity of Illness Index; Survival Rate | 2014 |
Therapy of acute and fulminant hepatitis B.
Topics: Antiviral Agents; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver; Liver Failure, Acute; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine | 2014 |
Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in Malawi.
Topics: Adult; Anti-HIV Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Malawi; Male; Nevirapine; Phylogeny; Retrospective Studies; Sequence Analysis, DNA; Stavudine; Viral Load; Virus Replication | 2014 |
Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience.
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence | 2014 |
Hepatitis B virus mother-to-child transmission among HIV-infected women receiving lamivudine-containing antiretroviral regimens during pregnancy and breastfeeding.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; Child; Coinfection; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Risk Factors; Young Adult | 2015 |
Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion.
Topics: Adult; Aged, 80 and over; Antiviral Agents; Biopsy; DNA, Mitochondrial; Female; Hepatitis B; Humans; Lamivudine; Male; Microscopy, Electron; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; Muscular Diseases; Peripheral Nerves; Peripheral Nervous System Diseases; Predictive Value of Tests; Real-Time Polymerase Chain Reaction; Retrospective Studies; Telbivudine; Thymidine; Young Adult | 2014 |
[Retrospective analysis of the efficacy and safety of anti-hepatitis B virus drugs taken during pregnancy in women from the Guangdong Province].
Topics: Adenine; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Mothers; Organophosphonates; Pregnancy; Retrospective Studies; Telbivudine; Thymidine; Time Factors | 2014 |
Different mechanism of selection of adefovir-resistant mutant viruses during adefovir monotherapy in patients with lamivudine-resistant chronic hepatitis B.
Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation Rate; Mutation, Missense; Organophosphonates; Point Mutation; Retrospective Studies; RNA-Directed DNA Polymerase; Selection, Genetic; Young Adult | 2014 |
Editorial commentary: the conundrum of Lamivudine and tenofovir disoproxil fumarate for hepatitis B: fetus versus infant.
Topics: Adenine; Anti-HIV Agents; Breast Feeding; Disease Transmission, Infectious; Female; Hepatitis B; Humans; Lamivudine; Organophosphonates; Pregnancy | 2015 |
[Clinical pathology of recurrent hepatitis B after liver transplantation].
Topics: Adenine; Antiviral Agents; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence | 2014 |
The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study.
Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Incidence; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Lamivudine; Longitudinal Studies; Male; Middle Aged; Postoperative Complications; Prognosis; Propensity Score; Retrospective Studies; Risk Factors; Thailand; Tissue Donors | 2014 |
Prediction of prognosis to lamivudine in patients with spontaneous reactivation of hepatitis B virus-related acute-on-chronic liver failure: using virologic response at week 4.
Topics: Acute-On-Chronic Liver Failure; Adult; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Prognosis; Survival Analysis; Time Factors; Treatment Outcome | 2014 |
Postexposure prophylactic effect of hepatitis B virus (HBV)-active antiretroviral therapy against HBV infection.
Topics: Adenine; Animals; Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mice; Organophosphonates; Retrospective Studies; Tenofovir | 2015 |
Optimal antiviral prophylaxis against hepatitis B reactivation in patients receiving rituximab-based chemotherapy for lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male | 2014 |
Combining age and HBsAg level predicts post-treatment durability of nucleos(t)ide analogue-induced HBeAg seroconversion.
Topics: Adult; Aging; Antiviral Agents; Consolidation Chemotherapy; Female; Follow-Up Studies; Forecasting; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Nucleotides; Recurrence; Retrospective Studies; Risk; Seroconversion; Time Factors; Young Adult | 2015 |
Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine.
Topics: Antiviral Agents; Cell Line, Tumor; Cells, Cultured; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Inhibitory Concentration 50; Lamivudine; Microbial Sensitivity Tests; Mutation; Virus Replication | 2015 |
De novo hepatitis B virus infection after pediatric liver transplantations with hepatitis B core antibody-positive donors: a single-center 20-yr experience.
Topics: Adolescent; Child; Child, Preschool; Female; Graft Survival; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Incidence; Lamivudine; Liver Failure; Liver Transplantation; Living Donors; Male; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Factors | 2015 |
Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis?
Topics: Adenine; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir | 2015 |
Hepatitis B-related serological events in hematopoietic stem cell transplant patients and efficacy of lamivudine prophylaxis against reactivation.
Topics: Adolescent; Adult; Allografts; Autografts; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Infant; Lamivudine; Male; Middle Aged; Neoplasms; Virus Activation | 2016 |
Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management.
Topics: Antiviral Agents; Cost-Benefit Analysis; Heart Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Transplantation; Societies, Medical; Tissue and Organ Procurement; Tissue Donors; United States | 2015 |
Analysis of HBV genotype, drug resistant mutations, and pre-core/basal core promoter mutations in Korean patients with acute hepatitis B.
Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Promoter Regions, Genetic; Prospective Studies; Republic of Korea; Viral Core Proteins; Virus Replication | 2015 |
Relationship Between Serum DNA Replication, Clinicopathological Characteristics and Prognosis of Hepatitis B Virus-associated Glomerulonephritis with Severe Proteinuria by Lamivudine Plus Adefovir Dipivoxil Combination Therapy.
Topics: Adenine; Adult; Aged; Antiviral Agents; DNA Replication; DNA, Viral; Drug Therapy, Combination; Female; Glomerulonephritis; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prognosis; Proteinuria; Young Adult | 2015 |
Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy.
Topics: Aged; Antiviral Agents; Diabetes Mellitus; Drug Substitution; End Stage Liver Disease; Female; Glomerular Filtration Rate; Hepatitis B; Humans; Incidence; Kaplan-Meier Estimate; Kidney; Lamivudine; Liver Transplantation; Male; Middle Aged; Muscular Diseases; Polyneuropathies; Proportional Hazards Models; Prospective Studies; Recovery of Function; Recurrence; Renal Insufficiency, Chronic; Risk Factors; Telbivudine; Thymidine; Time Factors; Treatment Outcome; Turkey | 2015 |
The impact of hepatitis B virus (HBV) infection on clinical outcomes of patients with diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Rituximab; Survival Analysis; Treatment Outcome; Young Adult | 2015 |
Efficacy and safety of lamivudine or tenofovir plus intramuscular hepatitis B immunoglobulin in prevention of hepatitis B virus reinfection after liver transplant.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tenofovir; Time Factors; Treatment Outcome; Virus Activation; Young Adult | 2015 |
Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation.
Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir | 2015 |
Prevalence and types of drug-resistant variants in Chinese patients with acute hepatitis B.
Topics: Adenine; Adult; Antiviral Agents; China; DNA, Viral; Drug Resistance, Viral; Female; Genetic Variation; Guanine; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Organophosphonates; Prevalence; RNA-Directed DNA Polymerase; Telbivudine; Thymidine; Time Factors; Young Adult | 2015 |
Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.
Topics: Adult; Alanine Transaminase; Anti-Retroviral Agents; CD4 Lymphocyte Count; Coinfection; Cross-Sectional Studies; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome; Uganda; Viral Load | 2015 |
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.
Topics: Adult; Aged; Antiviral Agents; Coinfection; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Switzerland; Tenofovir; Viral Load; Young Adult | 2015 |
Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV.
Topics: Adult; Antiviral Agents; Biomarkers; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pregnancy; Pregnancy Complications, Infectious; Tenofovir; Treatment Outcome; Viral Load; Virus Replication | 2015 |
Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
Topics: Africa; Antiviral Agents; Biomarkers; Cohort Studies; Coinfection; Drug Therapy, Combination; Emtricitabine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Tenofovir; Time Factors | 2016 |
Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation.
Topics: Adult; Case-Control Studies; Female; Forkhead Transcription Factors; Hepatitis B; Hepatitis B virus; Humans; Interleukin-17; Lamivudine; Liver Transplantation; Male; Middle Aged; Prognosis; T-Lymphocytes, Regulatory; Th17 Cells; Transplantation, Homologous; Treatment Outcome | 2015 |
Adefovir- or Lamivudine-Induced Renal Tubular Dysfunction after Liver Transplantation.
Topics: Adenine; Female; Hepatitis B; Humans; Incidence; Kidney Diseases; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Republic of Korea; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors | 2015 |
Discrete virus infection model of hepatitis B virus.
Topics: Antiviral Agents; Computer Simulation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Models, Biological; Virus Replication | 2015 |
Long-term efficacy of Peg-Interferon/Ribavirin with and without Lamivudine therapy for HBeAg-positive hepatitis B and C dual infection.
Topics: Adult; Antiviral Agents; Biomarkers; Coinfection; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome; Young Adult | 2016 |
Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(-) donors.
Topics: Adult; Antiviral Agents; Female; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver; Male; Middle Aged; Postoperative Complications; Tenofovir; Tissue Donors; Transplant Recipients | 2016 |
De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
Topics: Adolescent; Child; Child, Preschool; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Immunoglobulins; Infant; Injections, Intramuscular; Lamivudine; Liver; Liver Transplantation; Living Donors; Male; Retrospective Studies; Treatment Outcome | 2016 |
A novel method for nucleos(t)ide analogues susceptibility assay of hepatitis B virus by viral polymerase transcomplementation.
Topics: Antiviral Agents; Cell Line; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Genetic Complementation Test; Genetic Predisposition to Disease; Guanine; HEK293 Cells; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Inhibitory Concentration 50; Lamivudine; Lentivirus; Mutation; Nucleotides; Real-Time Polymerase Chain Reaction; RNA Viruses; Transduction, Genetic; Virus Replication | 2016 |
Lamivudine Monotherapy-Based cART Is Efficacious for HBV Treatment in HIV/HBV Coinfection When Baseline HBV DNA <20,000 IU/mL.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; China; Cohort Studies; Coinfection; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Tenofovir | 2016 |
Prophylaxis for hepatitis B reactivation during and after chemotherapy: many questions, some answers.
Topics: Antineoplastic Agents; Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Virus Activation | 2016 |
Hepatitis B immune reconstitution syndrome in a patient with HIV infection.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Coinfection; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Treatment Outcome | 2016 |
Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus.
Topics: Antiviral Agents; Cloning, Molecular; Drug Resistance, Viral; Genes, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation; Oligonucleotides | 2016 |
Hepatitis B virus related cryoglobulinemic vasculitis: A multicentre open label study from the Gruppo Italiano di Studio delle Crioglobulinemie - GISC.
Topics: Adenine; Aged; Antiviral Agents; Cryoglobulinemia; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome; Vasculitis | 2016 |
Betaine Inhibits Hepatitis B Virus with an Advantage of Decreasing Resistance to Lamivudine and Interferon α.
Topics: Antiviral Agents; Betaine; Drug Resistance, Viral; Endoplasmic Reticulum Chaperone BiP; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Viral Proteins; Virus Replication | 2016 |
HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.
Topics: Anti-HIV Agents; Antiviral Agents; Coinfection; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Genotype; Ghana; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Mutation; Viral Load | 2017 |
Dually Active HIV/HBV Antiretrovirals as Protection Against Incident Hepatitis B Infections: Potential for Prophylaxis.
Topics: Adult; Antiviral Agents; Chemoprevention; Emtricitabine; Female; Follow-Up Studies; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Prospective Studies; Tenofovir | 2016 |
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor.
Topics: Adult; Carrier State; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Transplantation, Autologous; Transplantation, Homologous; Virus Activation | 2016 |
Delayed, Uncommon Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Case Report.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Neoplasm Recurrence, Local; Recurrence; Tacrolimus; Tissue Donors; Treatment Outcome | 2016 |
Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection.
Topics: Adult; Female; Fingolimod Hydrochloride; Hepatitis B; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Reverse Transcriptase Inhibitors | 2017 |
Long-term nucleos(t)ide analog(s) monoprophylaxis in Delta coinfected liver transplant recipients.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation | 2017 |
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required?
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Neoplasms; Virus Activation | 2017 |
Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.
Topics: Adolescent; Adult; Allografts; Child; Child, Preschool; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Infant; Lamivudine; Liver Failure; Liver Transplantation; Living Donors; Male; Middle Aged; Retrospective Studies; Risk Factors; Tissue Donors; Young Adult | 2017 |
Response to Tenofovir Among Lamivudine-experienced Hepatitis B and HIV-coinfected Adolescents.
Topics: Adolescent; Adult; Antiviral Agents; Child; Coinfection; DNA, Viral; Hepatitis B; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Prospective Studies; Tenofovir; Young Adult | 2017 |
Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.
Topics: Adult; Coinfection; Drug Combinations; Drug Resistance, Viral; Endemic Diseases; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Tenofovir; Treatment Outcome | 2016 |
Potential effect of lamivudine-induced S gene mutations on liver-related pathogenesis in hepatitis D virus infection.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis D; Hepatitis Delta Virus; Humans; Lamivudine; Liver Transplantation; Mutation | 2017 |
Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
Topics: Adolescent; Adult; Base Sequence; Cameroon; Child, Preschool; Coinfection; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Male; Middle Aged; Mutation; Phylogeny; Prevalence; Prospective Studies; Risk Factors; Sequence Analysis; Young Adult | 2017 |
[Application of serum hepatitis B virus large surface protein determination in lamivudine anti-viral therapy for patients with hepatitis B].
Topics: Adult; Antiviral Agents; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Polymerase Chain Reaction; Treatment Outcome; Viral Envelope Proteins; Young Adult | 2008 |
Early hepatitis B virus DNA suppression can predict virologic response to peginterferon and lamivudine treatment.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Polyethylene Glycols; Predictive Value of Tests; Prognosis; Recombinant Proteins; ROC Curve; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2008 |
Interaction of hepatitis B and C viruses in patients infected with HIV.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; HIV Infections; Humans; Lamivudine; Male; RNA, Viral | 2008 |
Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV.
Topics: Adenine; Adult; Antiviral Agents; Bilirubin; Disease Progression; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Patient Selection; Predictive Value of Tests; Prognosis; Prothrombin Time; Retrospective Studies; Treatment Outcome | 2008 |
Lamivudine treatment improves the prognosis of fulminant hepatitis B.
Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure, Acute; Male; Middle Aged; Retrospective Studies; Survival Analysis; Systemic Inflammatory Response Syndrome | 2008 |
Pretreatment alanine transaminase level may not be the most important predictor of HBeAg loss in the older patient.
Topics: Adult; Age Factors; Alanine Transaminase; Hepatitis B; Hepatitis B e Antigens; Humans; Korea; Lamivudine; Middle Aged; Models, Biological | 2009 |
[Prevention and treatment of hepatitis B recurrence after liver transplantation].
Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Secondary Prevention | 2008 |
Subacute cutaneous lupus erythematosus and interstitial myositis occurring with hepatitis B infection: response to antiviral therapy with lamivudine.
Topics: Aged; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Lupus Erythematosus, Cutaneous; Mitochondria; Myositis; Skin; Treatment Outcome | 2008 |
A decline in hepatitis B virus surface antigen (hbsag) predicts clearance, but does not correlate with quantitative hbeag or HBV DNA levels.
Topics: 2-Aminopurine; Antiviral Agents; DNA, Viral; Famciclovir; Female; Heart Transplantation; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Predictive Value of Tests; Treatment Outcome | 2008 |
Reevaluation of the effect of lamivudine therapy preoperative to prevent HBV recurrence after liver transplantation.
Topics: DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Glucocorticoids; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Mutation; Mycophenolic Acid; Odds Ratio; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Assessment; Secondary Prevention; Time Factors; Treatment Outcome | 2008 |
Immediate allergy, drug-induced eruption, by entecavir.
Topics: Adult; Antiviral Agents; Drug Eruptions; Drug Hypersensitivity; Guanine; Hepatitis B; Humans; Lamivudine; Male | 2009 |
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Epidemiologic Methods; Female; Hepatitis B; Hepatitis B e Antigens; HIV-1; Humans; Lamivudine; Liver Diseases; Male; Middle Aged; Recurrence; Switzerland; Viral Load | 2009 |
Hepatitis B virus reactivation after a resolutive acute hepatitis leading to a diagnosis of T cell lymphoma.
Topics: Aged; Antiviral Agents; DNA, Viral; Fatal Outcome; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Lamivudine; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Recurrence; Remission, Spontaneous | 2009 |
Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance.
Topics: Adult; AIDS-Related Opportunistic Infections; Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clinical Audit; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged | 2008 |
[Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
Topics: Adult; Aged; Amino Acid Motifs; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence | 2008 |
Lamivudine treatment for severe acute HBV hepatitis.
Topics: Acute Disease; Adult; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Male; Middle Aged | 2008 |
Hepatitis B reactivation prophylaxis in immune-suppressed patients.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Virus Activation | 2008 |
Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.
Topics: Adenine; Adult; Antiviral Agents; DNA Probes; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Sensitivity and Specificity | 2009 |
Occult hepatitis B virus infection in immunocompromised patients.
Topics: Adult; Aged; Case-Control Studies; CD4 Lymphocyte Count; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Immunocompromised Host; Lamivudine; Male; Middle Aged; Prevalence; Renal Dialysis; Viral Load | 2008 |
Hepatitis B reactivation in allogeneic hemopoietic stem cell transplantation setting: a pediatric experience.
Topics: Adolescent; Antiviral Agents; Child; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Diseases; Male; Transplantation, Homologous; Treatment Outcome; Virus Activation | 2009 |
Prophylactic use of lamivudine with chronic immunosuppressive therapy for rheumatologic disorders.
Topics: Adult; Aged; Biomarkers; DNA, Viral; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Middle Aged; Opportunistic Infections; Retrospective Studies; Reverse Transcriptase Inhibitors; Rheumatic Diseases; Treatment Outcome; Viral Load | 2009 |
Erythema nodosum migrans in a male patient with hepatitis B infection.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Erythema Nodosum; Hepatitis B; Humans; Lamivudine; Leg; Male; Potassium Iodide; Treatment Outcome | 2009 |
Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Secondary Prevention | 2008 |
What is the optimal regimen for preventing hepatitis B recurrence after liver transplantation?
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Treatment Outcome | 2009 |
Costs and efficacy of "on demand" low-dose immunoprophylaxis in HBV transplanted patients: experience in the Romanian program of liver transplantation.
Topics: Adult; Comorbidity; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis D; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunotherapy; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Program Evaluation; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Romania; Survival Analysis; Treatment Outcome | 2008 |
Hepatitis B: a "GLOBAL" health challenge.
Topics: Antiviral Agents; DNA, Viral; Global Health; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Nucleosides; Patient Selection; Pyrimidinones; Randomized Controlled Trials as Topic; Telbivudine; Thymidine; Virus Replication | 2009 |
Management of hepatitis B reactivation in patients with lupus nephritis.
Topics: Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Lupus Nephritis; Male; Middle Aged; Retrospective Studies; Virus Activation | 2009 |
Hepatitis B virus prevention strategies for antibody to hepatitis B core antigen-positive liver donation: a survey of North American, European, and Asian-Pacific transplant programs.
Topics: Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2009 |
Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations.
Topics: Adenine; Adult; Aged; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cross-Sectional Studies; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Polymerase Chain Reaction; Retrospective Studies; Tenofovir; Viral Load; Viremia | 2009 |
Emergence of adefovir-resistant mutants after reversion to YMDD wild-type in lamivudine-resistant patients receiving adefovir monotherapy.
Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Multiple, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Polymorphism, Restriction Fragment Length; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors; Treatment Outcome; Viral Load | 2009 |
Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
Topics: Adenine; Adult; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Treatment Outcome; Virus Replication | 2009 |
Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients.
Topics: Adenine; Adult; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Viral Proteins | 2009 |
The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains.
Topics: Adenine; Anti-HIV Agents; Cell Line, Tumor; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Nucleosides; Organophosphonates; Pyrimidinones; Telbivudine; Tenofovir; Thymidine; Viral Proteins; Virus Replication | 2009 |
Lamivudine combined with hepatitis B immunoglobulin in for prophylaxis of hepatitis B recurrence after liver transplantation: time for a change?
Topics: Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Secondary Prevention | 2009 |
Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.
Topics: Adenine; Antiviral Agents; Base Sequence; DNA Primers; DNA, Viral; Drug Resistance, Viral; Genetic Variation; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Mutation; Organophosphonates; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase | 2009 |
Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion.
Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Immunosuppressive Agents; Lamivudine | 2009 |
[Evaluation of the effect of living donor liver transplantation on the treatment of severe hepatitis].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Follow-Up Studies; Hepatitis B; Humans; Immunoglobulins; Immunosuppressive Agents; Kidney Function Tests; Lamivudine; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Postoperative Period; Treatment Outcome; Young Adult | 2009 |
Treatment of subacute hepatitis B with lamivudine: a pilot study in Serbia.
Topics: Acute Disease; Adult; Aged; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Liver Failure, Acute; Male; Middle Aged | 2009 |
Effective treatment for de novo hepatitis B with nucleotide analogue in patients with hematological malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cervix Uteri; Cyclophosphamide; Doxorubicin; Etoposide; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Recurrence; Remission Induction; Stomach; Transplantation, Autologous; Vincristine | 2009 |
[Hepatitis B viral infection treated with lamivudine during pregnancy].
Topics: Acute Disease; Adult; Female; Hepatitis B; Humans; Lamivudine; Pregnancy; Pregnancy Complications, Infectious | 2009 |
Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
Topics: Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Point Mutation; Polymorphism, Genetic; Retrospective Studies; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; South Africa; Viral Proteins; Young Adult | 2009 |
Emergency transplantation for acute reactivation of chronic hepatitis B with high viral load: role of antiviral therapy.
Topics: Adenine; Blood Chemical Analysis; DNA, Viral; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Secondary Prevention; Tenofovir; Ultrasonography; Viral Load | 2009 |
The controversial role of lamivudine prophylaxis in occult HBV carriers treated with chemo-immune therapy.
Topics: Antiviral Agents; Carrier State; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Humans; Lamivudine; Lymphoma; Retrospective Studies | 2009 |
[Prophylaxsis against recurrance of hepatitis B virus after liver transplantation].
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Young Adult | 2008 |
Liver transplantation and management of the hepatitis B virus. Preface.
Topics: Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications; Secondary Prevention | 2009 |
High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.
Topics: Adolescent; Adult; Aged; Female; Guanine; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Incidence; Lamivudine; Male; Middle Aged; Plasma Exchange; Risk; Virus Activation; Young Adult | 2009 |
Lamivudine prophylaxis and hepatitis B vaccination for prevention of hepatitis B virus reverse seroconversion in long-term survivors after allogeneic stem cell transplantation.
Topics: Aged; Anti-HIV Agents; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Risk Factors; Time Factors; Transplantation, Homologous; Vaccination; Virus Activation | 2009 |
Prophylaxis of hepatitis B virus recurrence after liver transplantation.
Topics: Antiviral Agents; Cost-Benefit Analysis; DNA, Viral; Drug Costs; Drug Therapy, Combination; Female; Health Care Costs; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Patient Selection; Secondary Prevention; Viral Load | 2009 |
[Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Carrier State; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Middle Aged; Nucleosides; Retrospective Studies; Virus Activation | 2009 |
Successful treatment of fulminant hepatitis B during pregnancy.
Topics: Anti-HIV Agents; Female; Hepatitis B; Humans; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Treatment Outcome; Young Adult | 2009 |
Early hepatitis B virological rebound on entecavir through selection of lamivudine-associated mutations.
Topics: Adult; Amino Acid Sequence; Antiviral Agents; Drug Resistance, Viral; Guanine; Hepatitis B; Humans; Lamivudine; Male; Molecular Sequence Data; Mutation, Missense; Selection, Genetic; Treatment Outcome | 2009 |
Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus.
Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; Creatinine; DNA, Viral; Drug Resistance, Viral; Fanconi Syndrome; Female; Hepatitis B; Hepatitis B virus; Humans; Kidney; Lamivudine; Male; Middle Aged; Organophosphonates; Phosphates; Renal Insufficiency; Serum; Treatment Outcome; Viral Load | 2010 |
Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Incidence; Lamivudine; Lymphoma, B-Cell; Male; Middle Aged; Premedication; Retrospective Studies; Rituximab; Virus Activation | 2010 |
A case of acute rejection shortly after initiation of lamivudine therapy in a simultaneous pancreas and kidney recipient with viral hepatitis type B.
Topics: Adult; Antiviral Agents; Graft Rejection; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Pancreas Transplantation | 2009 |
Favorable outcome of de novo hepatitis B infection after liver transplantation with lamivudine and adefovir therapy.
Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis, Biliary; Liver Transplantation; Middle Aged; Organophosphonates; Treatment Outcome | 2009 |
The significance of enzyme immunoassay for the assessment of hepatitis B virus core-related antigen following liver transplantation.
Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoenzyme Techniques; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Organophosphonates; Time Factors; Virus Replication | 2009 |
[Prevention and management of hepatitis B virus reinfection after liver transplantation].
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Period; Retrospective Studies; Secondary Prevention; Young Adult | 2009 |
The management of cirrhotic ascites.
Topics: Antiviral Agents; Ascites; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Neoplasms; Liver Transplantation; Practice Guidelines as Topic | 2009 |
[Investigation of oxidative stress and antioxidant defense in patients with hepatitis B virus infection and the effect of interferon-alpha plus lamivudine combination therapy on oxidative stress].
Topics: Acute Disease; Adult; Alanine Transaminase; Antioxidants; Antiviral Agents; Aspartate Aminotransferases; Carrier State; Case-Control Studies; Drug Therapy, Combination; Female; Glutathione Peroxidase; Hepatitis B; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver; Male; Malondialdehyde; Oxidative Stress; Superoxide Dismutase | 2009 |
The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirin.
Topics: Adult; Aged; Antiviral Agents; Drug Administration Schedule; Female; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
Topics: Adult; Aged; Antiviral Agents; Brazil; Cross Infection; DNA, Viral; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C Antibodies; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Prevalence; Renal Dialysis; Viral Envelope Proteins | 2010 |
Serial knife stabbings with HIV exposure--implications for post-exposure prophylaxis.
Topics: Anti-HIV Agents; Crime Victims; Disease Transmission, Infectious; Drug Combinations; Hepatitis B; Hepatitis C; HIV Infections; Humans; Lamivudine; Lopinavir; Post-Exposure Prophylaxis; Pyrimidinones; Viral Load; Wounds, Stab; Zidovudine | 2010 |
Description of liver disease in a cohort of HIV/HBV coinfected patients.
Topics: Adult; Alanine Transaminase; Analysis of Variance; Anti-HIV Agents; Aspartate Aminotransferases; Cohort Studies; DNA, Viral; Female; Hepatitis B; HIV; HIV Infections; Humans; Lamivudine; Male; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Statistics, Nonparametric | 2010 |
Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Immunologic Factors; Lamivudine; Lymphoma; Male; Middle Aged; Prevalence; Rituximab; Virus Activation; Virus Latency; Virus Replication | 2010 |
[Lamivudine, interferon-alpha and oxymatrine treatment for the surviving hepatic failure patients with hepatitis B].
Topics: Adolescent; Adult; Alkaloids; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver Failure; Liver Function Tests; Male; Matrines; Middle Aged; Quinolizines; Treatment Outcome; Young Adult | 2009 |
Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation.
Topics: Adult; Antiviral Agents; Computer Simulation; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Viral Proteins | 2010 |
Co-infection of Toxoplasma gondii with HBV in HIV-infected and uninfected pregnant women in Burkina Faso.
Topics: Adult; Anti-HIV Agents; Burkina Faso; Female; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Complications, Parasitic; Surveys and Questionnaires; Toxoplasma; Toxoplasmosis; Young Adult | 2009 |
Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV.
Topics: Animals; Astragalus Plant; Body Weight; Emodin; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatocytes; Humans; Lamivudine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Plant Extracts; Polysaccharides; Protein Kinase Inhibitors; Random Allocation; Virus Replication | 2009 |
Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure.
Topics: Acute Disease; Adult; Antiviral Agents; China; Cohort Studies; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Viral Load | 2010 |
Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.
Topics: Adenine; Adolescent; Adult; Cohort Studies; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome | 2010 |
[Protocol for the antiviral therapy of hepatitis B and D].
Topics: Adenine; Antiviral Agents; Biopsy; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis D; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Lamivudine; Liver Cirrhosis; Nucleotides; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir | 2010 |
[Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy].
Topics: Adult; Aged; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Lymphoma, B-Cell; Male; Middle Aged; Prednisolone; Rituximab; Vincristine; Virus Activation | 2009 |
Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Japan; Lamivudine; Male; Middle Aged; Mutation; Phenotype; Prevalence; Severity of Illness Index; Young Adult | 2010 |
[The antiviral treatment impacts on clinical outcomes of renal transplantation recipients with hepatitis B virus infection].
Topics: Adenine; Adult; Aged; Antiviral Agents; Case-Control Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome | 2009 |
[Construction and application of a genechip method for detection of hepatitis B virus lamivudine-resistant mutants and basal core promotor/Pre-C mutants].
Topics: Antiviral Agents; Base Sequence; Drug Resistance, Viral; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Molecular Sequence Data; Mutation; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic | 2009 |
Prevention of de novo hepatitis B virus infections: more seems no better.
Topics: Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver; Liver Transplantation | 2010 |
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.
Topics: Adult; Aged; Antiviral Agents; Graft Survival; Hepatitis; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Immunoglobulins; Immunologic Deficiency Syndromes; Infections; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Virus Diseases; Viruses | 2010 |
Hepatitis B virus drug resistance in HIV-1-infected patients taking lamivudine-containing antiretroviral therapy.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Prevalence; Risk Factors; Treatment Outcome | 2010 |
Hepatitis B virus-associated nephropathy: an International Data Analysis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Glomerulonephritis; Hepatitis B; Humans; Infant; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Young Adult | 2010 |
Molecular characterization of hepatitis B virus and a 9-year clinical profile in a patient infected with genotype I.
Topics: Amino Acid Substitution; Antiviral Agents; Canada; Cluster Analysis; DNA, Viral; Genotype; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Molecular Sequence Data; Phylogeny; Polymorphism, Genetic; Sequence Analysis, DNA; Sequence Homology; Vietnam | 2010 |
Viral resistance in hepatitis B: prevalence and management.
Topics: Adenine; Antiviral Agents; Drug Resistance, Viral; Genetic Testing; Genotype; Guanine; Hepatitis B; Humans; Lamivudine; Nucleosides; Organophosphonates; Phenotype; Pyrimidinones; Telbivudine; Tenofovir; Thymidine | 2010 |
Inhibitory effect on hepatitis B virus in vitro by a peroxisome proliferator-activated receptor-gamma ligand, rosiglitazone.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Ligands; PPAR gamma; Rosiglitazone; Thiazolidinediones; Virus Replication | 2010 |
Transmission of antiviral drug resistant hepatitis B virus: implications for public health and patient management.
Topics: Acute Disease; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Phenotype; Prevalence; Public Health; Severity of Illness Index; Treatment Outcome | 2010 |
Education and imaging. Hepatobiliary and pancreatic: multiple sexually transmitted infections.
Topics: Acute Disease; Anti-Infective Agents; Antiprotozoal Agents; Antiviral Agents; Colonoscopy; Entamoebiasis; Gastrointestinal Hemorrhage; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Homosexuality, Male; Humans; Immunoglobulin M; Jaundice; Lamivudine; Male; Metronidazole; Middle Aged; Penicillins; Rectum; Syphilis Serodiagnosis; Syphilis, Cutaneous; Unsafe Sex | 2010 |
[Therapeutic recommendations for year 2010: antiviral treatment of chronic HBV infection].
Topics: Antiviral Agents; Disease Management; Health Services Accessibility; Hepatitis B; Hepatitis B, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Poland; Practice Guidelines as Topic; Practice Patterns, Physicians'; Primary Health Care; Recombinant Proteins | 2010 |
Peptide nucleic acid array for detection of point mutations in hepatitis B virus associated with antiviral resistance.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation, Missense; Oligonucleotide Array Sequence Analysis; Organophosphonates; Peptide Nucleic Acids; Point Mutation; Sensitivity and Specificity | 2010 |
Acute hepatitis B infection associated with drug-resistant hepatitis B virus.
Topics: Adenine; Adult; Amino Acid Substitution; Antiviral Agents; China; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Organophosphonates; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Viral Proteins | 2010 |
Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Incidence; Lamivudine; Liver Transplantation; Longitudinal Studies; Middle Aged; Mutation; Nucleosides; Retrospective Studies; Risk Factors; Transplantation; Treatment Outcome; Viral Envelope Proteins; Young Adult | 2010 |
[Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy].
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Evolution, Molecular; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine | 2010 |
[Genotypic resistance to entecavir in chronic hepatitis B patients].
Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymorphism, Restriction Fragment Length; Retrospective Studies; RNA-Directed DNA Polymerase | 2010 |
Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.
Topics: Adenine; Adult; Aged; Antiviral Agents; Asian People; DNA, Circular; DNA, Viral; Drug Resistance; Female; Gene Products, pol; Genetic Variation; Genome, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Organophosphonates; Phylogeny; Tenofovir; Trans-Activators; Viral Envelope Proteins; Viral Regulatory and Accessory Proteins; Virus Replication | 2011 |
High viremia, prolonged Lamivudine therapy and recurrent hepatocellular carcinoma predict posttransplant hepatitis B recurrence.
Topics: Adult; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Predictive Value of Tests; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors | 2010 |
High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brazil; Comorbidity; Cross-Sectional Studies; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Tenofovir; Viral Core Proteins; Viral Load; Viral Proteins | 2010 |
Posttransplant prophylaxis strategies for hepatitis B.
Topics: Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Secondary Prevention | 2010 |
Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin.
Topics: Adult; Aged; Costs and Cost Analysis; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Secondary Prevention; Viral Load | 2010 |
[Resistance mutation patterns of hepatitis B virus in patients with suboptimal response to adefovir dipivoxil therapy after lamivudine resistance].
Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates | 2010 |
Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients.
Topics: Adenine; Adolescent; Adult; Antiviral Agents; Asian People; China; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Organophosphonates; Prevalence; Young Adult | 2010 |
Short Communication: Hepatitis B Virus Harboring Nucleotide Deletions in the Basal Core Promoter in HBe-Positive HIV-Coinfected Patients Under Lamivudine Therapy.
Topics: Anti-HIV Agents; DNA, Viral; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Promoter Regions, Genetic; Sequence Analysis, DNA; Sequence Deletion | 2011 |
Sensitive assay for quantification of hepatitis B virus mutants by use of a minor groove binder probe and peptide nucleic acids.
Topics: Adult; Antiviral Agents; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Microbial Sensitivity Tests; Mutation; Oligonucleotide Probes; Peptide Nucleic Acids; Sensitivity and Specificity | 2010 |
Anti-hepatitis B virus activities of cinobufacini and its active components bufalin and cinobufagin in HepG2.2.15 cells.
Topics: Animals; Antiviral Agents; Bufanolides; Bufonidae; Drugs, Chinese Herbal; Hep G2 Cells; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; Humans; Lamivudine; RNA, Messenger; Transfection | 2010 |
Hepatitis B genotype G and high frequency of lamivudine-resistance mutations among human immunodeficiency virus/hepatitis B virus co-infected patients in Brazil.
Topics: Adult; Antiviral Agents; Brazil; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Polymerase Chain Reaction; Viral Load | 2010 |
Rapid detection of drug-resistant mutations in hepatitis B virus by the PCR-Invader assay.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation, Missense; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sensitivity and Specificity; Viral Proteins | 2011 |
Lamivudine treatment in infantile fulminant hepatitis B.
Topics: Antiviral Agents; Hepatitis B; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Liver Failure, Acute; Male; Reverse Transcriptase Inhibitors | 2010 |
Hepatitis B after transplantation: competition between the recipient virus and the donor virus.
Topics: DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleotides; Polymerase Chain Reaction; Specimen Handling; Tissue Donors; Transplants | 2010 |
Occult hepatitis B virus infection of donor and recipient origin after liver transplantation despite nucleoside analogue prophylaxis.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunohistochemistry; Lamivudine; Liver Transplantation; Male; Middle Aged; Nucleosides; Tissue Donors | 2010 |
HBsAg-negative mono-infection with hepatitis B virus genotype G.
Topics: Antiviral Agents; Blood Donors; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Phylogeny; Serotyping | 2011 |
Fatal hepatitis B virus reactivation due to a lamivudine mutant despite undetectable initial viral load.
Topics: Drug Resistance, Viral; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Lymphoma; Male; Middle Aged; Splenic Neoplasms; Viral Load; Virus Activation | 2011 |
Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immune Tolerance; Infectious Disease Transmission, Vertical; Interferon-alpha; Lamivudine; Longitudinal Studies; Male; Mutation; T-Lymphocytes | 2011 |
Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.
Topics: Adenine; Antiviral Agents; Combined Modality Therapy; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Perioperative Care; Secondary Prevention; Tenofovir; Treatment Outcome | 2011 |
Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation.
Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Injections, Intravenous; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prohibitins; Prospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention | 2010 |
Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy.
Topics: Adult; Aged; Algorithms; Anthracyclines; Antibiotic Prophylaxis; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Breast Neoplasms; Carcinoma; Case-Control Studies; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Female; Hepatitis B; Humans; Incidence; Lamivudine; Middle Aged; Postoperative Complications; Retrospective Studies | 2011 |
Lamivudine treatment is associated with improved survival in fulminant hepatitis B.
Topics: Biomarkers; China; Cohort Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure, Acute; Male; Retrospective Studies; Survival Analysis; Treatment Outcome | 2011 |
Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?
Topics: Adult; Antiviral Agents; Female; Graft Survival; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Tissue Donors | 2011 |
Low liver stiffness among cirrhotic patients with hepatitis B after prolonged treatment with nucleoside analogs.
Topics: Adenine; Adult; Elasticity Imaging Techniques; Female; Hepatitis B; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors | 2011 |
Long-term results of hepatitis B immunoglobulin and lamuvidine for hepatitis B prophylaxis after liver transplantation.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors | 2011 |
Regression of indolent B-cell lymphoma after Lamivudine prophylaxis of hepatitis B virus infection.
Topics: Antiviral Agents; Asymptomatic Diseases; Bone Marrow; Carrier State; Cell Transformation, Viral; Disease Progression; Female; Genes, bcl-2; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, B-Cell; Lymphoma, Follicular; Middle Aged; Neoplasm, Residual; Remission Induction; Splenic Neoplasms | 2011 |
Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Boronic Acids; Bortezomib; Comorbidity; Endemic Diseases; Female; Hepatitis B; Humans; Immunologic Factors; Incidence; Lamivudine; Male; Middle Aged; Multiple Myeloma; Prevalence; Prospective Studies; Pyrazines; Retrospective Studies; Risk Factors; Secondary Prevention; Stem Cell Transplantation; Transplantation, Autologous; Virus Activation | 2012 |
The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Rituximab; Survival Rate; Treatment Outcome; Virus Activation; Young Adult | 2012 |
Interference of replication between hepatitis B and C viruses in patients infected with HIV.
Topics: Adult; Antibodies, Viral; CD4 Lymphocyte Count; Cell Line, Tumor; China; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; HIV; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Male; Mutation; Plasmids; Risk Factors; RNA, Viral; Transfection; Virus Replication | 2011 |
Successful treatment of hepatitis B virus associated nephrotic syndrome with oral Lamivudine in a Nigerian child: a case report.
Topics: Antiviral Agents; Child; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Nephrotic Syndrome; Nigeria; Remission Induction | 2012 |
A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximab-reactivated hepatitis B.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Hepatitis B; Humans; Infliximab; Lamivudine; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Treatment Outcome | 2011 |
Detection of hepatitis B virus variants in HBV monoinfected and HBV/HIV coinfected Iranian patients under lamivudine treatment.
Topics: Adult; Anti-HIV Agents; Cohort Studies; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Gene Frequency; Genotype; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Iran; Lamivudine; Male; Mutation; Phylogeny | 2011 |
HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in Spain.
Topics: Adult; Cohort Studies; Drug Resistance, Viral; Female; Gene Products, pol; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Spain | 2011 |
Risk of liver-associated morbidity and mortality in a cohort of HIV and HBV coinfected Han Chinese.
Topics: Adult; Alanine Transaminase; Anti-HIV Agents; CD4 Lymphocyte Count; China; Cohort Studies; Coinfection; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Lamivudine; Liver; Male; Middle Aged; Retrospective Studies; Risk Factors; RNA, Viral; Young Adult | 2011 |
Design, synthesis, and biological evaluation of triazolo-pyrimidine derivatives as novel inhibitors of hepatitis B virus surface antigen (HBsAg) secretion.
Topics: Adenine; Animals; Antiviral Agents; Biological Availability; Drug Design; Drug Resistance, Viral; Guanine; Hep G2 Cells; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Mice; Models, Chemical; Molecular Structure; Mutation; Organophosphonates; Pyrimidines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tenofovir; Tetrazoles | 2011 |
Cost-effectiveness of maternal treatment to prevent perinatal hepatitis B virus transmission.
Topics: Adult; Cost Savings; Cost-Benefit Analysis; Decision Trees; DNA, Viral; Female; Hepatitis B; Humans; Immunoglobulins; Infant, Newborn; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Reverse Transcriptase Inhibitors; Viral Load | 2011 |
Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China.
Topics: Antiviral Agents; China; Drug Resistance, Viral; Enzyme-Linked Immunosorbent Assay; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Logistic Models; Mutation; Odds Ratio; Real-Time Polymerase Chain Reaction | 2011 |
Identification of hepatitis B virus rtS117F substitution as a compensatory mutation for rtM204I during lamivudine therapy.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Antiviral Agents; DNA Mutational Analysis; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutagenesis, Site-Directed; Mutation, Missense; Sequence Analysis, DNA; Virus Replication | 2012 |
Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; End Stage Liver Disease; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Prognosis; Retrospective Studies; Secondary Prevention; Time Factors; Treatment Outcome; Young Adult | 2012 |
Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G.
Topics: Adenine; Adult; Anti-HIV Agents; Coinfection; Deoxycytidine; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Retrospective Studies; Tenofovir; Time Factors; Treatment Outcome | 2012 |
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Chemoprevention; Drug Therapy; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Lamivudine; Mutation, Missense; Rituximab; Virus Activation; Withholding Treatment | 2012 |
How does hepatitis B virus infection react to hepatocellular carcinoma treatment?
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Female; Hepatectomy; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Liver Neoplasms; Male; Virus Activation | 2012 |
Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon.
Topics: Adult; Anti-HIV Agents; Base Sequence; Cameroon; Coinfection; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Gene Products, pol; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Sequence Analysis, DNA | 2012 |
Sequence analysis of the polymerase gene in hepatitis B virus infected blood donors in Iran.
Topics: Adult; Aged; Antiviral Agents; Blood Donors; DNA, Viral; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Iran; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA | 2012 |
Anti-HBV activities of Streblus asper and constituents of its roots.
Topics: Antiviral Agents; Biphenyl Compounds; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Humans; Inhibitory Concentration 50; Lamivudine; Lignans; Molecular Structure; Moraceae; Phytotherapy; Plant Extracts; Plant Roots; Plant Structures | 2012 |
Hepatitis B virus reactivation in rheumatoid arthritis and ankylosing spondylitis patients treated with anti-TNFα agents: a retrospective analysis of 49 cases.
Topics: Adult; Amino Acid Motifs; Antiviral Agents; Arthritis, Rheumatoid; DNA-Directed DNA Polymerase; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Retrospective Studies; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha; Virus Activation | 2012 |
Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice.
Topics: Animals; Antiviral Agents; Chimera; Cytidine; DNA, Viral; Hepatitis B; Humans; Lamivudine; Mice; Mice, SCID; Molecular Structure; Urokinase-Type Plasminogen Activator; Viremia; Zalcitabine | 2012 |
[Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
Topics: Adenine; Antiviral Agents; Comorbidity; Consensus; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Guanine; Hepacivirus; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Hungary; Interferon-alpha; Interferons; Lamivudine; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; RNA, Viral; Tenofovir; Time Factors; Treatment Outcome | 2012 |
In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates.
Topics: Adult; Antiviral Agents; Benzylisoquinolines; Cell Survival; China; DNA, Viral; Down-Regulation; Drug Resistance, Viral; Gene Expression Regulation, Viral; Hep G2 Cells; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatocytes; HSC70 Heat-Shock Proteins; Humans; Inhibitory Concentration 50; Lamivudine; Male; Recombinant Proteins; RNA, Messenger; Virus Replication | 2012 |
The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation.
Topics: Adult; Amino Acid Substitution; Antiviral Agents; Cell Line; China; Drug Resistance, Viral; Female; Gene Products, pol; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Virus Replication | 2012 |
Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir.
Topics: Adenine; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prognosis; Retrospective Studies; Treatment Failure | 2012 |
Antiviral activity of FNC, 2'-deoxy-2'-β-fluoro-4'-azidocytidine, against human and duck HBV replication.
Topics: Animals; Antiviral Agents; Azides; Cell Line, Tumor; Deoxycytidine; Ducks; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatocytes; Humans; Lamivudine; Liver; Virus Replication | 2012 |
[Prognosis analysis of hepatitis B virus recurrence after liver transplantation: a single-center study of 38 cases].
Topics: Adenine; Adult; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prognosis; Recurrence; Retrospective Studies | 2012 |
Hepatitis B virus variants in HBV mono-infected versus HBV/HIV co-infected patients.
Topics: Anti-HIV Agents; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male | 2012 |
Convergence and coevolution of hepatitis B virus drug resistance.
Topics: Adult; Antiviral Agents; Child; Drug Resistance, Viral; Evolution, Molecular; Female; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Phylogeny; RNA-Directed DNA Polymerase; Viral Proteins | 2012 |
Interruption of mother-to-infant transmission of hepatitis B: time to include selective antiviral prophylaxis?
Topics: Antiviral Agents; Developing Countries; Female; Hepatitis B; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nucleosides; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine; Vaccination | 2012 |
Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; DNA, Viral; Donor Selection; Female; Heart Failure; Heart Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Retrospective Studies; Taiwan; Time Factors; Treatment Outcome; Viral Load; Virus Activation; Young Adult | 2012 |
Treatment effects on patient-important outcomes can be small, even with large effects on surrogate markers.
Topics: Biomarkers; Hepatitis B; Hepatitis B e Antigens; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors | 2012 |
Immunological and virological responses to cART in HIV/HBV co-infected patients from a multicenter cohort.
Topics: Adolescent; Adult; Aged; Anti-Retroviral Agents; CD4 Lymphocyte Count; Coinfection; Disease Progression; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult | 2012 |
Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation.
Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Nucleotides; Organophosphonates; Secondary Prevention; Tenofovir; Treatment Outcome; Young Adult | 2012 |
Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Female; Guideline Adherence; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Rituximab; Virus Activation; Young Adult | 2013 |
Letter: acute hepatitis B - to treat or not to treat?
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Lamivudine; Randomized Controlled Trials as Topic; Survival Rate | 2012 |
Detection of mixed populations of wild-type and YMDD hepatitis B variants by pyrosequencing in acutely and chronically infected patients.
Topics: DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymorphism, Single Nucleotide; Sequence Analysis, DNA | 2012 |
Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing.
Topics: Antiviral Agents; Drug Resistance, Viral; Guanine; Haplotypes; Hepatitis B; Hepatitis B virus; High-Throughput Nucleotide Sequencing; Humans; Lamivudine; Mutation; Reproducibility of Results | 2012 |
Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry.
Topics: Adenine; Adult; Antiviral Agents; Congenital Abnormalities; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Phosphorous Acids; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Treatment Outcome | 2012 |
Predictive factors of lamivudine treatment success in an hepatitis B virus-infected pediatric cohort: a 10-year study.
Topics: Adolescent; Alanine Transaminase; Antiviral Agents; Child; Child, Preschool; Female; Hepatitis B; Humans; Lamivudine; Male; Retrospective Studies; Treatment Outcome | 2012 |
Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand.
Topics: Adult; Alanine Transaminase; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Thailand; Viral Load; Virus Replication | 2012 |
Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa.
Topics: Anti-HIV Agents; Body Mass Index; CD4 Lymphocyte Count; Coinfection; Disease Progression; Female; Ghana; Hepatitis B; Hepatitis B Surface Antigens; HIV Infections; Humans; Lamivudine; Male; Prevalence; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load | 2013 |
Clinical prediction of failure of Lamivudine prophylaxis for hepatitis B virus-infected patients undergoing cytotoxic chemotherapy for malignancy.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Prognosis; Rituximab; Survival Rate; Treatment Failure; Viral Load | 2012 |
Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapy.
Topics: Adenine; Adult; Aged; Antiviral Agents; Cloning, Molecular; DNA, Viral; Drug Resistance, Viral; Drug Substitution; Escherichia coli; Evolution, Molecular; Female; Follow-Up Studies; Gene Products, pol; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Tenofovir; Viremia | 2012 |
Does genotype predict response to treatment in children infected with hepatitis B perinatally?
Topics: Adenine; Adolescent; Anti-Inflammatory Agents; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; DNA, Viral; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferons; Lamivudine; Organophosphonates; Prednisolone; Treatment Outcome | 2012 |
Emergence of lamivudine resistance hepatitis B virus mutations in pregnant women infected with HBV and HIV receiving antiretroviral prophylaxis for the prevention of mother-to-infant transmission in Malawi.
Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Malawi; Mutation; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Viral Load; Young Adult | 2012 |
Clinical characteristics and chronicity of acute hepatitis B induced by lamivudine-resistant strains.
Topics: Adult; Antiviral Agents; China; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Sequence Analysis, DNA | 2012 |
Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection?
Topics: Acute Disease; Adenine; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis D; Hepatitis Delta Virus; Humans; Interferons; Lamivudine; Male; Organophosphonates; RNA, Viral; Superinfection; Tenofovir; Young Adult | 2012 |
Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States.
Topics: Acute Disease; Adenine; Adult; Antiviral Agents; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Viral; Female; Genotype; Guanine; Hepatitis B; Humans; Lamivudine; Male; Mutation; Organophosphonates; Retrospective Studies; Sequence Analysis, DNA; United States | 2013 |
Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Coinfection; Deoxycytidine; Emtricitabine; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome; Viral Load; Virus Replication | 2012 |
Lamivudine prophylaxis for hepatitis B virus carrier patients with breast cancer during adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Polymerase Chain Reaction; Premedication; Prognosis; Prospective Studies; Reverse Transcriptase Inhibitors; Virus Activation | 2014 |
Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Function Tests; Lymphoma, B-Cell; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Rituximab; Virus Activation | 2013 |
Severe acute hepatitis B in a treatment-naïve patient with antiviral drug resistant mutations in the polymerase gene.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Mutation, Missense; Organophosphonates; Telbivudine; Tenofovir; Thailand; Thymidine; Travel; Treatment Outcome | 2013 |
Influence of HIV-associated degree of immune suppression on molecular heterogeneity of hepatitis B virus among HIV co-infected patients.
Topics: Adult; Amino Acid Sequence; Anti-HIV Agents; CD4 Lymphocyte Count; Coinfection; DNA, Viral; Female; Genetic Variation; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV; HIV Infections; Humans; Immunosuppression Therapy; Lamivudine; Male; Sequence Analysis, DNA; Viral Load | 2013 |
An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antiviral Agents; Female; Hepatitis Antigens; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Neoplasms; Pilot Projects; Reverse Transcriptase Inhibitors; Secondary Prevention; Survival Rate; Treatment Outcome; Virus Activation; Young Adult | 2013 |
Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection.
Topics: Adenine; Antiviral Agents; Child, Preschool; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Organophosphonates; Tenofovir; Treatment Outcome | 2013 |
Lamivudine-induced muscle mitochondrial toxicity.
Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Mitochondrial Myopathies | 2002 |
Advances in liver disease. Highlights from the 51st Annual Meeting of the American Association for the Study of Liver Diseases, October 27-31, 2000, Dallas, TX.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver Neoplasms; Liver Transplantation; Polyethylene Glycols; Recombinant Proteins | 2001 |
Hepatitis B: weighing the costs of treatment.
Topics: Antiviral Agents; Cost-Benefit Analysis; Disease Progression; Drug Costs; Hepatitis B; Hepatitis B virus; Humans; Interferon Type I; Lamivudine; Life Expectancy; Recombinant Proteins | 2002 |
[Questions to professeur Patrick Marcellin].
Topics: Antiviral Agents; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver; Mutation | 2002 |
[HBV cirrhosis].
Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence | 2002 |
Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment.
Topics: Antiviral Agents; Arabinofuranosyluracil; Baculoviridae; Cell Line; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Kinetics; Lamivudine; Recombination, Genetic; Virus Replication | 2002 |
Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.
Topics: Adenine; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir; Virus Replication | 2002 |
[Fatal fibrosing cholestatic hepatitis following renal transplantation].
Topics: Aged; Antiviral Agents; Cholestasis; DNA, Viral; Fatal Outcome; Fibrosis; Hepatitis B; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Reverse Transcriptase Inhibitors; Viral Load | 2002 |
Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine.
Topics: Adult; Anemia, Aplastic; Antiviral Agents; Hepatitis B; Humans; Lamivudine; Male; Remission, Spontaneous | 2002 |
Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
Topics: Adult; Amino Acid Motifs; Amino Acid Sequence; Antiviral Agents; Base Sequence; DNA, Viral; Drug Resistance, Viral; Female; Genes, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence | 2002 |
Liver transplantation in hepatitis B patients with preoperative resistance formation during lamivudine treatment.
Topics: Drug Resistance, Viral; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Recurrence; Reoperation; Treatment Outcome | 2002 |
The use of antiviral monotherapy and combination therapy for patients with hepatitis B virus infection after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Function Tests; Liver Transplantation; Recurrence | 2002 |
Prophylaxis of hepatitis B recurrence after liver transplantation with lamivudin and hepatitis B immunoglobulin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Treatment Outcome | 2002 |
Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
Topics: Biopsy; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Histocompatibility Testing; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Safety; Survival Analysis; Treatment Outcome | 2002 |
Treatment of recurrent hepatitis B infection in liver transplant recipients.
Topics: 2-Aminopurine; Adenine; Antiviral Agents; Famciclovir; Hepatitis B; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors | 2002 |
Indefinite passive immunization after liver transplantation for hepatitis B.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors | 2002 |
Histological improvement with lamivudine therapy for de novo hepatitis B occurring in an anti-HBs-positive child after bone marrow transplantation.
Topics: Adolescent; Antibodies, Viral; Bone Marrow Transplantation; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Leukemia, Myeloid, Acute; Liver Cirrhosis; Virus Activation | 2002 |
Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
Topics: Antiviral Agents; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Middle Aged; Recurrence | 2002 |
Pulmonary involvement in hepatitis B-related polyarteritis nodosa.
Topics: Adrenal Cortex Hormones; Adult; Combined Modality Therapy; Hemorrhage; Hepatitis B; Humans; Lamivudine; Lung Diseases; Male; Plasmapheresis; Polyarteritis Nodosa; Prognosis; Risk Assessment; Treatment Outcome | 2002 |
Prophylactic lamivudine therapy for hepatitis B patients undergoing immunosuppressive therapy.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Recurrence; Virus Activation | 2002 |
Editorial comment: a tale of two viruses.
Topics: Adenine; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; HIV Infections; Humans; Lamivudine; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir | 2002 |
Evolving experience of hepatitis B virus prophylaxis in liver transplantation.
Topics: Adult; Chemoprevention; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Incidence; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors | 2002 |
Combination of HBIG and lamivudine-resistant mutations: a formula for trouble?
Topics: DNA-Directed DNA Polymerase; Drug Resistance; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Mutation; Postoperative Complications; Reverse Transcriptase Inhibitors; Virus Replication | 2002 |
Characterization of nuclease-resistant ribozymes directed against hepatitis B virus RNA.
Topics: Animals; Antiviral Agents; DNA, Viral; Endonucleases; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microbial Sensitivity Tests; RNA, Catalytic; RNA, Viral; Tumor Cells, Cultured | 2002 |
Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Hepatitis B; Hepatitis B Core Antigens; Humans; Infant; Lamivudine; Liver Transplantation; Living Donors; Retrospective Studies | 2002 |
Seroconversion in patients with acute hepatitis B reinfection after liver transplantation with a combined treatment of lamivudine and hepatitis B immune globulin.
Topics: Acute Disease; Adult; Base Sequence; DNA Primers; DNA, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Retrospective Studies; Time Factors | 2002 |
[Clinical and histological features of fibrosing cholestatic hepatitis].
Topics: Adult; Anti-HIV Agents; Cholestasis, Intrahepatic; DNA, Viral; Female; Fibrosis; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Retrospective Studies | 2002 |
[Efficacy and safety of long-term lamivudine therapy in the patients with decompensated liver cirrhosis secondary to hepatitis B].
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Treatment Outcome | 2002 |
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.
Topics: Adult; Aged; Alanine Transaminase; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; United States | 2003 |
Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.
Topics: Adenine; Adult; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Tenofovir | 2003 |
A renal allograft recipient with viral-burden, steatoviral, and fibroviral hepatitis B who achieved remission with Lamivudine.
Topics: Adult; Alanine Transaminase; DNA, Viral; Fatty Liver; gamma-Glutamyltransferase; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Liver Cirrhosis; Male; Remission Induction; Reverse Transcriptase Inhibitors; Transplantation, Homologous | 2003 |
Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation.
Topics: Adult; Aged; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Female; Graft Survival; Hepatitis B; Humans; Immunoglobulins; Injections, Intramuscular; Injections, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Period; Reverse Transcriptase Inhibitors; Safety; Secondary Prevention; Survival Analysis; Treatment Outcome | 2003 |
Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency.
Topics: Adenine; Adult; Antiviral Agents; Bacterial Infections; Cholestasis; Drug Resistance, Microbial; Fibrosis; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Cirrhosis; Male; Organophosphonates; Peritonitis; Recurrence; Renal Insufficiency; Reverse Transcriptase Inhibitors | 2003 |
Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
Topics: Adenine; Antiviral Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Virus Activation | 2003 |
In vivo immunization following virus suppression: a novel approach for inducing immune control in chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Chronic Disease; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Humans; Immunization; Interferon-alpha; Lamivudine; Virus Replication | 2003 |
Characteristics of and current treatment options for hepatitis B and hepatitis C.
Topics: Adult; Antiviral Agents; Drug Combinations; Hepatitis B; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Lamivudine; Reverse Transcriptase Inhibitors; Ribavirin | 2000 |
The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment.
Topics: Adult; Aged; Amino Acid Motifs; Drug Administration Schedule; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Severity of Illness Index | 2003 |
Combination hepatitis B immune globulin and lamivudine versus hepatitis B immune globulin monotherapy in preventing recurrent hepatitis B virus infection in liver transplant recipients.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies | 2003 |
Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation.
Topics: Adult; Aged; Antibodies, Viral; Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies | 2003 |
Lamivudine treatment for acute hepatitis B virus infection during allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adult; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Reverse Transcriptase Inhibitors | 2003 |
[Genotyping of hepatitis B virus and clinical investigation].
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Polymerase Chain Reaction; Treatment Outcome | 2002 |
HBV associated nephrotic syndrome: resolution with oral lamivudine.
Topics: Administration, Oral; Antigens, Viral; Child; Glomerulonephritis, Membranous; Hepatitis B; Humans; Lamivudine; Male; Microscopy, Electron; Nephrotic Syndrome; Reverse Transcriptase Inhibitors | 2003 |
Another case of HBV associated membranous glomerulonephritis resolving on lamivudine.
Topics: Child, Preschool; Female; Glomerulonephritis, Membranous; Hepatitis B; Humans; Lamivudine; Nephrotic Syndrome; Reverse Transcriptase Inhibitors; Treatment Outcome | 2003 |
Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
Topics: Adult; Aged; Female; Graft Survival; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors; Tissue Donors; Treatment Outcome | 2003 |
Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Cytarabine; Daunorubicin; Doxorubicin; Enzyme Inhibitors; Female; Fusion Proteins, bcr-abl; Hepatitis B; Humans; Imatinib Mesylate; Immunosuppressive Agents; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Neoplasm Proteins; Peripheral Blood Stem Cell Transplantation; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Pyrimidines; Remission Induction; Salvage Therapy; Vincristine | 2003 |
Detection of mutations in the hepatitis B virus polymerase gene.
Topics: Aged; Antiviral Agents; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Retrospective Studies | 2003 |
Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation.
Topics: Adult; Cost-Benefit Analysis; Drug Administration Schedule; Female; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Injections, Intramuscular; Injections, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Time Factors | 2003 |
Decompensated hepatitis B virus-related cirrhosis successfully treated with lamivudine allowing surgery for hepatocellular carcinoma.
Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Hepatectomy; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Radiography | 2003 |
Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Follicular; Mutation; Rituximab | 2003 |
Combined lamivudine and interferon-alpha therapy for chemotherapy-induced reactivation of hepatitis B virus.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Lymphoma, Non-Hodgkin; Male; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation | 2003 |
Excellent outcome of Lamivudine treatment in patients with chronic renal failure and hepatitis B virus infection.
Topics: Adult; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Failure, Chronic; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors | 2003 |
Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation | 2003 |
Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection.
Topics: Adolescent; Adult; Case-Control Studies; Female; Follow-Up Studies; Hepatitis B; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Probability; Prospective Studies; Reference Values; Reverse Transcriptase Inhibitors; Risk Assessment; Severity of Illness Index; Treatment Outcome; Viral Load | 2003 |
Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment.
Topics: Biomarkers; Case-Control Studies; Cohort Studies; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Immunoenzyme Techniques; Lamivudine; Male; Monitoring, Physiologic; Probability; Reference Values; Treatment Outcome | 2003 |
The effect of lamivudine on the replication of hepatitis B virus in HIV-infected patients depends on the host immune status (CD4 cell count).
Topics: Adult; CD4 Lymphocyte Count; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Virus Replication | 2003 |
Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.
Topics: Adenine; Animals; Capsid; Combined Modality Therapy; Disease Models, Animal; Gene Expression Regulation, Viral; Genetic Therapy; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Lamivudine; Liver; Male; Mice; Mice, Inbred Strains; Organophosphonates; Reverse Transcriptase Inhibitors; RNA, Small Interfering; Specific Pathogen-Free Organisms; Virus Replication | 2003 |
Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV-HBV co-infected individuals.
Topics: Adult; Aged; CD4 Lymphocyte Count; Chronic Disease; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Prevalence; Regression Analysis; Retrospective Studies; Reverse Transcriptase Inhibitors; Statistics, Nonparametric; Viremia | 2003 |
Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results.
Topics: Adolescent; Adult; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Survival Rate | 2003 |
[Analysis of three lamivudine-resistant HBV mutants with the method of restriction enzyme digestion and its application].
Topics: Adolescent; Adult; Antiviral Agents; DNA Mutational Analysis; DNA Primers; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Polymerase Chain Reaction | 2003 |
[Study the mutations in polymerase gene of hepatitis B virus by three methods].
Topics: Alanine Transaminase; DNA, Viral; Gene Products, pol; Hepatitis B; Humans; Lamivudine; Mutation | 2003 |
Liver transplantation in patients with fulminant hepatitis B: experience in Canton, China.
Topics: Adult; Hepatic Encephalopathy; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Survival Rate | 2002 |
Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; DNA (Cytosine-5-)-Methyltransferases; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Vidarabine; Virus Activation | 2003 |
Successful clearance of hepatitis B virus after allogeneic stem cell transplantation: beneficial combination of adoptive immunity transfer and lamivudine.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunotherapy, Adoptive; Kinetics; Lamivudine; Male; Peripheral Blood Stem Cell Transplantation; Reverse Transcriptase Inhibitors; Transplantation, Homologous | 2003 |
Prophylaxis and treatment of hepatis B virus infection after liver transplantation.
Topics: Antiviral Agents; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications | 2003 |
Use of combined treatment of hepatitis B immune globulin and lamivudine as prevention of hepatitis B virus recurrence in liver allograft.
Topics: Adult; Aged; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Transplantation, Homologous | 2003 |
Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary results.
Topics: Antiviral Agents; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Humans; Immunization Schedule; Immunoglobulins; Lamivudine; Liver Transplantation; Recurrence; Time Factors | 2003 |
Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy.
Topics: Base Sequence; Drug Resistance, Viral; Evolution, Molecular; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA | 2003 |
[Clinical evaluation of polymerase chain reaction (PCR) method for the detection of hepatitis B virus (HBV)-DNA].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Infant; Lamivudine; Male; Middle Aged; Molecular Probes; Polymerase Chain Reaction | 2003 |
Plasma pituitary adenylate cyclase activating polypeptide (PACAP) levels in chronic hepatitis B patients under lamivudine treatment.
Topics: Adult; Antiviral Agents; Biomarkers; Case-Control Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Male; Middle Aged; Neuropeptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Radioimmunoassay; Viral Load | 2003 |
Rapid and high throughput detection of HBV YMDD mutants with fluorescence polarization.
Topics: Drug Resistance, Viral; Fluorescence Polarization; Genetic Testing; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2003 |
Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations.
Topics: Adult; Alanine Transaminase; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome | 2003 |
HBV resistant to lamivudine: experimental and clinical studies.
Topics: Alanine Transaminase; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance; Hepatitis Antibodies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Time Factors | 2002 |
Prophylaxis and treatment of hepatitis B virus reinfection following liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Postoperative Complications; Reverse Transcriptase Inhibitors; Secondary Prevention | 2002 |
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B virus; Hepatitis C Antibodies; Humans; Lamivudine; Liver Failure; Lymphoma, Non-Hodgkin; Male; Middle Aged; Sequence Homology; Vidarabine; Virus Activation | 2003 |
PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine.
Topics: Adolescent; Adult; Amino Acid Motifs; Aspartic Acid; Base Sequence; Child; DNA-Directed DNA Polymerase; Drug Resistance; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Methionine; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Inhibitors; Tyrosine | 2002 |
Role of lamivudine in the reactivation of hepatitis B virus infection in immunodepressed patients.
Topics: Adult; Female; Hepatitis B; Humans; Immunosuppression Therapy; Lamivudine; Male; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors | 2003 |
Evolution of wild type and mutants of the YMDD motif of hepatitis B virus polymerase during lamivudine therapy.
Topics: Alanine Transaminase; Amino Acid Motifs; Cloning, Molecular; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Time Factors | 2003 |
The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Doxorubicin; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Rate; Virus Activation | 2003 |
Subclones of drug-resistant hepatitis B virus mutants and the outcome of breakthrough hepatitis in patients treated with lamivudine.
Topics: Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Mutation; Treatment Outcome | 2003 |
Lamivudine therapy for decompensated liver cirrhosis related to hepatitis B virus infection.
Topics: Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Transplantation; Reverse Transcriptase Inhibitors; Severity of Illness Index | 2003 |
Hepatitis B-assocciated adult-onset Still's disease presenting with neutrophilic urticaria.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Fever of Unknown Origin; Hepatitis B; Humans; Indomethacin; Lamivudine; Male; Prednisolone; Recurrence; Reverse Transcriptase Inhibitors; Still's Disease, Adult-Onset; Time Factors; Urticaria | 2003 |
Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine.
Topics: Adolescent; Adult; Alanine Transaminase; Antiviral Agents; Drug Resistance, Viral; Female; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation | 2003 |
Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy in human immunodeficiency virus coinfected patients: performance of CLIP sequencing and line probe assay.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Nucleic Acid Hybridization; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Sequence Analysis, DNA | 2003 |
Designing clinical development programs for anti-hepatitis B virus drugs.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Viral; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferons; Lamivudine; Research Design | 2004 |
Clinical characteristics of asymptomatic hepatitis B virus carriers with YMDD mutant not treated with lamivudine.
Topics: Adult; Aged; Amino Acid Sequence; Antiviral Agents; Carrier State; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Viral Proteins | 2003 |
Antiretroviral therapy and HIV/hepatitis B virus coinfection.
Topics: Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Organophosphonates; Organophosphorus Compounds; Tenofovir | 2004 |
[Viral hepatitis B/C and HIV. Therapy of double infections].
Topics: Acquired Immunodeficiency Syndrome; Adenine; Anti-HIV Agents; Antiviral Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Treatment Outcome | 2003 |
Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Alkaline Phosphatase; Anti-HIV Agents; Antineoplastic Agents; Female; gamma-Glutamyltransferase; Glutamyl Aminopeptidase; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulin G; Immunoglobulin M; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Virus Activation | 2004 |
Treatment of hepatitis B virus-related polyarteritis nodosa: two case reports and a review of the literature.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Fatal Outcome; Glucocorticoids; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Magnetic Resonance Imaging; Male; Middle Aged; Plasma Exchange; Polyarteritis Nodosa; Tomography, X-Ray Computed; Treatment Refusal | 2004 |
Horse antilymphocytic globulin in hepatitis B exacerbation after bone marrow transplantation adoptive immunity transfer.
Topics: Adoptive Transfer; Animals; Antilymphocyte Serum; Antiviral Agents; Bone Marrow Transplantation; Child; Disease Progression; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Heterozygote; Histocompatibility Testing; Horses; Humans; Immunotherapy, Adoptive; Lamivudine; Liver; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors; Tissue Donors | 2004 |
Fibrosing cholestatic hepatitis secondary to precore/core promoter hepatitis B variant with lamivudine resistance: successful retransplantation with combination adefovir dipivoxil and hepatitis B immunoglobulin.
Topics: Adenine; Adult; Antiviral Agents; Cholestasis, Intrahepatic; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Organophosphonates; Promoter Regions, Genetic; Reoperation; Treatment Outcome | 2004 |
Effect of SEN virus coinfection on outcome of lamivudine therapy in patients with hepatitis B.
Topics: Adult; DNA Virus Infections; Hepatitis B; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Treatment Outcome | 2004 |
Preemptive use of lamivudine in breast cancer patients carrying hepatitis B virus undergoing cytotoxic chemotherapy: a longitudinal study.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Chemoprevention; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Middle Aged; Prospective Studies; Risk Factors; Time Factors | 2004 |
Emergence of YMDD mutant hepatitis B virus after allogeneic stem cell transplantation from a HBsAG-positive donor during lamivudine prophylaxis.
Topics: Antibodies, Viral; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Lymphoma, T-Cell; Mutation; Premedication; Reverse Transcriptase Inhibitors; Tissue Donors; Transplantation, Homologous | 2004 |
Adefovir dipivoxil as a treatment for hepatic failure caused by lamivudine-resistant HBV strains.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Organophosphonates; Retreatment; Reverse Transcriptase Inhibitors; Treatment Outcome | 2004 |
HIV-1 and hepatitis B virus: time for a re-think?
Topics: Acute Disease; Adult; Aged; Anti-HIV Agents; Drug Resistance, Viral; Female; Hepatitis B; HIV Infections; HIV-1; Humans; Lamivudine; Male | 2004 |
Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation.
Topics: Antiviral Agents; Costs and Cost Analysis; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins, Intravenous; Italy; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 2004 |
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation.
Topics: Antiviral Agents; Cost-Benefit Analysis; Hepatitis B; Hepatitis B Antibodies; Humans; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence | 2004 |
Lamivudine-resistant hepatitis B virus and ongoing lamivudine therapy: stop the merry-go-round, it's time to get off!
Topics: Amino Acid Motifs; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase | 2004 |
Long-term follow-up of HIV/HBV coinfected patients from a Greek center.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Follow-Up Studies; Greece; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Reverse Transcriptase Inhibitors | 2004 |
Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis.
Topics: Adult; Antiviral Agents; Chemoprevention; Cohort Studies; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Survival Analysis; Treatment Outcome | 2004 |
Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Lymphoma, Non-Hodgkin; Rituximab; Serologic Tests; Virus Activation | 2004 |
Prospective study on lamivudine-resistant hepatitis B in renal allograft recipients.
Topics: Adult; Aged; Alanine Transaminase; Amino Acid Motifs; Codon; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Time Factors | 2004 |
Immune reconstitution hepatitis in HIV and hepatitis B coinfection, despite lamivudine therapy as part of HAART.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Female; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Immunity; Lamivudine; Middle Aged | 2004 |
Hepatitis B.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Remission Induction; Survival Rate; Viral Load | 2004 |
Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNA.
Topics: Blood; Carrier State; Desiccation; DNA, Viral; Genetic Variation; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors | 2004 |
Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment.
Topics: Adult; Antiviral Agents; Brain Death; Cadaver; Female; Hepatitis B; Hepatitis B Antigens; Histocompatibility Testing; Humans; Kidney Transplantation; Lamivudine; Liver; Male; Tissue Donors | 2004 |
Management of the coinfected patient: human immunodeficiency virus/hepatitis B and human immunodeficiency virus/hepatitis C.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chronic Disease; Contraindications; Hepatitis B; Hepatitis C; HIV Infections; Humans; Lamivudine; Liver Diseases; Nucleosides; Practice Guidelines as Topic | 2004 |
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
Topics: Adenine; Adult; Antiviral Agents; Cell Line; DNA-Directed DNA Polymerase; DNA, Viral; Dose-Response Relationship, Drug; Drug Resistance, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Middle Aged; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Transfection; Virus Replication | 2004 |
A novel pattern (sW195a) in surface gene of HBV DNA due to YSDD (L180M plus M204S) mutation selected during lamivudine therapy and successful treatment with adefovir dipivoxil.
Topics: Adenine; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation, Missense; Organophosphonates | 2004 |
Comparison of sequence analysis and a novel discriminatory real-time PCR assay for detection and quantification of Lamivudine-resistant hepatitis B virus strains.
Topics: Base Sequence; Computer Systems; DNA Primers; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Longitudinal Studies; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viral Load | 2004 |
Frequency of hepatitis B virus mutant in asymptomatic hepatitis B virus carriers receiving prophylactic lamivudine during chemotherapy for hematologic malignancies.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; DNA, Viral; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Mutation | 2004 |
Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
Topics: Adenine; Administration, Oral; Amino Acid Motifs; Amino Acid Substitution; Animals; Antiviral Agents; Disease Models, Animal; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Virus, Woodchuck; Lamivudine; Marmota; Mutation, Missense; Organophosphonates; Protein Structure, Tertiary; Viremia; Virus Replication | 2004 |
Adefovir dipivoxil to prevent exacerbation of lamivudine-resistant hepatitis B infection during chemotherapy for non-Hodgkin's lymphoma.
Topics: Adenine; Adult; Antiviral Agents; Carrier State; Drug Resistance; Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Organophosphonates; Reverse Transcriptase Inhibitors | 2004 |
Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection.
Topics: Adolescent; Adult; Amino Acid Motifs; Chronic Disease; Female; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Oligonucleotide Array Sequence Analysis; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Sequence Analysis, DNA | 2004 |
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.
Topics: Adult; Amino Acid Substitution; Antiviral Agents; Capsid Proteins; Cell Line, Tumor; Cells, Cultured; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Genotype; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Phenotype; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Treatment Failure; Virus Replication | 2004 |
Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
Topics: Adult; Alanine Transaminase; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Cyclophosphamide; DNA-Directed DNA Polymerase; DNA, Viral; Doxorubicin; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, B-Cell; Male; Mutation; Prednisone; Recurrence; Reverse Transcriptase Inhibitors; Rituximab; Sequence Analysis, DNA; Vincristine; Virus Activation | 2004 |
The use of lamivudine for patients with acute hepatitis B (a series of cases).
Topics: Acute Disease; Adult; Aged; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Renal Dialysis; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome | 2004 |
Long-term follow-up study of Chinese patients with YMDD mutations: significance of hepatitis B virus genotypes and characteristics of biochemical flares.
Topics: Adolescent; Adult; Amino Acid Sequence; Amino Acid Substitution; DNA, Viral; Female; Follow-Up Studies; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Recurrence; RNA-Directed DNA Polymerase | 2004 |
Oligonucleotide chip for detection of Lamivudine-resistant hepatitis B virus.
Topics: DNA Primers; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutagenesis, Site-Directed; Oligonucleotide Array Sequence Analysis; Oligonucleotide Probes; Sensitivity and Specificity | 2004 |
Treatment of an HBs-Ag positive stem cell donor with lamivudine to prevent the development of hepatitis B in the recipient.
Topics: Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Leukemia, Myeloid, Acute; Male; Middle Aged; Reverse Transcriptase Inhibitors; Stem Cell Transplantation; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 2004 |
Pyrosequencing for detection of lamivudine-resistant hepatitis B virus.
Topics: Base Sequence; Diphosphates; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA | 2004 |
Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade.
Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Graft Survival; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Organophosphonates; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome | 2004 |
Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant.
Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Drug Resistance, Viral; Enzyme-Linked Immunosorbent Assay; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Recurrence | 2004 |
Tenofovir therapy for lamivudine resistance following liver transplantation.
Topics: Adenine; Adult; Antiviral Agents; Chronic Disease; Drug Resistance, Viral; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Organophosphonates; Retrospective Studies; Salvage Therapy; Tenofovir; Treatment Outcome | 2004 |
Adefovir dipivoxil as the rescue therapy for lamivudine-resistant hepatitis B post liver transplant.
Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Resistance; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Retrospective Studies | 2004 |
Heart transplantation using donors positive for hepatitis.
Topics: Adolescent; Adult; Antiviral Agents; Brain Death; Cause of Death; Child; Child, Preschool; Female; Heart Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Humans; Infant; Lamivudine; Male; Middle Aged; Retrospective Studies; Tissue Donors | 2004 |
Adefovir dipivoxil for treatment of breakthrough hepatitis caused by lamivudine-resistant mutants of hepatitis B virus.
Topics: Adenine; Adult; Alanine Transaminase; Drug Resistance, Microbial; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Organophosphonates; Safety; Treatment Outcome | 2004 |
Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Breast Neoplasms; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Middle Aged; Molecular Sequence Data; Monitoring, Physiologic; Primary Prevention; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Risk Assessment; Secondary Prevention; Serologic Tests; Treatment Outcome | 2004 |
Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chi-Square Distribution; DNA, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Statistics, Nonparametric; Treatment Outcome | 2004 |
Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Chronic Disease; DNA-Directed DNA Polymerase; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load | 2004 |
Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection.
Topics: Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Male; Reverse Transcriptase Inhibitors | 2004 |
Treatment of polyarteritis nodosa: comment on the article by Guillevin et al.
Topics: Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Hepatitis B; Humans; Lamivudine; Plasma Exchange; Polyarteritis Nodosa; Reverse Transcriptase Inhibitors | 2004 |
Prevention of hepatitis B virus recurrence after living donor liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Living Donors; Preoperative Care; Recurrence; Retrospective Studies; RNA, Viral; Viral Load | 2004 |
Adefovir treatment in posttransplant hepatitis B virus infection resistant to lamivudine plus hepatitis B virus immunoglobulin.
Topics: Adenine; Adult; Antibodies, Viral; Antiviral Agents; Drug Resistance; Female; Hepatitis B; Hepatitis B Antibodies; Humans; Lamivudine; Living Donors; Male; Middle Aged; Organophosphonates; Recurrence | 2004 |
Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans.
Topics: Adult; Blood Cell Count; Case-Control Studies; CD8-Positive T-Lymphocytes; Cross Infection; Dendritic Cells; Female; Hepatitis B; Humans; Immunity, Innate; Immunocompromised Host; Interferon-alpha; Killer Cells, Natural; Lamivudine; Leukocytes, Mononuclear; Liver Cirrhosis; Male; Middle Aged; Virus Replication | 2004 |
Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carrier State; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Japan; Lamivudine; Liver; Male; Middle Aged; Prevalence; Reverse Transcriptase Inhibitors; Virus Activation | 2005 |
[Effect of lamivudine for hepatitis B virus reactivation in blood cancer patients undergoing immunosuppressive chemotherapy].
Topics: Adult; Aged; Antineoplastic Agents; Antiviral Agents; Bone Marrow Transplantation; Female; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Virus Activation | 2004 |
No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
Topics: Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Prospective Studies; Recurrence | 2005 |
Hepatitis B virus reactivation and alemtuzumab therapy.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation | 2005 |
Rhabdomyolysis due to Lamivudine administration in a liver transplant recipient.
Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Rhabdomyolysis | 2005 |
Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft.
Topics: Adult; Azathioprine; Caroli Disease; Cyclosporine; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunosuppressive Agents; Infant, Newborn; Lamivudine; Liver; Liver Transplantation; Male; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Reverse Transcriptase Inhibitors | 2005 |
Quantification of the relative levels of wild-type and lamivudine-resistant mutant virus in serum of HBV-infected patients using microarray.
Topics: Base Sequence; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Molecular Sequence Data; Mutation; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Sensitivity and Specificity; Treatment Outcome; Viral Load | 2005 |
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence.
Topics: Adult; Antiviral Agents; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Viral Load | 2005 |
Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hospitals, Urban; Humans; Interferons; Japan; Lamivudine; Longitudinal Studies; Male; Middle Aged; Risk Factors; Sexual Behavior | 2005 |
[HBV-specific CD8+ T cells for sustained HBeAg seroconversion after lamivudine therapy].
Topics: Adult; Antiviral Agents; CD8-Positive T-Lymphocytes; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Recurrence; Viral Load | 2005 |
Survival of infantile fulminant hepatitis B and treatment with Lamivudine.
Topics: Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Infant; Lamivudine; Liver Failure; Male; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome | 2005 |
Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy.
Topics: Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Interferon-alpha; Lamivudine; Mice; Mice, Transgenic; Pregnancy; Pregnancy Complications, Infectious; Viremia | 2005 |
Lamivudine prophylaxis in HBV carriers with haemato-oncological malignancies who receive chemotherapy.
Topics: Antiviral Agents; Carrier State; Hematologic Neoplasms; Hepatitis B; Humans; Lamivudine; Time Factors; Virus Activation | 2005 |
Treatment with adefovir dipivoxil in a renal transplant patient with renal insufficiency and lamivudine-resistant hepatitis B infection.
Topics: Adenine; Antiviral Agents; Creatinine; Drug Resistance, Viral; Follow-Up Studies; Hepatitis B; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Male; Middle Aged; Organophosphonates; Treatment Outcome | 2005 |
Adefovir dipivoxil therapy in liver transplant recipients with lamivudine-resistant hepatitis B virus.
Topics: Adenine; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunosuppression Therapy; Lamivudine; Liver Transplantation; Middle Aged; Organophosphonates; Retrospective Studies; Viral Load | 2005 |
Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Survival Rate; Treatment Outcome | 2005 |
Prevalence, incidence, and clinical relevance of the reverse transcriptase V207I mutation outside the YMDD motif of the hepatitis B virus polymerase during lamivudine therapy.
Topics: Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Polyethylene Glycols; Recombinant Proteins; RNA-Directed DNA Polymerase | 2005 |
Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation.
Topics: Adult; Aged; Antiviral Agents; Chemoprevention; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Pancreas Transplantation | 2005 |
Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients.
Topics: Acute Disease; Adult; Anti-HIV Agents; Fatal Outcome; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Leukemia, Myeloid; Liver Failure, Acute; Lymphoma, Non-Hodgkin; Male | 2005 |
HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy.
Topics: Adult; Aged; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Virus Replication | 2005 |
[Study on efficacy and safety of lamivudine and interferon-alpha in treatment of hepatitis B virus transgenic mice with pregnancy].
Topics: Animals; Antiviral Agents; Disease Models, Animal; Drug Administration Routes; Female; Hepatitis B; Hepatitis B virus; Interferon-alpha; Lamivudine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pregnancy; Pregnancy Complications, Infectious; Random Allocation; Viral Load | 2005 |
Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.
Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Waiting Lists | 2005 |
Simultaneous detection of two major lamivudine-resistant mutants using competitively differentiated-PCR.
Topics: Antiviral Agents; DNA Primers; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors | 2005 |
[Efficacy and safety of adefovir dipivoxil in patients with decompensated liver cirrhosis with Lamivudine resistance compared to patients with compensated liver disease].
Topics: Adenine; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Organophosphonates | 2005 |
Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?
Topics: Antineoplastic Agents; Antiviral Agents; Breast Neoplasms; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine | 2005 |
Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker.
Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Aspartate Aminotransferases; Biomarkers; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; HIV Infections; Humans; Lamivudine; Male; Recurrence | 2005 |
Hepatitis B reactivation after withdrawal of pre-emptive lamivudine in patients with haematological malignancy on completion of cytotoxic chemotherapy.
Topics: Adult; Aged; Antineoplastic Agents; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Male; Middle Aged; Virus Activation | 2005 |
Mutations outside the YMDD motif in the P protein can also cause DHBV resistant to Lamivudine.
Topics: Amino Acid Sequence; Animals; Chick Embryo; Disease Models, Animal; Drug Resistance, Viral; Ducks; Gene Products, pol; Hepatitis B; Hepatitis B virus; Lamivudine; Molecular Sequence Data; Reverse Transcriptase Inhibitors | 2005 |
Lamivudine treatment in a patient with hepatitis B virus reactivation after allogenic peripheral bone marrow transplantation.
Topics: Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; DNA Replication; Female; Graft vs Host Disease; Hepatitis B; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Liver; Middle Aged; Mutation | 2005 |
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations.
Topics: Aged; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Fatal Outcome; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Lymphoma, B-Cell; Male; Prednisone; Rituximab; Vincristine; Virus Activation | 2005 |
[SNaPshot technique for detection of single-nucleotide polymorphisms (SNPs) in HBV polymerase gene region of HBV gene].
Topics: Antiviral Agents; Base Sequence; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Hepatitis B; Humans; Lamivudine; Polymorphism, Single Nucleotide; Sequence Analysis, DNA | 2005 |
High replicative full-length lamivudine-resistant hepatitis B virus isolated during acute exacerbations.
Topics: Amino Acid Substitution; Antiviral Agents; Cell Line; Drug Resistance, Viral; Female; Gene Expression; Genes, Viral; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Mutation; Viral Load; Virus Replication | 2005 |
[Adefovir dipivoxil-a new effective treatment for chronic infection with hepatitits B virus.].
Topics: Antiviral Agents; Drug Interactions; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Herpesvirus 1, Cercopithecine; Humans; Lamivudine; Treatment Outcome | 2005 |
Lamivudine therapy for hepatitis B infection in post-renal transplant patients: results after 36 months follow-up.
Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged | 2005 |
Dual-probe assay for detection of lamivudine-resistance hepatitis B virus by real-time PCR.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA | 2006 |
Liver targeting of hepatitis-B antiviral lamivudine using the HepDirect prodrug technology.
Topics: Animals; Antiviral Agents; Area Under Curve; Cells, Cultured; Hepatitis B; Hepatocytes; Humans; Kinetics; Lamivudine; Liver; Microsomes, Liver; Models, Chemical; Phosphates; Phosphorylation; Prodrugs; Rats; Time Factors | 2005 |
Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus.
Topics: Animals; Cell Line, Tumor; Chimera; DNA, Viral; Genetic Engineering; Hepatitis B; Hepatitis B virus; Hepatocytes; Histocytochemistry; Humans; Lamivudine; Liver; Mice; Mutation; Time Factors; Viremia | 2005 |
Rapid and accurate genotyping of YMDD motif variants in the hepatitis B virus genome by an improved reverse dot blot method.
Topics: Amino Acid Motifs; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Nucleic Acid Hybridization; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2005 |
Mass needle stick injury in children from the Western cape.
Topics: Adolescent; Anti-HIV Agents; Child; Child, Preschool; Communicable Disease Control; Environmental Exposure; Hepatitis B; Hepatitis B Vaccines; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Medical Waste; Needlestick Injuries; South Africa; Treatment Outcome; Zidovudine | 2006 |
Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H.
Topics: Adenine; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Organophosphonates; Recurrence; Treatment Outcome | 2006 |
Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.
Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prospective Studies | 2005 |
Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
Topics: Adolescent; Adult; Antiviral Agents; Combined Modality Therapy; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged | 2005 |
Long-term lamivudine therapy is not reasonable for HBV-associated nephropathy.
Topics: Drug Resistance; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Nephrosis; Secondary Prevention; Time Factors | 2006 |
Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico.
Topics: Codon; DNA, Viral; Drug Resistance, Viral; Gene Amplification; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Mexico; Reverse Transcriptase Inhibitors | 2006 |
Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients.
Topics: Adult; Amino Acid Substitution; Antiretroviral Therapy, Highly Active; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Sequence Analysis, DNA | 2005 |
Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus.
Topics: Adenine; Alanine Transaminase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Lamivudine; Liver Transplantation; Male; Organophosphonates; Recurrence; Retrospective Studies; Safety | 2005 |
Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?
Topics: Adult; Female; Graft Survival; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Kidney Transplantation; Lamivudine; Male; Reverse Transcriptase Inhibitors; Virus Activation | 2006 |
Wild type and YMDD variant of hepatitis B virus: no difference in viral kinetics on lamivudine/tenofovir therapy in HIV-HBV co-infected patients.
Topics: Adenine; Adult; Anti-HIV Agents; DNA, Viral; Drug Resistance, Viral; Genetic Variation; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Kinetics; Lamivudine; Male; Middle Aged; Organophosphonates; RNA, Viral; Tenofovir | 2006 |
Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants.
Topics: Adult; Aged; Amino Acid Substitution; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Japan; Lamivudine; Male; Middle Aged; Mutation, Missense; RNA-Directed DNA Polymerase; Sequence Analysis, DNA; Viral Load | 2006 |
Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance.
Topics: Adult; Aged; Cohort Studies; DNA, Viral; Drug Resistance; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Predictive Value of Tests; Probability; Prognosis; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Statistics, Nonparametric; Viral Core Proteins | 2006 |
A case of emphysematous pyelonephritis in a renal allograft.
Topics: Abscess; Antiviral Agents; Fatal Outcome; Hepatitis B; Humans; Kidney Transplantation; Lamivudine; Liver Failure, Acute; Male; Middle Aged; Pyelonephritis | 2006 |
Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation.
Topics: Adenine; Adult; Antineoplastic Agents; Combined Modality Therapy; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Leukemia, Myeloid, Acute; Organophosphonates; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Viral Load; Virus Activation | 2006 |
[The safety and effect of lamivudine in treating pregnant women infected with hepatitis B virus].
Topics: Adult; Female; Hepatitis B; Humans; Lamivudine; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors | 2006 |
YMDD mutations and genotypes of hepatitis B virus in northern China.
Topics: Antiviral Agents; China; DNA Mutational Analysis; Genes, Viral; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors | 2006 |
Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Treatment Outcome | 2006 |
Hepatitis B-related polyarteritis nodosa presenting necrotizing vasculitis in the hepatobiliary system successfully treated with lamivudine, plasmapheresis and glucocorticoid.
Topics: Antiviral Agents; Cholecystitis; Gallbladder Diseases; Glucocorticoids; Hepatitis B; Humans; Lamivudine; Liver Diseases; Male; Middle Aged; Plasmapheresis; Polyarteritis Nodosa | 2006 |
Long-term lamivudine therapy in hepatitis B-associated membranous nephropathy?
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Glomerulonephritis, Membranous; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Remission Induction; Time Factors | 2006 |
Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Polymerase Chain Reaction; Recurrence; Retrospective Studies | 2006 |
Prophylactic use of low-dose, on-demand, intramuscular hepatitis B immunoglobulin and lamivudine after liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Drug Administration Schedule; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Failure; Liver Transplantation; Recurrence; Retrospective Studies; Time Factors | 2006 |
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Drug Resistance, Viral; Genes, pol; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Immune Tolerance; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viral Envelope Proteins; Viral Load; Viremia | 2006 |
Lamivudine for nephrotic syndrome related to hepatitis B virus (HBV) infection.
Topics: Biopsy; Diagnosis, Differential; DNA, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Nephrotic Syndrome; Reverse Transcriptase Inhibitors | 2006 |
Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal.
Topics: Bone Marrow Transplantation; Fatal Outcome; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Multiple Myeloma; Renal Insufficiency; Reverse Transcriptase Inhibitors; Sepsis; Virus Activation | 2006 |
HBV genotypes and antiviral-resistant variants in HBV infected subjects in Northern Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Italy; Lamivudine; Male; Middle Aged; Sequence Analysis, DNA | 2006 |
Case report of lamivudine-resistant hepatitis B virus infection post liver transplantation from a hepatitis B core antibody donor.
Topics: Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Middle Aged; Tissue Donors | 2006 |
Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis.
Topics: Adenine; Adult; Aged; Antiviral Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Health Care Costs; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Markov Chains; Middle Aged; Organophosphonates; Recurrence | 2006 |
Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation.
Topics: Adolescent; Adult; Aged; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Lung Transplantation; Middle Aged; Reverse Transcriptase Inhibitors | 2006 |
[Relationship between Shenzhen HBV genotype and precore/core promoter mutation and antiviral effects].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; DNA, Viral; Female; Genotype; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Mutation; Promoter Regions, Genetic; Treatment Outcome; Viral Core Proteins; Young Adult | 2006 |
[Development of acute type, CD 8 positive adult T-cell leukemia in a carrier of hepatitis B virus--possible therapeutic effect of lamivudine combined with chemotherapy].
Topics: Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carrier State; CD8-Positive T-Lymphocytes; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hepatitis B; HTLV-I Antibodies; Humans; Irinotecan; Lamivudine; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mitoxantrone; Nitrosourea Compounds; Pentostatin; Prednisone; Vincristine | 2006 |
Lamivudine-resistant hepatitis B virus infection post-liver transplantation from a hepatitis B core antibody donor.
Topics: Disease Transmission, Infectious; Drug Resistance, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Tissue Donors | 2006 |
[Hepatitis B virus reactivation after cessation of prophylaxis with lamivudine in a patient with non-Hodgkins lymphoma treated with chemotherapy and rituximab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Female; Hepatitis B; Hepatitis B Antigens; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Rituximab; Virus Activation | 2006 |
[Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
Topics: Antiviral Agents; Combined Modality Therapy; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Lamivudine; Liver Transplantation; Male; Prospective Studies; Risk Factors; Secondary Prevention; Time Factors | 2006 |
Performance of sequence analysis, INNO-LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations.
Topics: DNA Probes; DNA, Viral; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Lamivudine; Mutation; Promoter Regions, Genetic; Protein Precursors; Reagent Kits, Diagnostic; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sequence Analysis, DNA | 2006 |
Duration of lamivudine prophylaxis in inactive hepatitis B virus carriers with haemato/oncological malignancies who receive chemotherapy.
Topics: Antineoplastic Agents; Antiviral Agents; Drug Administration Schedule; Hematologic Neoplasms; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Virus Activation | 2006 |
Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
Topics: Antitubercular Agents; Antiviral Agents; Drug Therapy, Combination; Hepatitis B; Humans; Isoniazid; Lamivudine; Male; Middle Aged; Rifampin; Tuberculosis, Pulmonary | 2006 |
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.
Topics: Adenine; Adult; Disease Progression; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Gene Products, pol; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Virus Replication | 2006 |
Efficient treatment of crescentric glomerulonephritis associated with hepatitis B virus with lamivudin in a case referred with acute renal failure.
Topics: Acute Kidney Injury; Adult; Female; Glomerulonephritis; Hepatitis B; Humans; Lamivudine; Reverse Transcriptase Inhibitors | 2006 |
Hepatitis B-related membranous nephropathy should be treated with a specific anti-viral agent.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Resistance, Viral; Glomerulonephritis, Membranous; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Remission Induction; Secondary Prevention; Time Factors; Treatment Outcome | 2006 |
Intramuscular hepatitis B immune globulin combined with lamivudine in prevention of hepatitis B recurrence after liver transplantation.
Topics: Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; Hepatitis B; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Male; Middle Aged; Secondary Prevention; Survival Rate | 2006 |
Extended double-dosage HBV vaccination after liver transplantation is ineffective, in the absence of lamivudine and prior wash-out of human Hepatitis B immunoglobulins.
Topics: Adult; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Vaccines; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors | 2006 |
Reactivation of hepatitis B virus in rheumatologic patients receiving immunosuppressive agents.
Topics: DNA, Viral; Fatal Outcome; Female; Hepatitis Antibodies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Lamivudine; Liver Function Tests; Male; Middle Aged; Reverse Transcriptase Inhibitors; Rheumatic Diseases; Treatment Outcome; Virus Activation | 2006 |
Therapy with lamivudine and steroids in a patient with acute hepatitis B and rapidly progressive glomerulonephritis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Female; Follow-Up Studies; Glomerulonephritis; Glucocorticoids; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Hypertension; Kidney Glomerulus; Kidney Tubules, Proximal; Lamivudine; Methylprednisolone; Prednisone; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome | 2006 |
Prevention of mortality from hepatitis B and hepatitis C.
Topics: Carcinoma, Hepatocellular; Female; Hepatitis B; Hepatitis C, Chronic; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Liver Cirrhosis; Liver Neoplasms | 2006 |
Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis.
Topics: Adult; Carcinoma, Hepatocellular; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C Antibodies; HIV Infections; Humans; Lamivudine; Liver Neoplasms; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Survival Analysis | 2006 |
Outcomes of hepatitis B virus recurrence after liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Liver Transplantation; Recurrence; Retrospective Studies; Time Factors | 2006 |
Successful treatment of hepatitis B virus infection with Lamivudine after heart transplantation.
Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Heart Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 2006 |
Detection of YMDD mutation using mutant-specific primers in chronic hepatitis B patients before and after lamivudine treatment.
Topics: Amino Acid Motifs; Antiviral Agents; Cloning, Molecular; DNA Primers; Genes, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Viral Proteins | 2006 |
Severe reactivation of hepatitis B virus infection in a patient with hairy cell leukemia: Should lamivudine prophylaxis be recommended to HBsAg-negative, anti-HBc-positive patients?
Topics: Aged; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Hairy Cell; Male; Virus Activation | 2006 |
Beneficial effects of short-term lamivudine treatment for de novo hepatitis B virus reactivation after liver transplantation.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Recurrence; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome | 2006 |
Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.
Topics: DNA, Viral; Female; Follow-Up Studies; Heart Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome | 2006 |
Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Chemoprevention; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Outcome; Virus Activation | 2006 |
Patterns of hepatitis B virus infection in Brazilian human immunodeficiency virus infected patients: high prevalence of occult infection and low frequency of lamivudine resistant mutations.
Topics: Adult; Anti-HIV Agents; Brazil; DNA, Viral; Drug Resistance, Viral; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Polymerase Chain Reaction; Risk Factors; Viral Load | 2006 |
Hepatitis B immunoglobulin in combination with lamivudine for prevention of hepatitis B virus reactivation in children undergoing bone marrow transplantation.
Topics: beta-Thalassemia; Bone Marrow Transplantation; Child; Child, Preschool; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunologic Factors; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Reverse Transcriptase Inhibitors; Secondary Prevention; Transplantation, Homologous; Virus Activation | 2006 |
Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir.
Topics: Cell Line; DNA-Directed DNA Polymerase; DNA, Viral; Drug Synergism; Drug Therapy, Combination; Guanine; Hepacivirus; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mycophenolic Acid; Ribavirin; RNA-Directed DNA Polymerase | 2007 |
Treatment of lamivudine-resistant hepatitis B infection in post-renal transplant patients with adefovir dipivoxil: preliminary results.
Topics: Adenine; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B Core Antigens; Humans; Kidney; Kidney Transplantation; Lamivudine; Middle Aged; Organophosphonates; Postoperative Complications | 2006 |
Lamivudine reverses severe acute hepatitis B and pancytopenia after renal transplantation: a case report.
Topics: Adult; Female; Hepatitis B; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Liver Function Tests; Pancytopenia; Treatment Outcome | 2006 |
Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations.
Topics: Adenine; Amino Acid Motifs; Aspartic Acid; Cryoglobulinemia; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Methionine; Middle Aged; Mutation; Organophosphonates; Recurrence; Tyrosine; Vasculitis | 2006 |
[Hepatitis B and C virus infection and liver dysfunction in patients receiving chemotherapy].
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Chemical and Drug Induced Liver Injury; Female; Hepatitis B; Hepatitis C; Humans; Lamivudine; Liver Diseases; Male; Middle Aged; Neoplasms; Prevalence | 2006 |
Aminotransferase elevation in HIV/hepatitis B virus co-infected patients treated with two active hepatitis B virus drugs.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; DNA, Viral; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Tenofovir; Transaminases | 2006 |
Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Famciclovir; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Virus Activation | 2007 |
Successful treatment of hepatitis B-associated leukocytoclastic vasculitis with lamivudine treatment in a child patient.
Topics: Antiviral Agents; Blood Vessels; Child; Drug Administration Schedule; Female; Hepatitis B; Humans; Lamivudine; Liver; Reverse Transcriptase Inhibitors; Treatment Outcome; Turkey; Vasculitis, Leukocytoclastic, Cutaneous | 2007 |
Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan.
Topics: Acute Disease; Adolescent; Adult; Aged; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Japan; Lamivudine; Male; Middle Aged; Mutation; Odds Ratio; Reverse Transcriptase Inhibitors; Species Specificity; Viral Proteins | 2007 |
Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation.
Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Agents; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Recurrence; Retrospective Studies; Risk Factors | 2007 |
Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B.
Topics: Adenine; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Humans; Kidney Diseases; Lamivudine; Liver Transplantation; Organophosphonates; Secondary Prevention; Tenofovir | 2007 |
Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.
Topics: Adult; Aged; Drug Administration Schedule; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Lamivudine; Liver; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome; Virus Activation | 2007 |
Real-time PCR detection of multiple lamivudine-resistant mutations with displacing probes in a single tube.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA; Serum; Statistics as Topic | 2007 |
A homosexual Japanese man with acute hepatitis due to hepatitis B virus genotype ae, concurrent with amebic colitis.
Topics: Acute Disease; Adult; Antiprotozoal Agents; Asian People; Dysentery, Amebic; Genotype; Hepatitis B; Hepatitis B virus; Homosexuality, Male; Humans; Lamivudine; Male; Metronidazole; Reverse Transcriptase Inhibitors | 2007 |
Fatal liver failure caused by reactivation of lamivudine-resistant hepatitis B virus: a case report.
Topics: Amino Acid Sequence; Antiviral Agents; Drug Resistance, Viral; Fatal Outcome; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Molecular Sequence Data; Mutation | 2007 |
Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Virus Activation | 2007 |
Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; DNA, Viral; Glioblastoma; Hepatitis B; Humans; Immunocompromised Host; Immunosuppression Therapy; Lamivudine; Liver; Male; Middle Aged; Patient Selection; Reverse Transcriptase Inhibitors; Risk Factors; Spinal Neoplasms; Temozolomide; Treatment Outcome; Viral Load; Virus Activation | 2007 |
A prophylactic approach for bone marrow transplantation from a hepatitis B surface antigen-positive donor.
Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Tissue Donors; Viral Load | 2007 |
Changes in serologic markers of hepatitis B following autologous hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Biomarkers; DNA, Viral; Endemic Diseases; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Immunocompromised Host; Korea; Lamivudine; Male; Middle Aged; Retrospective Studies; Serologic Tests; Transplantation, Autologous | 2007 |
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.
Topics: Adult; Aged; Antiviral Agents; Australia; Disease-Free Survival; DNA, Viral; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Kaplan-Meier Estimate; Lamivudine; Liver Diseases; Liver Transplantation; Male; Middle Aged; New Zealand; Postoperative Complications; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Secondary Prevention; Time Factors; Treatment Outcome | 2007 |
Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin.
Topics: Adenine; Adult; Aged; Antibodies, Viral; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Retrospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome | 2007 |
Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.
Topics: Adenine; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure | 2007 |
Mutation analysis of lamivudine resistant hepatitis B virus strains by TaqMan PCR.
Topics: Antiviral Agents; DNA Mutational Analysis; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Microbial Sensitivity Tests; Mutation, Missense; Oligonucleotide Probes; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sensitivity and Specificity | 2007 |
Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
Topics: Antiviral Agents; Cell Line; Cell Survival; DNA Primers; Down-Regulation; Gene Expression Regulation, Viral; Genes, Viral; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Image Processing, Computer-Assisted; Lamivudine; Oligonucleotide Array Sequence Analysis; Oligonucleotides, Antisense; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection | 2008 |
Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Replication; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Neoplasms; RNA, Messenger; RNA, Small Interfering; RNA, Viral; Transfection; Virus Replication | 2007 |
[Clinical case of the month. Hepatitis B reactivation in an Ag HBs negative patient].
Topics: Adrenal Cortex Hormones; Aged; Glomerulonephritis; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Male; Reverse Transcriptase Inhibitors; Treatment Outcome; Virus Activation | 2007 |
Rapid emergence of a viral resistant mutant in WHV chronically infected woodchucks treated with lamivudine and a pre-S/S CHO-derived hepatitis B virus vaccine.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B Vaccines; Hepatitis B Virus, Woodchuck; Inflammation; Kinetics; Lamivudine; Liver; Marmota; Monocytes; Mutation; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Vaccination | 2007 |
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment.
Topics: Adenine; Adult; Aged; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Nucleosides; Nucleotides; Organophosphonates; Reverse Transcriptase Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Viremia | 2007 |
Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
Topics: Adult; Antiviral Agents; Blood Donors; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Population Surveillance; Time Factors; Transplantation, Homologous; Virus Activation | 2007 |
Living donor liver transplantation from hepatitis B core antibody positive donors.
Topics: Hepatitis B; Hepatitis B Core Antigens; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Living Donors; Patient Selection; Prevalence; Retrospective Studies; Reverse Transcriptase Inhibitors; Turkey | 2007 |
Lack of hepatotoxicity upon sirolimus addition to a calcineurin inhibitor-based regimen in hepatitis virus-positive renal transplant recipients.
Topics: Adult; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver; Male; Middle Aged; Monitoring, Immunologic; Mycophenolic Acid; Retrospective Studies; Sirolimus; Tacrolimus | 2007 |
Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen.
Topics: Adult; China; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Analysis | 2007 |
The HBV drug entecavir - effects on HIV-1 replication and resistance.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Drug Resistance, Viral; Guanine; Hepatitis B; Hepatitis B virus; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Male; Middle Aged; Mutation; Phylogeny; Reverse Transcriptase Inhibitors; Reverse Transcription; RNA, Viral; Virus Replication; Zidovudine | 2007 |
[Hepatitis B immunoglobulin treatment after liver transplantation--our experiences].
Topics: Antiviral Agents; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Secondary Prevention | 2007 |
The relationship of hepatitis B virus infection and non-Hodgkin's lymphoma and its impact on clinical characteristics and prognosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthracyclines; Drug Therapy, Combination; Female; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prevalence; Prognosis; Steroids; Survival Rate | 2007 |
[Clinical application of microarray technique to quantify the lamivudine-resistant gene mutant of hepatitis B virus].
Topics: Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Mutation; Oligonucleotide Array Sequence Analysis | 2007 |
Treating acute hepatitis B.
Topics: Acute Disease; Hepatitis B; Humans; Lamivudine; Reverse Transcriptase Inhibitors | 2007 |
Hepatitis B serological evaluation in diagnostic work up of lymphoma.
Topics: Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma; Reverse Transcriptase Inhibitors; Virus Activation | 2007 |
Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: a decision analysis model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cost-Benefit Analysis; Cyclophosphamide; Decision Support Techniques; Doxorubicin; Health Care Costs; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Lymphoma; Prednisolone; Treatment Outcome; Vincristine | 2007 |
Hepatitis B viral infection with nephrotic syndrome treated with lamivudine.
Topics: Child, Preschool; Hepatitis B; Humans; Lamivudine; Male; Nephrotic Syndrome; Reverse Transcriptase Inhibitors | 2007 |
Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
Topics: Adenine; Adult; Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biomarkers; Carrier State; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; London; Male; Organophosphonates; Prevalence; Tenofovir | 2007 |
Lamivudine resistance and exacerbation of hepatitis B in infliximab-treated Crohn's disease patient.
Topics: Adult; Antibodies, Monoclonal; Crohn Disease; Drug Resistance; Follow-Up Studies; Hepatitis B; Humans; Infliximab; Lamivudine; Male; Practice Guidelines as Topic; Virus Activation | 2007 |
[Hepatitis B associated polyarteriitis nodosa with cerebral vasculitis].
Topics: Anti-Inflammatory Agents; Antiviral Agents; Diagnosis, Differential; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunosuppressive Agents; Lamivudine; Male; Middle Aged; Polyarteritis Nodosa; Prednisolone; Reverse Transcriptase Inhibitors; Treatment Outcome; Vasculitis, Central Nervous System | 2007 |
[Relationship between hepatitis B virus YMDD mutation and serum viral DNA loadings].
Topics: Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Viral Load | 2007 |
Prophylaxis of hepatitis B recurrence in post-liver transplantation patients with lamivudine-resistant YMDD mutant.
Topics: Adenine; Adult; Aged; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Organophosphonates; Recurrence | 2007 |
Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.
Topics: Adolescent; Adult; Antiviral Agents; Child; Female; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Humans; Kidney Transplantation; Lamivudine; Liver; Liver Function Tests; Male; Middle Aged; Reverse Transcriptase Inhibitors; Survival Rate; Treatment Outcome | 2007 |
[Reactivation of hepatitis B virus due to rituximab plus CHOP after preemptive lamivudine administration in a patient with diffuse large B-cell lymphoma].
Topics: Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA, Viral; Doxorubicin; Female; Hepatitis B; Hepatitis B virus; Humans; Interferon-beta; Lamivudine; Lymphoma, B-Cell; Middle Aged; Prednisone; Rituximab; Vincristine; Virus Activation | 2007 |
[New German and American guidelines for therapy of hepatitis B. Discrepancies and similarities].
Topics: Adenine; Alanine Transaminase; Antiviral Agents; Biopsy; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Germany; Guanine; Hepatitis B; Humans; Lamivudine; Liver; Liver Cirrhosis; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Telbivudine; Thymidine; United States | 2007 |
[An analysis of long term prophylaxis of virus recurrence with antiviral treatment in HBV infected liver transplant recipient patients].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Period; Prognosis; Retrospective Studies; Secondary Prevention; Treatment Outcome; Young Adult | 2007 |
Development of a novel mouse model to evaluate drug candidates against hepatitis B virus.
Topics: Adenine; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Drug Evaluation, Preclinical; Hepatitis B; Hepatitis B virus; Lamivudine; Mice; Mice, Nude; Organophosphonates; Reproducibility of Results; Tenofovir | 2007 |
Successful treatment of an entecavir-resistant hepatitis B virus variant.
Topics: Adenine; Adult; Antiviral Agents; Drug Administration Schedule; Drug Resistance, Multiple, Viral; Female; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Organophosphonates; Viral Load | 2007 |
Prophylaxsis against recurrance of hepatitis B virus after liver transplantation: a retrospective analysis spanning 20 years.
Topics: Adenine; Adult; Antiviral Agents; Dose-Response Relationship, Drug; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Retrospective Studies; Secondary Prevention; Virginia | 2008 |
Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy.
Topics: Adult; Alanine Transaminase; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Aspartate Aminotransferases; Benzoxazines; CD4-Positive T-Lymphocytes; Cyclopropanes; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis C; HIV Infections; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Linear Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Stavudine; Zidovudine | 2007 |
Preoperative lamivudine therapy in HBV DNA positive recipients: is it always necessary?
Topics: Adult; DNA, Viral; Female; Hepatitis B; Humans; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Models, Statistical; Recurrence; Treatment Outcome | 2007 |
Prolonged hepatitis after acute infection with genotype H hepatitis B virus.
Topics: Acute Disease; Antiviral Agents; Genotype; Hepatitis B; Hepatitis B virus; Humans; Interferons; Lamivudine; Male; Middle Aged; Salvage Therapy; Treatment Failure | 2007 |
Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
Topics: Adenine; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Recurrence; Serologic Tests | 2007 |
[Diagnosis and therapy for attention-getting infections (discussion)].
Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Cause of Death; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Drug Resistance, Viral; Global Health; Hepatitis B; HIV Infections; Humans; Japan; Lamivudine; Measles; Practice Guidelines as Topic; Pseudomonas Infections; Reverse Transcriptase Inhibitors; Viral Vaccines | 2007 |
Clearance of chronic HCV infection during acute delta hepatitis.
Topics: Acute Disease; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Hepatitis B; Hepatitis C, Chronic; Hepatitis D; Humans; Lamivudine; Liver Function Tests; Male; Substance Abuse, Intravenous; Superinfection | 2009 |
The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.
Topics: Adult; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Follow-Up Studies; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Viral Proteins | 2007 |
Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B.
Topics: Analysis of Variance; Antiviral Agents; Carcinoma, Hepatocellular; Disease-Free Survival; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Neoplasm Staging; Postoperative Complications; Recurrence; Retrospective Studies; Survival Analysis; Survivors; Time Factors; Virus Diseases | 2007 |
Potency of tenofovir in chronic hepatitis B: mono or combination therapy?
Topics: Adenine; Antiviral Agents; Deoxycytidine; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis B, Chronic; Humans; Lamivudine; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Outcome; Viral Load | 2008 |
Matrix metalloproteinases and their tissue inhibitors in children with chronic hepatitis B treated with lamivudine.
Topics: Adolescent; Antiviral Agents; Biopsy; Child; Female; Fibrosis; Hepatitis B; Humans; Lamivudine; Liver; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; ROC Curve; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2007 |
[A 40-year-old female patient with seronegative autoimmune hepatitis following a newly acquired hepatitis B infection].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Autoimmunity; Biopsy; Female; Glucocorticoids; Hepatitis B; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Lamivudine; Liver; Prednisolone; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome | 2008 |
Prevention of hepatitis B recurrence after liver transplantation using lamivudine and hepatitis B immune globulin.
Topics: Adult; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Hepatitis B Antibodies; Humans; Immunologic Factors; Lamivudine; Liver Transplantation; Male; Retrospective Studies; Secondary Prevention; Treatment Outcome | 2007 |
The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Lymphoma; Male; Middle Aged; Recurrence; Rituximab; Salvage Therapy; Virus Activation | 2008 |
Efficacies of beta-L-D4A against Hepatitis B virus in 2.2.15 cells.
Topics: Antiviral Agents; Cell Line; Dideoxyadenosine; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Models, Chemical; Tetrazolium Salts; Thiazoles; Virus Replication | 2008 |
Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure.
Topics: Adenine; Amino Acid Sequence; DNA, Viral; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Molecular Sequence Data; Mutation; Organophosphonates; RNA-Directed DNA Polymerase; Treatment Failure | 2008 |
Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: a retrospective, multicenter, nonrandomized, open-label study.
Topics: Adenine; Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Multicenter Studies as Topic; Organophosphonates; Retrospective Studies; Time Factors; Treatment Outcome; Viral Load | 2008 |
Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response.
Topics: Antiviral Agents; DNA, Viral; Drug Monitoring; Drug Resistance, Viral; Genetic Predisposition to Disease; Genotype; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Longitudinal Studies; Mutation; Phenotype | 2008 |
Hepatitis B caused by a hepatitis B surface antigen escape mutant.
Topics: Aged; Amino Acid Substitution; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunity, Innate; Lamivudine; Male; Mutation; Sequence Analysis, Protein | 2008 |
[A study on mutations of the overlapping hepatitis B virus surface and polymerase gene in patients with HBV reinfection after liver transplantations].
Topics: Adult; Female; Gene Frequency; Genome, Viral; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Nested Genes; Recurrence | 2008 |
Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study.
Topics: Adenine; Adult; Aged; Cross-Sectional Studies; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates | 2008 |
Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: which method should be used?
Topics: Antiviral Agents; DNA, Viral; Drug Monitoring; Drug Resistance, Viral; Genetic Predisposition to Disease; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Nucleosides; Nucleotides; Phenotype | 2008 |
Determination of lamivudine-resistant variants of hepatitis B virus by denaturing gradient gel electrophoresis: a novel approach to monitoring drug resistance.
Topics: Amino Acid Motifs; Anti-HIV Agents; Automation; Base Sequence; Drug Resistance, Viral; Electrophoresis; Feasibility Studies; Gene Products, pol; Genome, Viral; Genotype; Hepatitis B; Humans; Lamivudine; Molecular Sequence Data; Mutation | 2008 |
Changes in serological markers of hepatitis B virus after renal transplantation.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B e Antigens; Humans; Kidney Transplantation; Lamivudine; Postoperative Complications; Prevalence; Retrospective Studies; Treatment Outcome | 2008 |
[Acute hepatitis B: is antiviral therapy indicated? Two case reports].
Topics: Acute Disease; Adenine; Adult; Algorithms; Antiviral Agents; Bilirubin; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Middle Aged; Organophosphonates; Prothrombin Time; Transaminases; Treatment Failure; Treatment Outcome | 2008 |
Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
Topics: Antiviral Agents; Clinical Trials as Topic; Epidemiologic Research Design; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferons; Lamivudine; Reverse Transcriptase Inhibitors; Treatment Outcome | 2008 |
Hepatitis B reactivation after lamivudine.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Prednisone; Recurrence; Virus Activation; Zalcitabine | 1995 |
A quarter-century of antiviral therapy.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis B; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Zalcitabine; Zidovudine | 1995 |
Viral dynamics in hepatitis B virus infection.
Topics: Alanine Transaminase; Antiviral Agents; Dose-Response Relationship, Drug; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; HIV Infections; Humans; Kinetics; Lamivudine; Models, Biological; Regression Analysis; Reverse Transcriptase Inhibitors; Time Factors; Viremia; Virus Replication; Zalcitabine | 1996 |
Lamivudine: a magic bullet for chronic hepatitis B?
Topics: Antiviral Agents; Chronic Disease; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Zalcitabine | 1996 |
In vitro evaluation of combination therapies against hepatitis B virus replication.
Topics: Acyclovir; Antiviral Agents; Drug Synergism; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B virus; Hepatoblastoma; Humans; Interferon-alpha; Lamivudine; Tumor Cells, Cultured; Virus Replication; Zalcitabine | 1996 |
Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.
Topics: Adult; Antiviral Agents; Base Sequence; Conserved Sequence; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Molecular Probes; Molecular Sequence Data; Mutation; Postoperative Complications; Recurrence; RNA, Viral; Viremia | 1996 |
Potential role of lamivudine (3TC) in the clearance of chronic hepatitis B virus infection in a patient coinfected with human immunodeficiency virus type.
Topics: Adult; Anti-HIV Agents; Chronic Disease; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male | 1996 |
Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
Topics: Adult; Antiviral Agents; Chronic Disease; DNA, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Core Antigens; Humans; Interferon-alpha; Lamivudine; Male; T-Lymphocytes, Helper-Inducer; Virus Replication | 1996 |
Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Virus Replication | 1996 |
Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation.
Topics: Adult; Female; Hepatitis B; Hepatitis, Chronic; Humans; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Male; Middle Aged; Neural Conduction; Pilot Projects; Treatment Outcome; Virus Replication | 1996 |
Clinical implications of lamivudine resistance by HBV.
Topics: Antiviral Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Immunocompetence; Lamivudine; Liver Failure; Liver Transplantation; Mutation | 1997 |
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.
Topics: Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Polymerase Chain Reaction; Recurrence | 1997 |
Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation.
Topics: Adult; Chronic Disease; Female; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence | 1997 |
Hepatitis B virus infection and liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B Vaccines; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Interferon-gamma; Lamivudine; Liver Transplantation; Patient Selection | 1997 |
Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns.
Topics: Adolescent; Adult; DNA Primers; Drug Resistance, Microbial; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunocompetence; Lamivudine; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors | 1997 |
Combination therapy for chronic hepatitis B.
Topics: Acyclovir; Animals; Antiviral Agents; Cells, Cultured; Chronic Disease; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Guanine; Hepatitis B; Hepatitis B Virus, Duck; Humans; Lamivudine; Liver; Virus Replication | 1997 |
[Lamivudine resistance impedes hepatitis B therapy].
Topics: Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors | 1997 |
[Preventive lamivudine against reinfection by hepatitis B after liver transplantation].
Topics: Follow-Up Studies; Hepatitis B; Hepatitis, Chronic; Humans; Lamivudine; Liver Transplantation; Postoperative Complications; Premedication; Recurrence; Reverse Transcriptase Inhibitors | 1997 |
The University of Toronto liver transplant program.
Topics: Adult; Alprostadil; Antiviral Agents; Child; Graft Survival; Hepatitis B; Hepatitis C; Hospitals, University; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Lamivudine; Liver Neoplasms; Liver Transplantation; Ontario; Patient Selection; Recurrence; Retrospective Studies; Ribavirin; Survival Rate; Transplantation, Heterologous | 1996 |
Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infection.
Topics: Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Reverse Transcriptase Inhibitors; Transplantation, Homologous | 1997 |
Lamivudine-stavudine-induced liver failure in hepatitis B cirrhosis.
Topics: Aged; Anti-HIV Agents; Ascites; Drug Combinations; Hepatitis B; Hepatitis, Chronic; HIV Infections; Humans; Jaundice; Lamivudine; Liver Cirrhosis; Liver Failure; Male; Reverse Transcriptase Inhibitors; Stavudine | 1997 |
Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine.
Topics: Antiviral Agents; Cholestasis, Intrahepatic; Diabetic Nephropathies; DNA, Viral; Graft Survival; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Liver; Liver Function Tests; Living Donors; Male; Middle Aged; Recurrence; Transplantation, Homologous; Virus Replication | 1997 |
Evaluation of anti-hepatitis B virus (HBV) drugs using the HBV transgenic mouse: application of the semiquantitative polymerase chain reaction (PCR) for serum HBV DNA to monitor the drug efficacy.
Topics: Adenine; Animals; Antiviral Agents; DNA Replication; DNA, Viral; Drug Monitoring; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Lamivudine; Liver; Mice; Mice, Transgenic; Polymerase Chain Reaction; Virion; Virus Replication | 1997 |
[Chronic HIV- and chronic HBV infection with hematuria and proteinuria].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Chronic Disease; Environmental Monitoring; Erythrocyte Count; Hazardous Substances; Hematuria; Hepatitis B; HIV-1; Humans; Lamivudine; Male; Occupational Exposure; Proteinuria; Zidovudine | 1998 |
Postliver transplant allograft reinfection with a lamivudine-resistant strain of hepatitis B virus: long-term follow-up.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Time Factors | 1998 |
[Prevention of hepatitis B--analysis of cost-effectiveness after liver transplantation].
Topics: 2-Aminopurine; Adult; Antiviral Agents; Cost-Benefit Analysis; Famciclovir; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence | 1997 |
Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment.
Topics: Amino Acid Substitution; DNA Primers; DNA-Directed DNA Polymerase; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Point Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors | 1998 |
Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group.
Topics: Amino Acid Sequence; Amino Acid Substitution; Drug Resistance, Microbial; Genes, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors | 1998 |
Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy.
Topics: Adult; Amino Acid Sequence; Base Sequence; Drug Resistance, Microbial; Female; Genes, Viral; Genome, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Reverse Transcriptase Inhibitors; Time Factors | 1998 |
Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation.
Topics: Acute Disease; Bilirubin; DNA, Viral; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Transaminases | 1998 |
Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Fatal Outcome; Hepatitis B; Humans; Lamivudine; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Recurrence | 1998 |
Efficacy of lamivudine re-treatment in a patient with hepatitis B virus (HBV) recurrence after liver transplantation and HBV-DNA breakthrough during the first treatment.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Retreatment | 1998 |
Treatment of fibrosing cholestatic hepatitis with lamivudine.
Topics: Adult; Cholestasis; DNA, Viral; Female; Fibrosis; Hepatitis B; Humans; Kidney Transplantation; Lamivudine; Reverse Transcriptase Inhibitors | 1998 |
Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation.
Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Health Care Costs; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence | 1998 |
Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation.
Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; Chronic Disease; DNA, Viral; Female; Hepatitis B; Humans; Lamivudine; Transplantation, Homologous | 1998 |
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.
Topics: Adult; Aged; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Postoperative Care; Postoperative Complications; Preoperative Care; Reverse Transcriptase Inhibitors; Secondary Prevention; Virus Replication | 1998 |
Lamivudine inhibits hepatitis B virus replication in kidney graft recipients.
Topics: Adult; Antiviral Agents; Drug Resistance, Microbial; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Postoperative Complications; Substance Withdrawal Syndrome; Virus Replication | 1998 |
Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; DNA, Viral; Drug Administration Schedule; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Homosexuality, Male; Humans; Lamivudine; Male; Middle Aged; Recurrence; Virus Activation | 1998 |
Advances in the treatment of viral hepatitis.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis C; Hepatitis, Viral, Human; Humans; Interferon-alpha; Lamivudine | 1998 |
Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Female; Glucocorticoids; Hepatitis B; Humans; Lamivudine; Lung Neoplasms; Prednisolone; Reverse Transcriptase Inhibitors; Treatment Failure; Treatment Outcome | 1998 |
[Successful treatment of an HB carrier developing severe hepatitis using lamivudine--case report].
Topics: Adult; Antiviral Agents; Carrier State; Hepatitis B; Humans; Lamivudine; Male | 1998 |
The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
Topics: 2-Aminopurine; Amino Acid Sequence; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance; Famciclovir; Hepatitis B; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Molecular Sequence Data; Mutation; Recurrence; Viral Proteins | 1998 |
Oral treatment for hepatitis B gets approval in the United States.
Topics: Administration, Oral; Antiviral Agents; Drug Approval; Hepatitis B; Humans; Lamivudine; United States; United States Food and Drug Administration | 1998 |
Lamivudine treatment for acute hepatitis B after liver transplantation.
Topics: Acute Disease; Adult; Antiviral Agents; Female; Hepatitis B; Humans; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Recurrence | 1998 |
The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Deoxycytidine; Disease Models, Animal; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney; Lamivudine; Liver; Liver Transplantation; Mice; Mice, Inbred NOD; Mice, SCID; Polymerase Chain Reaction; RNA, Messenger; Serum Albumin; Viremia | 1999 |
Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.
Topics: Acute Disease; Antineoplastic Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Follicular; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation | 1999 |
[HIV, hepatitis, influenza: new antiviral agents].
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiviral Agents; Child; Clinical Trials as Topic; Dideoxynucleosides; Enzyme Inhibitors; Guanidines; Hepatitis B; Humans; Influenza, Human; Lamivudine; Neuraminidase; Pyrans; Reverse Transcriptase Inhibitors; Sialic Acids; Zanamivir | 1999 |
Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Drug Evaluation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Point Mutation; Recurrence; Virus Replication | 1999 |
Lamivudine is safe and effective in fulminant hepatitis B.
Topics: Acute Disease; Adult; Antineoplastic Agents; Hepatitis B; Humans; Lamivudine; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reverse Transcriptase Inhibitors | 1999 |
Hepatitis B virus variants with lamivudine-related mutations in the DNA polymerase and the 'a' epitope of the surface antigen are sensitive to ganciclovir.
Topics: Adult; Amino Acid Sequence; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Epitopes; Ganciclovir; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Male; Molecular Sequence Data; Mutation | 1999 |
Successful use of lamivudine for severe acute hepatitis B virus infection in a cardiac transplant recipient.
Topics: Acute Disease; Antiviral Agents; Heart Transplantation; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors | 1999 |
Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha.
Topics: Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Polyarteritis Nodosa | 1999 |
Food and Drug Administration approves lamivudine for hepatitis B.
Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration | 1999 |
Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis?
Topics: Adolescent; Adult; Asian People; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis B e Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppression Therapy; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Methylprednisolone; Middle Aged; Recurrence; Reverse Transcriptase Inhibitors; Survival Rate | 1999 |
Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
Topics: 2-Aminopurine; Adult; Amino Acid Substitution; Antiviral Agents; DNA Primers; DNA-Directed DNA Polymerase; Famciclovir; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Methionine; Middle Aged; Point Mutation; Polymerase Chain Reaction; Prodrugs; Recurrence; Risk Factors; Valine | 1999 |
Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine.
Topics: Amino Acid Sequence; Animals; Antiviral Agents; Cells, Cultured; Drug Resistance, Microbial; Genotype; Hepatitis B; Hepatitis B Virus, Woodchuck; Humans; Lamivudine; Marmota; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Reverse Transcriptase Inhibitors; Sequence Homology, Amino Acid | 1999 |
Association of lamivudine resistance in recurrent hepatitis B after liver transplantation with advanced hepatic fibrosis.
Topics: Adult; Anti-HIV Agents; DNA, Viral; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence; Treatment Outcome | 1999 |
Human immunodeficiency virus and hepatitis B virus co-infection in two siblings: viral loads markedly reduced by triple-therapy including lamivudine.
Topics: Anti-HIV Agents; Child, Preschool; Comorbidity; DNA, Viral; Drug Therapy, Combination; Hepatitis B; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load | 1999 |
Is nucleoside analogue monotherapy sufficient for treatment of HBV infection? Lessons from HIV.
Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Deoxyguanosine; Famciclovir; Hepatitis B; HIV Infections; Humans; Lamivudine | 1999 |
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Mutation | 1999 |
European CPMP gives positive opinion on lamivudine for chronic hepatitis B.
Topics: Chronic Disease; Clinical Trials, Phase II as Topic; DNA, Viral; Drug Approval; European Union; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors | 1999 |
Lamivudine therapy of hepatitis B virus-related liver disease: cirrhosis, posttransplantation recurrence, and de novo infection.
Topics: Adult; Aged; Female; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors | 1999 |
Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
Topics: Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Prospective Studies; Reverse Transcriptase Inhibitors; Tissue Donors; Transplantation, Homologous | 1999 |
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients.
Topics: Adult; Amino Acid Sequence; Anti-HIV Agents; Cohort Studies; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Polymerase Chain Reaction | 1999 |
Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation.
Topics: Administration, Oral; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Reverse Transcriptase Inhibitors; Time Factors | 1999 |
Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immu
Topics: Adult; Case-Control Studies; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Reverse Transcriptase Inhibitors; Viral Core Proteins | 1999 |
Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients.
Topics: Adult; Alanine Transaminase; Amino Acid Motifs; Amino Acid Sequence; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Immunocompetence; Lamivudine; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA | 2000 |
[Treatment of liver cirrhosis due to hepatitis B with lamivudine].
Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors | 1999 |
Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants.
Topics: Antiviral Agents; Base Sequence; DNA Primers; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Genes, Viral; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Time Factors; Virology | 1999 |
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient.
Topics: Adult; Antiviral Agents; Drug Resistance, Microbial; Female; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications | 2000 |
Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin.
Topics: Adenine; Adult; Antiviral Agents; Carrier State; DNA-Directed DNA Polymerase; Drug Resistance; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Kidney Transplantation; Lamivudine; Liver Failure; Liver Transplantation; Mutation; Organophosphonates | 1999 |
Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
Topics: Adult; Amino Acid Sequence; Antineoplastic Agents; Base Sequence; Breast Neoplasms; Carcinoma, Small Cell; DNA Mutational Analysis; DNA, Viral; Female; Germinoma; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Molecular Sequence Data; Mutation, Missense; Promoter Regions, Genetic; Reverse Transcriptase Inhibitors; Trans-Activators; Viral Regulatory and Accessory Proteins; Virus Activation | 2000 |
Successful treatment of hepatitis B-associated polyarteritis nodosa with a combination of lamivudine and conventional immunosuppressive therapy: a case report.
Topics: Hepatitis B; Humans; Immunosuppression Therapy; Lamivudine; Male; Polyarteritis Nodosa | 2000 |
Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
Topics: 2-Aminopurine; Antiviral Agents; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Mutation; Reverse Transcriptase Inhibitors; Viral Load | 2000 |
[Emergence of resistant hepatitis B virus strains during long-term lamivudine therapy in human immunodeficiency virus co-infected patients].
Topics: Adult; Anti-HIV Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Middle Aged; Prospective Studies; Time Factors | 2000 |
Analysis of hepatitis B virus quasispecies changes during emergence and reversion of lamivudine resistance in liver transplantation.
Topics: Antiviral Agents; DNA, Viral; Drug Resistance; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Mutation | 1999 |
Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hepatitis B; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation | 2000 |
Lamivudine for the prevention of hepatitis B virus reactivation during autologous stem cell transplantation. A case report.
Topics: Adult; Antiviral Agents; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Transplantation, Autologous; Virus Activation | 2000 |
Lamivudine for hepatitis B in liver transplantation: a single-center experience.
Topics: Adult; Aged; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Postoperative Care; Postoperative Complications; Preoperative Care; Recurrence; Reverse Transcriptase Inhibitors; Virus Replication | 2000 |
Additional interferon alpha for lamivudine resistant hepatitis B infection after liver transplantation: a preliminary report.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Drug Resistance; Drug Therapy, Combination; Hepatitis B; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Retrospective Studies; Reverse Transcriptase Inhibitors | 2000 |
HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients.
Topics: Adult; Aged; Amino Acid Sequence; Base Sequence; DNA, Viral; Drug Resistance, Microbial; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Middle Aged; Renal Dialysis; Reverse Transcriptase Inhibitors; Viremia | 2000 |
Assessing virologic efficacy of combination lamivudine and low-dose hepatitis B immune globulin posttransplantation with the ultrasensitive digene hybrid capture II assay.
Topics: DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Postoperative Complications | 2000 |
Extension of transplantation free time by lamivudine in patients with hepatitis B-induced decompensated cirrhosis.
Topics: Adult; Hepatitis B; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Preoperative Care; Reverse Transcriptase Inhibitors; Time Factors; Treatment Outcome; Virus Replication | 2000 |
Evolution of lamivudine-resistant hepatitis B virus and HIV-1 in co-infected individuals: an analysis of the CAESAR study. CAESAR co-ordinating committee.
Topics: CD4 Lymphocyte Count; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Retrospective Studies; Reverse Transcriptase Inhibitors; Viral Load | 2000 |
Organ transplantation and discrimination. Patients with hepatitis B should not be given low priority.
Topics: Antiviral Agents; Contraindications; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Patient Selection; Refusal to Treat | 2000 |
Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.
Topics: Adult; Combined Modality Therapy; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Secondary Prevention | 2000 |
Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunoglobulins, Intravenous; Lamivudine; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Secondary Prevention | 2000 |
Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction; Reagent Kits, Diagnostic; Reproducibility of Results; Sensitivity and Specificity; Taq Polymerase | 2000 |
Lamivudine and hepatitis B: is the bloom already fading?
Topics: Adult; Hepatitis B; Humans; Lamivudine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors | 2000 |
Prevention of de novo hepatitis B infection after liver transplantation with allografts from hepatitis B core antibody positive donors.
Topics: Antiviral Agents; Disease Susceptibility; Graft Survival; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Probability; Survival Rate; Tissue Donors; Transplantation, Homologous | 2000 |
Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: long-term follow-up.
Topics: Biopsy; DNA, Viral; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Survival Rate | 2000 |
Genotypic succession of mutations of the hepatitis B virus polymerase associated with lamivudine resistance.
Topics: Adult; Antiviral Agents; Base Sequence; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Microbial; Female; Genotype; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Mutation; Transaminases | 2000 |
Fatal hepatitis B reinfection after orthotopic liver transplantation in an HBsAg negative patient following withdrawal of lamivudine.
Topics: Antiviral Agents; Fatal Outcome; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Middle Aged; Postoperative Period; Recurrence | 2000 |
Lamivudine in the treatment of acute hepatitis B.
Topics: Acute Disease; Aged; Female; Hepatitis B; Hepatitis B Antibodies; Humans; Lamivudine; Reverse Transcriptase Inhibitors | 2000 |
Continuous lamivudine treatment in an OLT patient despite the appearance of HBV resistant strain: longitudinal analysis.
Topics: Antiviral Agents; Hepatitis B; Humans; Immunity, Innate; Lamivudine; Liver Transplantation; Longitudinal Studies; Male; Middle Aged | 2000 |
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.
Topics: Adult; Age Factors; Alanine Transaminase; Female; Hepatitis Antibodies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Lamivudine; Liver Neoplasms; Male; Middle Aged; Neoplasms; Prospective Studies; Risk Factors; Sex Factors; Virus Activation | 2000 |
Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine.
Topics: Antiviral Agents; Base Sequence; Biopsy; DNA Primers; DNA, Viral; Drug Therapy, Combination; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Liver Function Tests; Male; Middle Aged; Molecular Sequence Data; Polyarteritis Nodosa; Prednisolone | 2000 |
[Prevention of hepatitis B flare-up using lamivudine in a patient with non-Hodgkin's lymphoma after allogeneic bone marrow transplantation].
Topics: Adult; Bone Marrow Transplantation; Hepatitis B; Humans; Lamivudine; Lymphoma, B-Cell; Male; Postoperative Period; Reverse Transcriptase Inhibitors; Transplantation, Homologous | 2000 |
An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
Topics: Adolescent; Adult; Aged; Cost-Benefit Analysis; DNA, Viral; Drug Therapy, Combination; Female; Graft Survival; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome; Virus Replication | 2000 |
Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amino Acid Sequence; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Molecular Sequence Data; Reverse Transcriptase Inhibitors; Virus Activation; Virus Replication | 2001 |
Managing hepatitis B reactivation in renal transplant recipients: a 12-year review with emphasis on early detection and early use of lamivudine.
Topics: Adult; Antiviral Agents; Carrier State; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Function Tests; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Analysis; Treatment Outcome | 2000 |
Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation.
Topics: 2-Aminopurine; Antiviral Agents; Famciclovir; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Postoperative Complications; Prodrugs; Prognosis; Recurrence; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome | 2000 |
Liver transplantation for patients with hepatitis B: prevention of hepatitis B recurrence by intravenous antihepatitis B immunoglobulin and lamivudine.
Topics: Adult; Antiviral Agents; Cyclosporine; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Transplantation; Male; Middle Aged; Monitoring, Physiologic; Recurrence; Time Factors; Treatment Outcome | 2000 |
Prophylaxis against hepatitis B recurrence following liver transplantation in HBs Ag(+) patients.
Topics: Adult; Antiviral Agents; Cadaver; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Rate; Tissue Donors | 2000 |
Lamivudine: a new strategy to suppress HBV replication in the pretransplant setting.
Topics: Adult; Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Middle Aged; Premedication; Recurrence; Virus Replication | 2000 |
Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Combined Modality Therapy; DNA, Viral; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Leukemia, Myeloid, Acute; Liver Failure; Male; Reverse Transcriptase Inhibitors | 2000 |
Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Fibrosis; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Complications | 2001 |
Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis.
Topics: Adolescent; Adult; Female; Graft Rejection; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hong Kong; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome | 2001 |
Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Adult; Aged; Antiviral Agents; DNA, Viral; Famciclovir; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Time Factors | 2001 |
Hepatitis B virus transgenic mice for the model of anti-hepatitis B virus drug study.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Female; Hepatitis B; Hepatitis B virus; Lamivudine; Male; Mice; Mice, Transgenic; Thymosin; Vaccines, DNA | 2001 |
The real danger of lamivudine-resistant hepatitis B virus infection in the immunocompromised host.
Topics: Antiviral Agents; Chronic Disease; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Immunocompromised Host; Lamivudine; Liver Cirrhosis; Liver Transplantation; Postoperative Complications | 2001 |
[Current treatment of hepatitis B].
Topics: 2-Aminopurine; Adenine; Anti-Inflammatory Agents; Antiviral Agents; DNA Replication; Famciclovir; Forecasting; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Prednisone; Prognosis; Reverse Transcriptase Inhibitors; Time Factors; Virus Replication | 2001 |
[Laboratory diagnosis of hepatitis B].
Topics: 2-Aminopurine; Acute Disease; Antiviral Agents; DNA Replication; DNA, Viral; Drug Resistance; Famciclovir; Genetic Variation; Genotype; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunohistochemistry; Lamivudine; Virus Replication | 2001 |
Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler.
Topics: Antiviral Agents; Drug Resistance, Microbial; Fluorescence; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Mutation; Polymerase Chain Reaction | 2001 |
[Management of pregnant women infected with HIV at Bichat Hospital between 1990 and 1998: analysis of 202 pregnancies].
Topics: Africa South of the Sahara; Antiviral Agents; Cesarean Section; Female; France; Hepatitis B; Hepatitis C; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Papillomaviridae; Papillomavirus Infections; Pregnancy; Pregnancy Complications, Infectious; Risk Factors; Sexually Transmitted Diseases; Zidovudine | 2001 |
A possible role for lamivudine as prophylaxis against hepatitis B reactivation in carriers of hepatitis B who undergo chemotherapy and autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Agents; DNA, Viral; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Reverse Transcriptase Inhibitors; Transplantation, Autologous; Virus Activation | 2001 |
Successful orthotopic liver transplantation.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Mutation; Recurrence | 2001 |
Lamivudine and glycyrrhizin for treatment of chemotherapy-induced hepatitis B virus (HBV) hepatitis in a chronic HBV carrier with non-Hodgkin lymphoma.
Topics: Anti-HIV Agents; Antineoplastic Agents; Chronic Disease; DNA, Viral; Drug Therapy, Combination; Glycyrrhizic Acid; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Testicular Neoplasms; Virus Activation | 2001 |
Lamivudine useful against hepatitis B-HIV co-infection.
Topics: Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Virus Replication; Zalcitabine; Zidovudine | 1995 |
A closer look at 3TC. Interview by Mark Mascolini.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Zalcitabine; Zidovudine | 1995 |
3TC recommended for hepatitis B.
Topics: Drug Approval; Hepatitis B; Lamivudine; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration | 1999 |
Opportunistic infections update.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Hepatitis B; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Lamivudine; Liver; Ribavirin | 1998 |
Lamivudine-resistant hepatitis B detected in HIV-infected patients.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Hepatitis B; HIV Infections; Humans; Lamivudine; Mutation; Polymerase Chain Reaction | 1999 |
Lamivudine in the treatment of polyarteritis nodosa associated with acute hepatitis B.
Topics: Acute Disease; Adult; Antiviral Agents; Combined Modality Therapy; Female; Glucocorticoids; Hepatitis B; Humans; Lamivudine; Plasmapheresis; Polyarteritis Nodosa; Prednisone | 2001 |
Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B.
Topics: Antineoplastic Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Virus Activation | 2001 |
Evans syndrome related to hepatitis B virus infection: a case that responded only to lamivudine therapy.
Topics: Anemia, Hemolytic; Child, Preschool; Hepatitis B; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors; Syndrome; Thrombocytopenia | 2001 |
Orthotopic liver transplantation in patients with hepatitis B-related liver disease.
Topics: Adolescent; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Follow-Up Studies; Graft Rejection; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Liver Transplantation; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Rate; Time Factors | 2001 |
Severe clinical course of de novo hepatitis B infection after liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Fatal Outcome; Female; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Middle Aged; Postoperative Complications; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome | 2001 |
Liver transplantation in patients with hepatitis B virus infection: outcome in Asian versus white patients.
Topics: Antiviral Agents; Asia; Asian People; Drug Resistance; Female; Hepatitis B; Hepatitis C; Hepatitis D; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome; White People | 2001 |
[Epidemiology of HBV infections and possibilities for therapeutic actions in children and adolescents with end-stage renal failure treated with dialysis].
Topics: Adolescent; Adult; Child; Child, Preschool; Comorbidity; Female; Hepatitis B; Hepatitis B Vaccines; Hepatitis C; Humans; Incidence; Interferon-alpha; Kidney Failure, Chronic; Lamivudine; Male; Poland; Renal Dialysis | 2001 |
Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
Topics: Adult; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Transplantation; Middle Aged; Tissue Donors | 2001 |
Limitations and improvements of the quantiplex branched-DNA assay in Hepatitis B virus-infected patients receiving lamivudine.
Topics: Branched DNA Signal Amplification Assay; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity | 2001 |
Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.
Topics: Adolescent; Adult; Amino Acid Motifs; Antiviral Agents; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Mutation; Recurrence; Risk Factors; Time Factors | 2001 |
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.
Topics: Adult; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Humans; Immunization, Passive; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence | 2001 |
Hepatitis B, lamivudine, and HIV.
Topics: Anti-HIV Agents; Drug Resistance, Microbial; Hepatitis B; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors | 2001 |
Hepatitis B virus subtypes and lamivudine resistance.
Topics: Carrier State; DNA, Viral; Drug Resistance; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Risk Factors; Sequence Alignment; Serotyping | 2001 |
Serum zinc status in chronic hepatitis B and its relationship to liver histology and treatment results.
Topics: Alanine Transaminase; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Infant, Newborn; Interferon-alpha; Lamivudine; Liver; Reverse Transcriptase Inhibitors; Zinc | 2001 |
Much remains to be solved in lamivudine treatment for HBV-associated liver diseases.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis B; Hepatitis Viruses; Humans; Lamivudine; Liver Neoplasms; Reverse Transcriptase Inhibitors; Treatment Outcome | 2001 |
Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort.
Topics: Adolescent; Adult; Aged; Cohort Studies; DNA, Viral; Drug Resistance; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Reverse Transcriptase Inhibitors; Severity of Illness Index; Survival Analysis; Virus Replication; Waiting Lists | 2001 |
T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.
Topics: Animals; Antigens, Viral; Chronic Disease; Hepatitis B; Hepatitis B Virus, Woodchuck; Immunotherapy, Active; Lamivudine; Liver; Marmota; Reverse Transcriptase Inhibitors; T-Lymphocytes, Helper-Inducer; Viral Load; Viremia | 2001 |
Emergence of YMDD motif mutant of hepatitis B virus during short-term lamivudine therapy in South Korea.
Topics: Adult; DNA, Viral; Drug Administration Schedule; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; Humans; Korea; Lamivudine; Male; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Reverse Transcriptase Inhibitors; Sequence Analysis, DNA; Time Factors | 2001 |
Outcome of liver transplantation for hepatitis B: report of a single center's experience.
Topics: Adult; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Longitudinal Studies; Male; Retrospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention; Treatment Outcome | 2001 |
[HIV-HBV coinfection and the liver].
Topics: Biopsy; Didanosine; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Lamivudine; Liver Cirrhosis; Male; Middle Aged; Ritonavir; Saquinavir; Stavudine | 2001 |
Life-threatening complications of hepatitis B virus-related polyarteritis nodosa developing despite interferon-alpha2b therapy: successful treatment with a combination of interferon, lamivudine, plasma exchanges and steroids.
Topics: Adult; Combined Modality Therapy; Critical Illness; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Interferon alpha-2; Interferon-alpha; Lamivudine; Plasma Exchange; Polyarteritis Nodosa; Recombinant Proteins; Risk Assessment; Steroids; Treatment Outcome | 2001 |
Real-time PCR for detection and quantitation of hepatitis B virus DNA.
Topics: Acute Disease; Antiviral Agents; Computers; DNA, Viral; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Polymerase Chain Reaction; Predictive Value of Tests; Sensitivity and Specificity | 2001 |
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study.
Topics: Adenine; Adult; Alanine Transaminase; Anti-HIV Agents; Antiviral Agents; DNA, Viral; Drug Administration Schedule; Drug Resistance, Microbial; Female; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Organophosphonates; Pilot Projects; Viral Load | 2001 |
Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part 2.
Topics: Amantadine; Antiviral Agents; Hepatitis B; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Lamivudine; Risk Factors | 2001 |
Living-related partial liver transplantation for decompensated hepatitis B without reactivation of hepatitis B in the following 30 months.
Topics: Adult; Antibodies; Female; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Living Donors; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Secondary Prevention | 2001 |
HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy.
Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis B; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Lamivudine | 2001 |
Hepatitis B surface antigen-positive organ transplantation recipients: can lamivudine alter their fate?
Topics: Carrier State; Disease Progression; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Liver Function Tests; Organ Transplantation; Postoperative Complications; Survival Rate; Transplantation Immunology; Treatment Outcome; Virus Activation | 2001 |
Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience.
Topics: Adult; Carrier State; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Function Tests; Male; Middle Aged; Organ Transplantation; Postoperative Complications; Retrospective Studies; Survival Rate; Transplantation Immunology; Virus Activation | 2001 |
Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Protein Precursors; Virion; Virus Replication | 2001 |
Acute hepatitis B by sexual transmission after interruption of lamivudine-containing antiretroviral regimen.
Topics: Acute Disease; Adult; Anti-HIV Agents; Coitus; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; HIV Infections; Humans; Lamivudine; Male; Pregnancy; Reverse Transcriptase Inhibitors; Sexually Transmitted Diseases, Viral | 2001 |
Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed.
Topics: 2-Aminopurine; Antiviral Agents; Computer Systems; DNA, Viral; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Time Factors; Viral Load | 2001 |
Preoperative antiviral treatment and postoperative prophylaxis in HBV-DNA positive patients undergoing liver transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; DNA, Viral; Famciclovir; Female; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies | 2001 |
Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1.
Topics: 2-Aminopurine; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Famciclovir; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Mutation; Treatment Failure | 2001 |
Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
Topics: Drug Resistance, Microbial; Female; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver; Liver Transplantation; Male; Reoperation; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome | 2001 |
Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hodgkin Disease; Humans; Lamivudine; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Pilot Projects; Prednisone; Vidarabine; Vincristine; Virus Activation | 2001 |
Lamivudine treatment failure in preventing fatal outcome of de novo severe acute hepatitis B in patients with haematological diseases.
Topics: Acute Disease; Adult; Aged; Child; Cross Infection; Disease Outbreaks; Fatal Outcome; Female; Hematologic Diseases; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; Treatment Failure | 2001 |
Primary infection with a lamivudine-resistant hepatitis B virus.
Topics: Adult; Anti-HIV Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B virus; HIV Infections; HIV-1; Humans; Lamivudine; Male; Reverse Transcriptase Inhibitors | 2002 |
Prophylaxis of hepatitis B reactivation using lamivudine in a patient receiving rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Rituximab; Treatment Outcome; Virus Activation | 2001 |
Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient.
Topics: Adult; Antiviral Agents; Ganciclovir; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Male; Treatment Outcome | 2001 |
Prevention and treatment of hepatitis B relapse after liver transplantation.
Topics: Adult; Carcinoma, Hepatocellular; Female; Hepatitis B; Humans; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence | 2001 |
Vaccination for hepatitis B after transplantation: a realistic goal?
Topics: DNA, Viral; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation | 2002 |
[Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reverse Transcriptase Inhibitors; Vincristine; Virus Activation | 2001 |
Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant.
Topics: 2-Aminopurine; Adult; DNA, Viral; Drug Resistance, Microbial; Famciclovir; Female; Hepatitis B; Hepatitis B virus; Humans; Kidney Failure, Chronic; Kidney Transplantation; Lamivudine; Mutation; Postoperative Complications | 2002 |
Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV.
Topics: Anti-HIV Agents; Drug Resistance, Viral; Fatal Outcome; Hepatitis B; Hepatitis B virus; HIV Infections; Humans; Lamivudine; Liver Failure; Male; Middle Aged; Mutation | 2002 |
Persistence of YMDD variants after withdrawal of Lamivudine.
Topics: DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Middle Aged; Reverse Transcriptase Inhibitors | 2002 |
Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation.
Topics: Amino Acid Sequence; Carcinoma, Hepatocellular; DNA, Viral; Drug Resistance, Viral; Gene Products, pol; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Neoplasms; Liver Transplantation; Molecular Sequence Data; Reverse Transcriptase Inhibitors; RNA, Messenger; RNA, Viral; Transfection; Tumor Cells, Cultured; Virus Replication | 2002 |
Lamivudine therapy for acute hepatitis B infection following peripheral blood stem cell transplantation.
Topics: Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors | 2002 |
Lamivudine therapy for hepatitis B in renal transplantation.
Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Graft Rejection; Hepatitis B; Hepatitis B virus; Humans; Kidney Transplantation; Lamivudine; Male; Prospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Virus Replication | 2002 |
[Orthotopic liver transplantation for end-stage liver diseases in 71 cases].
Topics: Adolescent; Adult; Biliary Tract Diseases; Child; Female; Follow-Up Studies; Hepatitis B; Humans; Lamivudine; Liver Diseases; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Survival Rate; Vascular Diseases | 2002 |
Successful allogeneic bone marrow transplantation from an HBV-positive donor into an HBV-positive recipient using lamivudine.
Topics: Adult; Anemia, Aplastic; Antiviral Agents; Bone Marrow Transplantation; Disease-Free Survival; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Liver Diseases; Tissue Donors; Transplantation, Homologous; Virus Activation | 2002 |
Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?
Topics: Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Predictive Value of Tests; Reverse Transcriptase Inhibitors | 2002 |
[Hepatitis B virus infection: diagnosis, clinical sequelae, therapy and prevention].
Topics: Adolescent; Adult; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B Vaccines; Humans; Infant, Newborn; Interferons; Lamivudine; Liver Function Tests; Male; Pregnancy; Prognosis | 2002 |
Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation.
Topics: Adult; Antiviral Agents; Bone Marrow Transplantation; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Humans; Immunosuppression Therapy; Lamivudine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Recurrence; Time Factors; Transplantation, Homologous | 2002 |
Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.
Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Vaccines; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Polymerase Chain Reaction; Tissue Donors | 2001 |
Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
Topics: 2-Aminopurine; Alanine Transaminase; Antiviral Agents; Child, Preschool; DNA, Viral; Drug Resistance, Viral; Famciclovir; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Male | 2002 |
[Toward the expected development of therapeutic combinations in hepatitis B?].
Topics: Drug Therapy, Combination; Hepatitis B; Humans; Interferon-alpha; Lamivudine | 2002 |
Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
Topics: Adult; Aged; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Humans; Immunization, Passive; Immunoglobulins; Incidence; Lamivudine; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tissue Donors; Transplantation, Homologous | 2002 |
Four cases of hepatitis B virus-related fibrosing cholestatic hepatitis treated with lamivudine.
Topics: Adult; Biopsy; Cholestasis; Fibrosis; Hepatitis B; Humans; Lamivudine; Liver; Male; Middle Aged; Reverse Transcriptase Inhibitors | 2002 |
Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide, prednisolone and lamivudine following emergency surgery.
Topics: Adult; Anti-Inflammatory Agents; Cyclophosphamide; Gastrointestinal Hemorrhage; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunosuppressive Agents; Lamivudine; Male; Polyarteritis Nodosa; Prednisolone; Pulse Therapy, Drug; Reverse Transcriptase Inhibitors | 2002 |
Vertical transmission of hepatitis B virus despite maternal lamivudine therapy.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Base Sequence; DNA, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Point Mutation; Pregnancy; Pregnancy Complications, Infectious; Sequence Analysis, DNA | 2002 |
Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: experience of 2 cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carrier State; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Reverse Transcriptase Inhibitors; Secondary Prevention; Time Factors; Virus Activation | 2002 |
Beneficial effect of lamivudine for hepatitis B transplant recipients.
Topics: Antiviral Agents; Hepatitis B; Humans; Lamivudine; Liver Transplantation; Waiting Lists | 2002 |
Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment?
Topics: Antineoplastic Agents; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Virus Activation | 2002 |
Safe use of livers from donors with positive hepatitis B core antibody.
Topics: Adolescent; Adult; Aged; Female; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Tissue Donors | 2002 |
Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis.
Topics: Adult; Aged; Alkaline Phosphatase; Antiviral Agents; Disease-Free Survival; Female; Hepatitis B; Hepatitis B Core Antigens; Humans; Immunoglobulins; Lamivudine; Liver; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 2002 |
Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus.
Topics: Adenine; Administration, Oral; Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Dose-Response Relationship, Drug; Hepatitis B; Hepatitis B virus; Lamivudine; Liver; Mice; Mice, Transgenic; Organophosphonates; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load | 2002 |
Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy.
Topics: Adult; Alanine Transaminase; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chemical and Drug Induced Liver Injury; Cohort Studies; Female; Hepatitis B; Hepatitis C; HIV Infections; HIV-1; Humans; Incidence; Lamivudine; Liver Function Tests; Male; Nevirapine; Proportional Hazards Models; Retrospective Studies; Reverse Transcriptase Inhibitors; Risk Factors; Ritonavir; Sex Factors; Transaminases | 2002 |
Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation.
Topics: 2-Aminopurine; Adult; Antiviral Agents; Famciclovir; Female; Hematopoietic Stem Cell Transplantation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Transplantation, Autologous; Transplantation, Homologous; Virus Activation | 2002 |
[Lamivudine treatment consensus from relative experts].
Topics: Alanine Transaminase; Antibodies, Viral; Antiviral Agents; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lamivudine; Polymerase Chain Reaction | 2002 |
Biochemical pharmacology of (+)- and (-)-2',3'-dideoxy-3'-thiacytidine as anti-hepatitis B virus agents.
Topics: Antiviral Agents; Base Sequence; Biological Transport; Cells, Cultured; Deoxycytidine Kinase; Hepatitis B; Hepatitis B virus; Humans; In Vitro Techniques; Lamivudine; Mitochondria; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; Oligodeoxyribonucleotides; Phosphorylation; Zalcitabine | 1992 |